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SUMMARY
In order to examine the physiology of verotoxin (VT) production in vitro, it was 
necessary to develop an assay to enable specific measurement of VTl and VT2 
expression. Initial efforts focussed on quantifying VTl and VT2 messenger RNA 
synthesis. RNA extraction and electrophoresis was consistently achieved, however, 
subsequent probing of Northern filters was not successful. A gene fusion between the 
slt-ll operon and the transposon vector TnphoA, such that expression of the phoA gene 
was brought under the control of the 5/MI promoter, was then developed. The presence 
and site of insertion of TnphoA within the s/MI operon was confirmed by restriction and 
sequence analysis, and a single copy fusion derivative within the VT2-producing E. coli 
strain E32511 was then obtained by exchange recombination. Use of the resulting 
single copy fusion derivative (E32511 SLF22/1) and a plasmid encoded slt-\. fïnphoA 
fusion (pSC105) demonstrated significant differences in the synthesis, secretion and 
localisation abilities of VTl and VT2 during growth under aerobic, anaerobic and iron 
limiting conditions. These characteristics could have important implications on the 
relative abilities of the two toxins to cause disease in vivo.
XXIII

1 Introduction
1.1 General introduction and historical background
Verocytotoxin producing Escherichia coli (VTEC) were first recognised as etiological 
agents of diarrhoea by Konowalchuk et al. in 1977. While investigating the usefulness of 
Vero (African green monkey kidney) cells for detecting cytotonic E. coli heat labile 
enterotoxin (LT), they found a cytotoxin in the culture filtrates of a number of E. coli 
strains. This toxin, designated verocytotoxin (VT) was cytotoxic for Vero but not for YI 
(mouse adrenal) or CHO (Chinese hamster ovary) cells. In addition it was labile to 
heat and not neutralised by antisera to LT. Shortly after it became apparent, by 
neutralisation tests, that there was more than one type of cytotoxin affecting Vero cells 
(Konowalchuk et al., 1978). Subsequently it was shown that the genes encoding toxin 
production were bacteriophage mediated (Scotland et al., 1983a; Williams Smith et aL, 
1983), and in earlier work by O'Brien et aL (1982) that the VT from Konowalchuk's 
reference strain, H30, was very closely related both biologically and immunologically to 
shiga toxin (ShT) produced by strains of Shigella dysenteriae type 1.
Since the initial description of VT by Konowalchuk and his colleagues, numerous 
studies have demonstrated the pathogenicity of VTEC. Both Konowalchuk et aL (1977) 
and Scotland et aL (1980) documented strains producing VT (VT+ ) among traditional 
serogroups of enteropathogenic E. coli (EPEC). Wade et aL (1979) in England first 
noted the presence of cytotoxin-producing E. coli 026 strains, (especially flagellar type 
H ll), in association with bloody diarrhoea. This finding was supported by reports from 
Scotland et al. (1979) in the UK and Wilson and Bettleheim (1980) in New Zealand. 
However, the major breakthroughs occurred in 1983 with the publication of studies that 
linked strains of E. coli producing high levels of VT, to two life threatening conditions of 
previously unknown cause, haemorrhagic colitis (HC), (Riley et a l, 1983; Johnson et al., 
1983) and the haemolytic uraemic syndrome (HUS), (Karmali et al., 1983). Riley et al.
l
(1983) and Johnson et a l  (1983) both associated the outbreaks and sporadic cases of 
HC they documented with E. coli 0157:H7, a serotype not previously recognised as a 
cause of diarrhoeal disease in humans. The discovery that VTEC are epidemiologically 
associated with HC and HUS generated tremendous interest in these organisms and 
their toxins. A  major area of multidisciplinary research interest in VTEC has resulted 
in significant progress in understanding the clinical and epidemiological features, 
natural history, laboratory diagnosis and pathogenesis of VTEC infections in humans 
and other animals, as well as fundamental knowledge of the structure-function 
relationship and molecular biology of VTs.
1.2 Nomenclature
Nomenclature for this group of cytotoxins remains confusing. While they were initially 
called verotoxins (VTs), the discovery by O'Brien et a l (1982) that certain VTs were 
neutralised by polyclonal antisera raised against ShT from S. dysenteriae type 1 led to 
the development of two different nomenclatures now used for the E. coli Vero cell 
cytotoxins, V Ts and shiga-like toxins (SLTs). The terms VT and SLT are synonymous 
and it would be far better and less confusing if a uniform nomenclature were adopted. 
Until recently only two distinct VTs were recognised, verotoxin 1 (VT1) and verotoxin 2 
(VT2). A  third VT was subsequently found in pigs with oedema disease (VTe). The 
recent identification of variants of both VT2 (VHv's), (Ito et al., 1990; Schmitt et al., 
1991) and VTe (VTeva), (Gannon et al., 1990) has only added to this confusion. The 
VT designation seems better suited to address the present and possible future variants, 
because it places VTe into a separate group. This would avoid confusion when 
referring to the VT2 variants and the VTe variants. The abbreviations, shown in table 
1.1, will therefore be utilised throughout this thesis.
Table 1.1 The family o f Verocytotoxins
Toxin Operon Reference
Class I 
VT1 sit-1 O'Brien & LaVeck (1983); Newland et al. (1985); 
Huang et al. (1986); Jackson et al. (1987a); 
Calderwood et al. (1987); De Grandis et al. (1987); 
Noda et al. (1987); Petric et al. (1987b).
Class II 
VT2 i/r-II Jackson et al. (1987b); Newland et al. (1987); 
Yutsudo et al. (1987); Downes et al. (1988); 
Dickie et al. (1989).
VTe sit-IIv Gyles et al. (1988); Weinstein et al. (1988a); 
Macleod & Gyles ( 1990).
VT2 variants
VT2va
VT2vb
VT2vc
vtx 2ha 
vtx 2hb 
j/f-IIc
Oku et al. (1989); Ito et al. (1990). 
Oku et al. (1989); Ito et al. (1990). 
Schmitt et al. (1991).
VTe variants
VTe va j/MIva Gannon et al. (1990).
13 Characterisation, structure and function of VTs
1.3.1 VT classes I and II • biological activity and immunological relationships
Konowalchuk et al. (1977, 1978) first described at least three distinct E. coli VTs, two of 
them being from human strains and a third from a porcine strain. Emerging evidence 
has since indicated that V Ts are a family of structurally and functionally related 
cytotoxins. They can be divided into classes I (VT1) and II (VT2, VTe, VT2 and VTe 
variants) and can be distinguished serologically or on the basis of gene sequence or host 
specificity. The members o f the two classes discovered to date are shown in table 1.1.
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Class I s The first E. coli cytotoxin to be discovered, VT1, from strain H30 
(Konowalchuk et al., 1977, 1978), was shown to be immunologically very similar to ShT 
of S. dysenteriae type 1 (O'Brien & LaVeck, 1982). The isoelectric point (pi) (table 1.2), 
subunit structure and biological activities were also similar with both toxins showing 
complete cross-neutralisation (O'Brien & LaVeck, 1983).
Class II : Class II encompasses an ever growing family of closely related VTs. VT2 
possesses the same biological activities as VT1, both are toxic to the same cell lines, 
cause paralysis and death in mice and fluid accumulation in rabbit ileal loops 
(Strockbine et al., 1986). VT2 however, is antigenically distinct. It is not neutralised by 
polyclonal antiserum to ShT and VT1 and conversely, VT2 neutralising antibodies do 
not neutralise ShT or VT1 (Strockbine et al., 1988). VTe, also known as "oedema 
disease principle” or EDP, (Lingwood & Thompson, 1987), has been found in pigs with 
oedema disease (ED). ED attacks thriving pigs about one week after weaning, the 
major feature being progressive incoordination leading to partial or complete paralysis 
and death. The disease is associated with bowel colonisation by specific E. coli 
serogroups, notably, 0138, 0139 and 0141 which produce VTe. VTe is antigenically 
similar to VT2 being neutralisable with antiserum to VT2 but not to VT1 (Marques et 
al., 1987). It is more heat-labile however, than VT1 and VT2. Also, whereas VT1 and 
VT2 possess the same biological activities, VTe is only cytotoxic to Vero cells and is 
non-cytotoxic to HeLa cells (Marques et al., 1987). This difference in biological activity 
on tissue culture cells has been one of the criteria commonly used to differentiate 
between VT2 and VTe in vitro. More recently however, toxins displaying similar 
biological properties to VTe have been associated with human disease as well (section 
1.4.3.4), (Oku et al., 1989; Gannon et al., 1990; Schmitt et al., 1991). These toxins can be 
distinguished on the basis of gene sequence and have been termed the VT2 (Ito et al., 
1990; Schmitt et al., 1991) and VTe variants (Gannon et al. 1990).
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Table U  Comparison o f the processed ShT/VTl, VT2 and VTe subunits
Subunit Base Pairs Amino acids Molecular weight pi
A
ShT/VTla 879 296
VT2 888 293
VTe 891 297
£
ShT/VTl 207 69
VT2 210 70
VTe 204 68
32,225/32,211 11.1
33,135 9.8
33,050 8.7
7,690 5.9
7,817 5.4
7,565 10.2
The ShT and VT1 A subunits have one amino acid difference, a threonine at 
position 45 in ShT and a serine at the corresponding position in VT1. Diis is 
reflected by a slight difference in the molecular weights of the A subunits.
13.2 Subunit structure
VTs are subunit toxins which like ShT holotoxin (Donohue-Rolfe et al., 1984), consist 
of one enzymatically active A subunit non-covalently linked to multiple copies, most 
likely five, of a B subunit (O'Brien & Holmes, 1987). A comparison of the processed 
subunits are shown in table 1.2. VT1 is almost identical to ShT (Noda et al., 1987) and 
the holotoxin is thought to have a relative molecular weight (MW) of 70 Kilodaltons 
(KDa). Estimated MW for the toxins have varied however. MW determined by gel 
flltration chromatography have been reported of 32 and 45 KDa (O'Brien & LaVeck, 
1983), 25 to 39 KDa (O'Brien & LaVeck, 1983; Petrie et al., 1987b) and 42 KDa (Head 
et al., 1988a) for ShT, VT1 and VT2 holotoxins respectively. The MW for VTe 
holotoxin was also much lower (40 to 43 KDa) than that expected from a l-A-subunit-5- 
B-subunit toxin molecule (MW 70,984), (MacLeod et al., 1991). Binding of the toxin to
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the gel matrix could be an explanation for the MW values determined by gel filtration. 
Padhye et al. (1986) isolated a cytotoxin from E. coli 0157:H7 strain 932 which was not 
neutralisable with antisera to ShT, had a pi of 5.2, and therefore resembled VT2. This 
toxin differed from the class I and class II VTs however, in that it appeared to lack the 
characteristic A and B subunit structure and migrated instead as a single 64 KDa band 
when subjected to sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS 
PAGE). Studies of its biological effects in mice suggested that this toxin may be 
responsible for colonic mucosal haemorrhage and lymphoid tissue lesions (Padhye et al., 
1987).
1 3 3  Mode of action
It has been shown (Endo et al., 1988; Saxena et al., 1989) that the toxic action o f ShT, 
class I and class II VTs is the same in sensitive mammalian cells (figure 1.1). The A 
subunit is enzymatically active and like the A chain of ShT (Reisbig et al., 1981) is 
responsible for inhibiting protein synthesis through the catalytic inactivation o f 60 S 
ribosomal subunits (section 13.3.2). The B subunit on the other hand, mediates 
receptor binding, cytotoxic specificity and extracellular localisation of the holotoxin 
(section 1.3.3.1), (Jackson et al., 1990). The 32 KDa A subunit can be cleaved in vitro 
into a catalytically active A l fragment of 27 KDa and an A2 fragment of 4.5 KDa by 
reduction and treatment with trypsin or endogenous proteases. Treatment of intact 
toxin with trypsin in the absence of reducing agents however, results in the A2 fragment 
remaining linked to the A l fragment by a disulphide bond. Whereas nicking and 
reduction of intact ShT results in increased activity in a cell-free system and reduced 
toxic activity on intact cells (Reisbig et al., 1981), nicking in the A subunit of VT1 has 
been found not to affect the biological or physical properties of the toxin, such as 
cytotoxic activity, heat stability and time necessary for binding to Vero cells 
(Kongmuang et al., 1988).
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Figure 1.1 Toxic action of Shiga toxin and the Verotoxin family
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The B subunit binds to specific receptors on the surface of the cell and the A  subunit 
internalised and proteolytically cleaved to an A' fragment. The latter has N-glycosidase 
activity and inactivates 60 S ribosomal subunits by cleaving the N-glycosidic bond at 
nucleotide residue 4324 in 28 S ribosomal RNA. This inhibits protein synthesis and 
leads to cell death. The site of action is the same as that of Ricin, a potent cytotoxic 
protein produced by the castor bean (Ricinus communis).
1 - acting site for Ricin, Shiga toxin and Verotoxin.
2 - acting site for the fugal toxin a-Sarcin (Endo & Wool, 1982).
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133.1 The role of the B subunit
As mentioned above (section 13.1), VT1 and VT2 are cytotoxic for both Vero and 
HeLa cells, whereas VTe and VT2v's are cytotoxic for Vero and not HeLa cells. 
Construction of hybrid cytotoxins comprised of the individual subunits of ShT, VT1, 
VT2 and VTe has demonstrated that the different cell specificity of VTe compared with 
ShT, VT1 and VT2 is dictated by the VTe B subunit (Weinstein et al., 1989). The B 
subunit of ShT, VT1 and VT2 has been shown to bind to cell surface receptors 
containing terminal galactose-a( l-4)-galactose disaccharides and with high affinity to 
the glycolipid, globotriosyl ceramide (Gb3), (Lindberg et al., 1987; Lingwood et al., 
1987; Waddell et al., 1988). In contrast, VTe binds minimally to Gb3 and binds with 
high affinity to globotetraosyl ceramide (Gb4), which contains an additional N- 
acetylgalactosamine (GalNAc) residue in /31-3 linkage to which VT1 and VT2 do not 
bind (De Grandis et al., 1989). A recent study has compared the glycolipid receptor 
specificities of VT2, VTe and VT2va (table 1.3), (Samuel et al., 1990). It was found that 
both VTe and VT2va recognise Gb3 contained in both Vero and HeLa cells and 
furthermore, VT2va (Oku et al., 1989) did not bind Gb4 . It has therefore been 
suggested that the effects of ShT and VTs in humans and animal models reflects the 
relative toxin binding affinity as well as the differential tissue distribution, cell surface 
concentration of receptors and sensitivity of cells to toxin (Boyd & Lingwood, 1989; 
Samuel et al., 1990). One model for this dependance proposes that when toxin is bound 
to a cell, all or at least several B subunits of the holotoxin must bind to separate 
receptor molecules. This in turn, may cause local destabilisation of the membrane and 
allow the enzymatically active A  subunit to translocate the membrane to the cytoplasm. 
Receptors must therefore occur at a sufficient density and be attracted by sufficient 
avidity to create this membrane disturbance.
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Table 1.3 structures o£ glycolipide that bind V T 2 , VTe and VT2 variants (Samuel et a l .. 1990)
Naæ Structure*
VTe
Binding6 
VT2V-  VT2 cells
Galabiosylceraside (Cb2> 
Clobotriaosylceraaide CCbj) 
Globotetraosylceraaide (GbO 
Galactosylglobotetraosylceraaide (GbJ)
Cai»!-(Calli-ICer 
G a U l-(C a lli-(C ic li-IC e r  
CalHAcll -ÌOeUl (C a lli (C id i  - ICer 
C a lli-iC a lN A d l-IC a l^ l-(C a lli-(C id i-IC e r
: <♦) MelaItela, PSIC, Vero Vero, PSIe Vero
• The underlined sugars ere the consensus binding sequence.
b Binding of glycolipids on thin-layer chrosatograas was graded as follows; ♦, strong binding; (♦ ), weak binding; - ,  no binding. 
c Piglet saall intestine aucosal cells.
d VT2v corresponds to VT2va (Ito  et a l. 1990) which is antigenically indistinguishable to VT2vb (Ito  et a l. .  1991).
In addition to cell specificity, it has been shown that the B subunit also dictates 
localisation of the toxin within the bacterial cell (Weinstein et al., 1989). Whereas VTe 
is predominantly extracellular, VT1 is almost completely cell-associated and VT2 more 
equally distributed between the cell-associated and extracellular fraction (Strockbine et 
al., 1986). The mechanisms by which the toxins are distributed according to their B 
subunit have not been explored but the carboxyl terminus is thought to be involved in 
determining the extracellular localisation of VTe (Jackson et al., 1990).
13.3.2 The role of the A subunit
The process of internalisation of the A subunit into the cytosol has not been precisely 
established but it is thought that like ShT, entry requires a Ca2 + flux through naturally 
occurring calcium channels (Sandvig & Brown, 1987). This hypothesis is supported by 
the fact that Verapamil, a licenced calcium channel blocker, prevents cell bound A 
subunit from entering Vero cells. It is not known at what point during entry that the 
disulphide bond of the protein toxin is reduced.
The enzymatic activity of ShT and VTs is the same as that of Ricin, a potent cytotoxic 
protein produced by the castor bean - Ricinus communis (Endo et al., 1987, 1988; 
Igarashi et al., 1987), (figure 1.1). They are N-glycosidases that inactivate 60 S 
ribosomal subunits by cleaving the N-glycosidic bond at adenine 4324 in 28 S ribosomal 
ribonucleic acid (rRNA). Subsequent treatment of the RNA with aniline causes release 
of a distinctive fragment of 400 nucleotides from 28 S rRNA (Endo et al., 1988). This 
specific N-glycosidase activity is not nucleotide sequence specific because the target 
sequence (figure 1.1 ), which is conserved between eukaryotes and prokaryotes, is only 
modified when this sequence is part of the eukaryotic ribosome (Endo et al., 1987). For 
ShT it has been shown that the enzymatic activity of the A l fragment can only be 
expressed when the 60 S subunit is in the 80 S complex (Reisbig et al., 1981). In contrast 
the A chain of Ricin can inactivate the isolated 60 S subunit. The mode of inhibitory
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action of all toxins involves the blocking of elongation-factor-l-dependent binding of 
aminoacyl-transfer RNA to ribosomes (Igarashi et al., 1987; Endo et al., 1988). This 
may explain why most VTEC infections have an initial watery diarrhoea, due to 
inhibition of salt and water absorption by the enterocytes on the villus tips.
1.4 Genetic basis and regulation of VTs
1.4.1 Toxin-converting bacteriophages
Production of VT1 and VT2 has been shown to result from infection by lysogenic 
bacteriophage carrying the structural genes for toxin production (Scotland et al., 1983a; 
Williams Smith et al., 1983). This was first demonstrated by Scotland et al. (1980) who 
showed that the property could be transferred from a strain oiE . coli 026:H11, strain 
H19, to £. coli K12. A family of VT-converting phages has been found to exist in nature 
(O'Brien et al., 1984). The VT phages from strain H19 (H19A and H19B) and phage 
933J from 0157:H7 strain 933 have very similar morphology when examined by electron 
microscopy. Comparison of phage-encoded polypeptides and restriction enzyme 
analysis of phage deoxyribonucleic acid (DNA) also indicated close relatedness 
(O'Brien et al., 1984). Subsequently, comparison of a limited number of VT-encoding 
phages (Willshaw et al., 1987) indicated that a VT1 encoding phage from E. coli 
0157:H7 strain E30480 (a VT1 and VT2 producer) and a VT2 encoding phage from 
0157:H‘ strain E32511 were closely related, being morphologically indistinguishable 
and having similar DNA restriction digest patterns. VT2 encoding phage 933W, from 
the 0157 strain 933 (Strockbine et al., 1986) was also found to belong to this family of 
0157 phages determining VT production. However, no VT2 encoding phage from 
strain E30480 was found in this study. Later experiments showed that the VT2 
encoding phage was only released after ultra violet (UV) induction of E30480. This 
phage remains to be characterised. In addition to being morphologically distinct, the 
molecular size of the phage DNA and restriction enzyme digests of the VT-encoding
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phages from the 0157 strains were clearly distinguishable from the VT1 encoding phage 
of E. coli 026  strain H19. There has been no report of a single phage carrying more 
than one VT operon.
No phage mediated cytotoxin production has been demonstrated for S. dysenteriae type 
1 or other Shigella species tested (Weinstein et al., 1988a) and phage mediated 
production of VTe has not been shown (Williams Smith et al., 1983). Some VT2 
producing E. coli strains have also been documented as not harbouring toxin-converting 
phage (Marques et al., 1987). It is possible that these strains are lysogenised with 
unstable or defective phage or that the conditions used for induction or detection of 
phage were not optimum. Another explanation is that the toxin structural genes are 
located on the chromosome or on plasmids of these strains. Although no plasmid 
involvement has been demonstrated, transfer of genes coding for VTe from a field 
isolate to a K12 strain by conjugation has been reported (Williams Smith et al., 1983).
These phages represent potentially mobile elements within the gene pools of E. coli and 
related organisms, as transduction could serve to disseminate the toxin structural genes 
among related bacteria. Indeed other strains of bacteria including non- 
enterohaemorrhagic E. coli, enterohaemorrhagic E. coli (EHEC), Shigellae, Vibrios and 
Campylobacter produce VTs in small amounts (O'Brien & Holmes, 1987). It is not 
known whether low-level VT producing organisms carry genes homologous to the VT 
genes carried by VTEC and differ only with respect to the regulation of their 
expression. This widespread production might suggest that VTs may also function in 
bacterial cell metabolism and are not necessarily virulence factors alone.
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1.4.2 Operon structure
The structural genes for class I and class II VTs have been cloned and the complete 
nucleotide sequence of the structural genes for the A and B polypeptides and the 
adjacent regulatory sequences determined (table 1.1, section 1.4.3). The structural 
genes for each VT are organised into an operon (figure 1.2) which is transcribed from a 
promoter upstream of the A subunit gene (Sung et al., 1990). Jackson et al. (1987a) 
identified a potential promoter located 5' to the sit-1 B subunit gene which evidence 
suggests can function in the absence of the promoter located 5' to the sit-1 A subunit 
gene (Newland et al., 1985; Huang et al., 1986; Weinstein et al., 1988b). It remains to be 
seen however, whether the promoter functions in a normal chromosomally situated sit-1 
operon. No evidence of an independent promoter for the B subunit gene of the sit-II 
operon has been found (Sung et al., 1990). An untranslated intergenic space of 12, 14 
and 15 nucleotides separates the A and B subunit genes in the slt-l, slt-U and slt-llv 
operons respectively (Jackson et al., 1987b; Gyles et al., 1988; Weinstein et al., 1988a). 
This results in translation of the A and B subunit genes of the sit-1 and slt-lIv operons in 
the same reading frame, while the A and B subunit genes of the slt-U operon are 
translated in different reading frames. The existence of separate ribosome binding sites 
5' to the A subunit gene and in the untranslated space between the subunit coding 
sequences suggests that the A and B subunit genes are translated independently from a 
polycistronic messenger RNA (mRNA), (Jackson et al., 1987b). It is thought that 
enhanced translation of the B subunit coding sequence from the latter results in the 
holotoxin consisting of multiple copies of the B subunit for every A subunit. Presumed 
E. coli signal peptidase I cleavage sites (Oliver, 1985) have been identified for the A and 
B polypeptides and analysis of the translated amino acid sequences indicate that the A 
and B polypeptides are synthesised as precursors with hydrophobic signal sequences at 
the amino termini that are removed by proteolysis to form the mature A and B 
polypeptides. Whereas processing of the A and B subunits of VT1 has been observed 
(Newland et al., 1985), comparison between the sizes of the VT2 subunits from whole
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Figure 1 2  Organisation and expression o f the Verotoxin operon
The structural genes for VT (sitA and sltB) in Escherichia coli appear to be transcribed 
as an operon (sit), from a promoter upstream of s/fA. It is likely however, that the A 
and B subunits are translated independently as analysis of translated amino acid 
sequences indicate that the A and B polypeptides contain hydrophobic signal sequences 
at the amino termini and therefore are probably synthesised as precursor forms of 
secreted periplasmic proteins.
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cell lysates and polymyxin B extracts failed to detect evidence of the processing of the 
VT2 subunits (Newland et al., 1987). It is unclear whether only the mature, or only the 
precursor forms of the subunits are being detected.
1.43 Gene cloning and DNA sequence homologies
1.43.1 V T1
The structural genes for VT1, designated sit-1 A and sit-1 B were cloned and sequenced 
from the genomes of bacteriophage 933J (Newland et al., 1985; Jackson et al., 1987a) 
and H19 (Willshaw et al., 1985; Huang et al., 1986; Calderwood et al., 1987). The ShT 
locus of S. dysenteriae 1 is almost identical to that of VT1, being greater than 99% 
homologous (Strockbine et al., 1988). There are only three nucleotide differences in the 
A subunit resulting in a single amino acid substitution, whereas the B subunits are 
identical. VT1 and ShT have identical signal peptides for the A and B subunits, as well 
as identical ribosome binding sites. Nucleotide sequence similarities upstream of the 
start sites of the A subunits suggest that both toxins have homologous promoter and 
regulatory regions.
1.433 V T2
The structural genes for VT2, s/i-II A and slt-ll B from phage 933W have also been 
cloned (Newland et al., 1987; Jackson et al., 1987b). Comparison of the VT1 and VT2 
nucleotide sequences indicates that they share 58% overall nucleotide and 56% amino 
acid sequence homology (table 1.4), (Jackson et al., 1987b). The sequence similarities 
are greatest in the areas coding for the mature B subunit and the processed Al 
polypeptide.
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Table 1.4 Nucleotide and deduced amino acid sequence homologies o f the
processed s it-1 : s lt-U  and s l t - l l  s s it-IIv subunits
A subunit B subunit A subunit B subunit
sit-1 i/MI slt-l slt-U «flr-II s/MIv slt-ll sit- liv
Nucleotide seq. 
homology (%)
57 60 94 80
Amino acid seq. 
homology (%)
55 57 94 84
VT2 has consistently been reported not to be cross-neutralised by either polyclonal 
antibody (PAb) or monoclonal antibody (MAb) to ShT or VT1. The lack of cross­
reactivity between ShT/VTl and VT2 is puzzling however, since the three toxins have 
the same specific mechanism of action and apparently bind to the same specific sugar 
structure, suggesting the potential presence of very similar epitopes in all three toxins. 
In one study (Donohue Rolfe et al., 1989), three of four MAbs produced, demonstrated 
that ShT and VT2 were related. The reason why this group obtained cross-reactive 
MAbs when a number of other investigators failed to do so is uncertain but may be due 
to use of a toxin for immunisation that had been purified to a high degree with a novel 
affinity column based on the sugar-binding specificity of the B subunit. It is possible 
that by doing this they were able to free the preparation of contaminants that inhibit the 
production of cross-reactive antibody. It is also possible that the simple single-step 
purification method used in this study resulted in less damage to the protein and that 
the immunogenicity of cross-reactive epitopes was maintained. There was however, no 
evidence to support these speculations.
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1 .4 3 3 VTe
The structural genes for VTe, sft-IIvA and s//-IIvB have been cloned from the total 
cellular DNA of ED-causing E. coli strains (Gyles et al., 1988; Weinstein et al., 1988a). 
Comparison of the genes determining the putative processed A and B subunits of VT2 
and VTe indicates that they are very closely related (table 1.4), (Gyles et al., 1988). The 
toxin genes exhibit a very high degree of sequence similarity in the upstream sequences 
(suggesting a common regulatory mechanism), the signal peptide and the A2 fragment 
region, suggesting an extremely close evolutionary relationship. Despite the high 
degree of homology however, the pi's of the B subunits of these toxins are very different 
due to significant variation of individual amino acids at comparable positions in the B 
polypeptides of VTe and VT2. Also, the greatest amino acid sequence differences were 
found near the carboxy termini of the respective B subunits and may explain through 
binding differences the different spectrum of cytotoxicity observed for the two toxins.
1.43.4 VT2 variant toxins (human and porcine)
A VT purified from an E. coli 091:H21 strain (B2F1) isolated from a patient with HUS 
was found to have greatly reduced activity in HeLa cells (Oku et al., 1989). The initial 
characterisation of this strain led to the speculation that the VT being produced was 
VTe. The subsequent cloning and sequencing of genes from E. coli 091:H21 identified 
two distinct genes capable of producing a VT similar to VT2 both of which had RNA N- 
glycosidase activity (Ito et al., 1990). The nucleotide sequences of the two operons 
designated vtx2ha and vtxlhb were determined and found to be nearly identical (table 
1.5). Both encoded A and B subunits of 319 and 89 amino acids respectively, the A and 
B genes being separated by a stretch of 14 nucleotides. It was speculated that the 
presence of two nearly identical vtx2h operons in cellular DNA can be explained by a 
mechanism such as insertion sequence-mediated gene duplication and Ito and co- 
workers are currently investigating whether the vix2h operons are flanked by insertion
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sequence-like elements. Nucleotide and deduced amino acid sequence homologies of
the v£r2ha genes with those o f the v£c2hb, sit-II and slt-U v  genes are shown in table 1.5.
Table 1.5 Nucleotide and deduced amino acid sequence homologies o f the v£r2ha
a Number of bases of vtx2ha genes are used as common denominators, 
k Number of amino acid residues of v£r2ha gene products 
are used as common denominators. 
c Values in brackets are for the products obtained when the gene 
products are processed and signal peptides are removed.
The nucleotide sequences of the presumed promoters and presumptive ribosome 
binding sites in the vtc2ha, vtt2hb, j/f-II and s/f-IIv operons were identical. These results 
imply that the vtx2h, s/MI and slt-llv operons are derived from a common ancestor, that 
the three operons simply represent a family of operons encoding VT2 and related toxins 
and that the nucleotide sequences of the A subunit genes are conserved better than 
those of the B subunit genes. This is in contrast to VT1, whose nucleotide sequences of 
the genes encoding the A and B subunits are both highly conserved. The products of 
vtx2ha and Wx2hb are antigenically indistinguishable and Ito et al. (1991) have 
subsequently demonstrated that the difference in antigenicity between VT2 and VT2va 
is due to a single amino acid difference in the B subunit of the two toxins.
genes with those of the v£r2hb, slt-II and slt-IIv genes (Ito et al., 1990)
Operons A subunit B subunit
Nucleotide sequence 
homology8 (%)
Deduced amino acid sequence 
homology **(%)
A subunit B subunit
vix2ha 
vtx 2hb 
sit-II 
slt-llv
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Recently additional VTEC strains containing two copies of VT2-related genes have 
been reported and the nucleotide sequences of two different VT2 operons from E. coli 
E32511 determined (Schmitt et al., 1991). One of these operons was determined to be 
that of slt-lI while the other, termed s//-IIc (table 1.1), in essence contained A subunit 
sequences from 5//-II and B subunit sequences from vtx2ha (table 1.6). Although VT2vc 
is closely homologous to VT2va of B2F1, it was found that VT2vc was only slightly less 
cytotoxic for HeLa cells than Vero cells. Schmitt et al. (1991) also proposed that the 
VT2 that was purified from EHEC strain J2 (Yutsudo et al., 1987) may be impure, as 
their results suggested the possibility of two slt-l I genes in this strain.
Table 1.6 Comparison of the nucleotide and predicted amino acid sequences of the
a Values represent % homology with the indicated sequences from the A & B subunits 
of slt-llc. Numbers in brackets are homologies comparing unprocessed gene products. 
b Sequences for vtx2ha & vtx2hb, sit-II, s/MIv and sit-lie were from references; Ito et al., 
1990; Jackson et al., 1987b; Weinstein et al., 1988; Schmitt et al., 1991 respectively.
A further VT2 variant has been purified from an E. coli 0128 strain isolated from a 
human infant with diarrhoea (Gannon et al., 1990). This strain was described as a VTe 
variant (VTeva) in view of the fact that it has 98% nucleotide homology with the B
processed A and B subunits of the slt-lIc genes with those of the slt-ll 
family (Schmitt et al., 1991)
Operonsb A subunit B subunit
Nucleotide sequence 
homology8 (%)
Deduced amino acid sequence 
homology8 (%)
A subunit B subunit
sit-lie 
vtc2ha 
vi*2hb 
sit-II 
slt-llv
100( 100)
99.0 (99.1)
99.0 (99.1) 
100 ( 100) 
94.2 (94.2)
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subunit of the VTe gene and only 78.1% homology with the B subunit of the VT2 gene. 
The A subunit of VTeva was found however, to be equally homologous to those of the 
VT2 (69.5% homology) and VTe (70.6% homology) genes. VTeva differs from VTe in 
that it is more heat-stable. No phage could be induced from this strain. VTeva like 
VTe has a 15 base pair (bp) gap between the A and B subunit genes. Using polymerase 
chain reaction (PCR) technology this strain showed no specific amplification with VT2, 
VT2v or VTe primers, indicating that VTeva represents a unique member of the VT 
family (Tyler et al., 1991). Tyler and colleagues also showed that a variety of class II 
genotypic combinations are possible. In addition, the presence of VT2v genes is not 
restricted to strains producing only VT2, as evidenced by one E. coli 091:H21 strain 
which also produced VT1. Although a link has been established between the presence 
of VT2 genes and disease-causing E. coli 0157 strains (Ostroff et al., 1989; Tarr et al., 
1989), whether multiple copies of sit-II operons are responsible for enhanced virulence 
of an EHEC strain remains to be determined.
Homology of the amino acid sequence of the processed A subunit of VTs with the A 
chain of Ricin has been noted by several workers (De Grandis et al., 1987; Calderwood 
et al., 1987; Weinstein et al., 1988a). This finding adds support to the possibility that 
prokaryotic toxins are evolutionarily related to eukaryotic enzymes, a hypothesis which 
has been suggested before in relation to diptheria and cholera toxins (Moss & Vaughan, 
1978).
1.4.4 Regulation of toxin production
1.4.4.1 High- and low- level production of VTs
VTEC produce variable amounts of toxin and in a study to determine the frequency and 
levels of VT produced by a wide variety of E. coli strains, Marques et al. (1986) 
examined culture supernatants and sonic lysates prepared from these strains for
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cytotoxic effects on HeLa cells. Cytotoxic titres expressed as the reciprocal of the 
cytotoxic dose required to kill 50% of HeLa cells (CD50), per ml of sonic lysate were 
defined as follows : low (2 x 10* to 6 x 10  ^CD50), moderate (10^ to 10* CD50), or high 
(105 to 10* CD50). It was discovered that although all the E. coli strains made at least 
small amounts of cell-associated toxin, only the E. coli strains which produced elevated 
(moderate or high) levels of VTs were associated with cases of diarrhoea, HC and 
HUS. This would suggest that cytotoxin may only be a virulence determinant for E. coli 
when it is produced in large amounts. E. coli that produce elevated levels of VTs most 
often belong to a restricted number of serotypes, including 0157:H7, 026:H11 and 
0111:NM. High-level toxin-producing strains are readily identified as VTEC and give 
clear results in toxin neutralisation tests. It has been found that ShT and VT1 are 
associated with organisms that produce high levels of cytotoxin while VT2 and VTe are 
associated with organisms that produce moderate levels of cytotoxin (Strockbine et al., 
1986). One possible explanation for the lower levels of cytotoxin produced by the VT2 
and VTe strains could be that the strengths of their promoters may be weaker than that 
of the stx/slt-\ promoter (section 1.4.4.2).
1.4.4.2 Transcriptional efficiencies
In contrast to the VTl/ShT promoter the nucleotide sequence of the VT2 promoter is 
not closely homologous to a consensus sequence established from a compilation of 
defined E. coli promoters (Sung et al., 1990). Promoters which lack homology with the 
consensus sequence are generally less efficient at initiating transcription than promoters 
with a high degree of homology. Sung et al. (1990) hypothesised therefore, that the slt-l 
promoter has a more effective transcription start signal than the slt-lI promoter. In 
support of this hypothesis was the observation that the cytotoxic activities observed in 
the cell lysates of VTl-producing EHEC strains are 100- to 1,000-fold higher than for 
VT2 or VTe producing strains (O'Brien & Holmes, 1987). During comparison of the 
transcriptional efficiencies of the ShT operon (str) and slt-U promoters in fusions to the
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chloramphenicol acetyltransferase gene, however, Sung et al. (1990) found that the 
constitutive activity of the slt-ll/slt-llv promoter was comparable to that of the stx/slt-l 
promoter under low iron growth conditions. Therefore, it is likely that the significant 
differences observed in the production of VT1 and VT2 by toxigenic clinical isolates of 
E. coli are not directly related to differences in the transcriptional efficiences of the 
stx/slt-l and slt-ll/slt-llv promoters.
1.4.43 Iron-mediated regulation
Production of ShT has long been known to be increased when cells are grown in 
medium of low iron concentration. Similarily, iron chelation has been reported to 
dramatically increase transcription of VT1 and result in an increased concentration of 
VT1 in the extracellular medium (De Grandis et al., 1987). However, conflicting results 
for the demonstration of iron-regulation of the sit-1 operon have been obtained under 
several experimental conditions. Iron regulation was demonstrated when the sit-1 genes 
were present on prophage in lysogenic cells (Weinstein et al., 1988b), or on a high-copy- 
number s/r-I::Tnp/ioA fusion plasmid (Calderwood & Mekalanos, 1987) but not when 
the sit-1 genes were present on the pBR328 vector (Weinstein et al., 1988b). ShT 
production in S. dysenteriae type 1 strain 60R has been found to also be regulated by 
temperature, reduced growth temperatures leading to a decrease in ShT production. 
VT1 production on the other hand is not affected by temperature (Weinstein et al., 
1988b).
The regulation of the sit 1 operon by iron depends on a separate chromosomal locus of 
the host bacterium, the fur gene (Betley et al., 1986; Calderwood & Mekalanos, 1987). 
The Fur protein is thought to function with iron as a corepressor to negatively regulate 
toxin production by binding to putative operator sequences and inhibiting transcription 
of VT1. A recognition site has been located in promoter regions of the VT1 and ShT 
opérons for the E. coli fur gene product (Calderwood & Mekalanos, 1987). Other
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phage-encoded toxin genes are known to be regulated by iron. For example, expression 
of the diphtheria toxin operon of the /J phage of Corynebacterium diphtheriae has been 
shown to be directly regulated by the iron-dependent binding of a bacterial factor, 
DtoxR, to the tox promoter region (Murphy et al., 1976; Fourel et al., 1989). Iron 
regulation of the tox promoter in E. coli had previously been shown to be dependent on 
the fur gene product (Tai & Holmes, 1988).
Iron is essential for the growth of most bacteria and thus specific mechanisms for its 
aquisition are present in most microbes. In addition to ShT and VT1, the Fur protein 
represses a variety of iron scavenging systems when sufficient iron is present in the 
medium. These include genes responsible for the biosynthesis of iron-binding ligands 
(siderophores) and genes encoding inner and outer membrane proteins involved in the 
binding and uptake of iron-siderophore complexes. In animal hosts, iron is sequestered 
by iron-binding proteins and as a result there is little free iron available, in contrast to 
the comparably high levels of free iron present in the environment. The shift from a 
high- to low-iron environment may serve through regulatory proteins such as Fur, as a 
signal to the bacterium that it has entered the mammalian host, triggering the 
coordinate expression of a number of virulence determinants.
Iron is found not to suppress VT2 or VTe production and neither of their putative 
promoter sequences show any sign of homology to a binding site for the Fur protein 
(Sung et a!., 1990). This indicates that the regulation of VT2 and VTe synthesis differs 
from that of ShT and VT1.
1.4.4.4 Kinetics of VT production
In an attempt to maximise VT1 production, Chart et al. (1987) examined the effect of 
iron-restricted/limited growth on VTEC with an aim to increasing yields of VT and 
enhancing the sensitivity of detection of low-level VT-producing strains of E. coli. The
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kinetics of VT production indicated that toxin was secreted throughout exponential 
growth with highest VT titres correlating with highest cell density. In contrast to De 
Grandis et al. (1987) and Weinstein et al. (1988b), Chart and colleagues found that iron- 
restriction led to poor growth and reduced yields of VT1 and that there was no 
advantage to be gained by growing bacteria under iron restriction/limitation.
1.4.4.5 Mitomycin C induction of VTs
Head et al. (1988a) demonstrated an increase in VT2 production following addition of 
mitomycin C to the culture medium. This induction has been utilised in conjunction 
with PI glycoprotein affinity chromatography to purify large amounts of VT1 and VT2 
from E. coli C600 (933J/W) (Donohue-Rolfe et al., 1989). The mechanism whereby 
mitomycin C increases VT1 and VT2 production is thought to be via the induction of 
bacteriophage, resulting in an increase in the copy number of toxin genes (Acheson et 
al., 1990). In contrast, mitomycin C has no effect on toxin production from S. 
dysenteriae type 1 strain 60R, in which the toxin genes are not phage associated. 
Another known inducer of phage replication, UV irradiation, also increases both phage 
and toxin production in irradiated cultures of C600 (933W), (Acheson et al., 1991). 
Additional proof that mitomyin C induces toxin via its effect on phage replication has 
been obtained by introducing transforming phage into E. coli strains with a recA' 
background (Acheson et aL, 1991). Phage induction is known to depend on the RecA 
gene product, which also functions in DNA repair responses. DNA damage, whether 
due to UV energy or alkylating agents such as mitomycin C, activates the RecA 
protease, which cleaves the LexA gene product. LexA is a repressor of several unlinked 
genes that encode DNA repair proteins. When LexA is cleaved these so-called damage- 
inducible (din) genes are de-repressed. RecA protease also cleaves phage repressor 
proteins, thus leading to the transition from the lysogenic to the lytic phase. In a recA' 
E. coli containing the VT-transforming phage it was found that mitomycin C was an 
ineffective inducer, indicating that the same control mechanism is applicable to VT-
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transforming phage. In an attempt to optimise conditions for VTe production from a 
strain containing the cloned genes for VTe, TB1 (pCG6), MacLeod and Gyles (1989) 
grew this strain in the presence of mitomycin C and found that the predominantly cell 
associated toxin in this strain was induced and released into the culture medium. TB1 
(pCG6) does not possess a phage toxin gene and the mechanism for toxin induction by 
mitomycin C in this strain remains uncertain.
1.5 Distinction of VTEC from other pathogenic E. coli
E. coli is part of the normal microflora of the intestinal tract of human beings and of 
most warm blooded animals. Generally the strains that colonise the human bowel are 
harmless commensals. However, there are pathogenic strains that cause distinct 
syndromes of diarrhoeal disease and that have been associated with foodbome illness. 
These foodborne pathogens are grouped into four major categories, summarised in 
figure 1.3 and described in detail in sections 1.5.1 to 1.5.4. These categories are based 
on distinct virulence properties, different interactions with the intestinal mucosa, 
distinct clinical syndromes, differences in epidemiology, and distinct OtH serogroups 
(Levine & Edelman, 1984; Robins-Browne, 1987; Levine, 1987).
1.5.1 Enterotoxigenic E. coli (ETEC)
ETEC are a major cause of bacterial diarrhoea in third world countries and of 
travellers' diarrhoea. ETEC infection is aquired principally by ingesting contaminated 
food or water and the clinical features are watery diarrhoea, nausea, abdominal cramps 
and low grade fever.
After ingestion, ETEC cells that have survived the hostile environment of the stomach 
overcome the peristaltic defense mechanism of the small intestine by adhering to the 
mucosa by means of specific fimbriae or colonisation factors. They are non-invasive
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and produce one or both of two plasmid encoded cholera-like toxins, LT-I or heat stable 
toxin (ST). It is the specific action of LT-I or ST on the enterocyte at the subcellular 
level that leads to fluid secretion, which results in watery diarrhoea in the patient. A 
further heat-labile toxin (LT-II) has now been described (Guth et aL, 1986; Holmes et 
aL, 1986) which has biological activities similar to LT-I but is antigenically distinct. 
Additionally the structural genes for LT-II are not encoded by plasmids.
Figure 1J A summary of the main characteristics of pathogenic E. coli
Pathogenic E. coli are grouped into four major categories; enterotoxigenic fETEC), 
enteroinvasive (EIEC), enteropathogenic (EPEC) and verotoxin-producing (VTEC), 
based on a number of distinguishing characteristics. These characteristics are 
summarised above and discussed in more detail in sections 1.5.1 to 1.6.2. ETEC 
elaborate one or both of two plasmid encoded toxins, heat labile (LT) and heat stable 
(ST) enterotoxins, VTEC produce verotoxin (VT) in their culture supernatants and 
EIEC produce a novel enteroinvasive enterotoxin (EC), in addition to low levels of VTs 
which are distinct from the VTs of VTEC. VTEC and EPEC both produce 
characteristic attaching and effacing (A/E) lesions in vivo and demonstrate localised 
(LA) and diffuse (DA) adherence to HEp-2 cells in tissue culture. LA in EPEC has 
been shown to be encoded by an EPEC adherence plasmid (EAF).
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1.5.2 Enteroinvasive E. coli (EIEC)
EIEC are an important cause of diarrhoeal disease and dysentery in young children in 
less developed countries and of food-borne outbreaks of enteric disease in adults in 
industrialised countries. For most food-related outbreaks, sources of EIEC 
contamination are associated with an infected foodhandler or contact with water that 
has probably been contaminated with sewage. Clinical symptoms include fever, severe 
abdominal cramps, malaise, toxaemia and watery diarrhoea followed by gross dysentery 
consisting of scanty stools of blood and mucus.
EIEC do not produce LT or ST but, like Shigellae, with which they share antigens, they 
have the ability to invade and multiply within the colonic epithelial cells and cause 
eventual death of the cell. These strains are able to produce inflammatory 
keratoconjunctivitis in the eye of a guinea pig (the Sereny test) and this invasive 
property depends on the presence of a large, approximately 140 megadalton (MDa) 
enteroinvasive plasmid (plnv) coding for the production of several outer membrane 
proteins involved in the invasion of mammalian cells (Harris et a i, 1982; Hale et al., 
1983). These polypeptides are encoded on a 22 MDa section of the large virulence 
plasmid and this segment is shared and highly conserved in the virulence plasmids of all 
Shigellae and EIEC (Hale & Formal, 1986). Recently it has been found that all major 
EIEC O serogroups produce low levels of VTs that are immunologically and genetically 
distinct from VT1 and VT2 of EHEC, (Fasano et aL, 1990). This corroborates earlier 
findings that EIEC strains elaborate cytotoxins that are not neutralised by anti-VTl or 
anti-VT2 antibodies (Cleary & Murray, 1988; Marques et aL, 1986). The significance of 
low-level cytotoxin production is uncertain. While epithelial cell invasiveness is clearly 
the predominant virulence property reponsible for the dysenteric syndrome, presence of 
these cytotoxins may dictate the severity of the symptoms. The EIEC strains tested by 
Fasano et al. (1990) were also found to produce an enterotoxin of approximately 68-80 
KDa, distinct from the EIEC cytotoxin. This novel enteroinvasive enterotoxin (EIET) is
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thought to be responsible for the watery diarrhoea which typically precedes dysentery in 
EIEC infection.
1.5J Enteropathogenic E. coli (EPEC)
EPEC strains belong to a limited number of serotypes and were the first E. coli strains 
to be implicated epidemiologically in diarrhoeal disease. An isolate is classified as an 
EPEC strain if it is isolated from a case of diarrhoea and belongs to one of the following 
O serogroups: 055, 086, O lll ,  0114, 0119, 0125, 0126, 0127, 0128, 0142, 0158. 
Clinically EPEC infection occurs most frequently in infants and young children and is 
characterised by fever, vomiting and diarrhoea with prominant amounts of mucus but 
without gross blood.
The mechanism by which EPEC cause disease remains to be defined. EPEC are not 
enteroinvasive and do not produce the classical LT or ST, although some strains have 
been shown to produce other toxins (Scotland et a l, 1980; O'Brien et aL, 1982; Katouli 
et al., 1989). In a later study by Cleary et al. (1985) it was found that EPEC strains, 
particularly those of serogroup 026, commonly produce VT. Although it was found that 
the amount of cytotoxin produced by EPEC is significantly higher than that produced by 
strains from healthy individuals, the biological significance of this remains unclear, since 
there is considerable overlap in the range of concentrations found. Adherence of many 
enteric pathogens to intestinal mucosal surfaces is a critical primary step in the 
pathogenesis of diarrhoeal disease. The importance of adherence factors in EPEC and 
VTEC are discussed in detail in section 1.5.5.
1.5.4 Verotoxin-produclng and enterohaemorrhagic E. coli (VTEC and EHEC)
VTEC refers to all E. coli strains that produce VT in their culture supernatants and can 
therefore be distinguished from other classes of E. coli that do not do so. Although the
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vast majority of E. coli strains do not make VT, it is common for both healthy infants 
and adults to have VTEC as part of their normal faecal flora (Cleary et aL, 1985). 
V'l tC  are not enteroinvasive (by the Sereny test) and do not produce the classic LT 
and ST. The term EHEC refers to strains that have the same clinical, epidemiological 
and pathogenic features associated with the prototype EHEC organism, E. coli 0157:H7 
described by Riley et aL in 1983 (Levine, 1987). Only two EHEC serotypes (0157:H7 
and 026:H11) have been classified by Levine, 1987. EHEC strain 026:H11 (H30) was 
previously categorised as an EPEC. Thus EHEC constitute a defined theoretical 
subgroup of VTEC.
1.6 Additional virulence determinants
Virulence factors are bacterial products that are required by the organism to cause 
disease. Deletion of any of these factors results in a reduction in, or loss of virulence.
In addition to toxin production, adherence of many enteric pathogens to intestinal 
mucosal surfaces is a critical primary step that results in bacterial colonisation of the 
intestine necessary for both delivery of elaborated toxins to enterocytes and tissue 
invasion. Enteroadherence of bacteria promotes increased colonisation of organisms 
since they are less susceptible to distal clearing by the peristaltic activity of the gut. 
Adherence can be mediated by various cell surface antigens including fimbriae (pili), 
flagella, outer membrane proteins, capsular polysaccharide and lipopolysaccharides 
(LPS).
Gram-negative bacteria, including ETEC and EPEC adhere by means of fimbriae. 
Adherence of fimbriae to specific receptors on the surface of the cell is the basis for the 
agglutination of erythrocytes or red blood cells (RBC) by fimbriated bacteria. The 
agglutination of guinea pig RBC by some strains of E. coli can be blocked with D- 
mannose or its analogues. These mannose-sensitive adhesins (type 1 fimbriae) are
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found on 50-70% of all E. coli isolates and are particularly prevalent among normal 
flora isolates of E. coli. By contrast most strains of E. coli that are associated with 
intestinal or extraintestinal disease in humans agglutinate guinea pig RBC even in the 
presence of mannose (Salit et aL, 1983). Whereas most other fimbriae produced by E. 
coli gastrointestinal pathogens are encoded on plasmids, type 1 fimbriae are 
chromosomally encoded. The presence of fimbriae by itself is not a marker for 
virulence since nonvirulent commensals tend to be much more fimbriated than 
pathogens when grown in broth, but the numbers of fimbriae on bacteria varies with the 
growth conditions employed (Salit et aL, 1983).
1.6.1 Adherence of EPEC
1.6.1.1 HEp-2 cell adherence
In 1979, Cravioto et aL, showed that the majority of EPEC outbreak strains could 
adhere to HEp-2 human epithelial cells in tissue culture in the presence of D-mannose. 
Attachment of these outbreak strains to HEp-2 cells was later found to be encoded on a 
large 55-60 MDa plasmid (Baldini et al., 1983). The name EPEC adherence factor 
(EAF) was given to this property and through volunteer studies the EAF adhesion 
system was shown to be important in the ability of EPEC to cause diarrhoea. EPEC 
adhere to HEp-2 cells in two distinct patterns, termed localised adherence (LA) and 
diffuse adherence (DA), (Scaletsky et aL, 1984; Nataro et a l, 1985a). EPEC showing 
LA, adhere in discrete microcolonies to localised areas of the HEp-2 cell surface, 
whereas those showing DA adhere to the entire cell surface. LA and DA are encoded 
for by different plasmids and use of a 1 kilobase (Kb) EAF DNA probe derived from a 
55 MDa EAF plasmid, pMAR2 from strain E2348, showed that the LA phenotype was 
EAF plasmid encoded (Nataro et aL, 1985a). Nataro et al. (1985b) subdivided the 
EPEC category into two classes on the basis of hybridisation with the 1 Kb EAF probe. 
Class I EPEC (EAF+ ) exhibit LA to HEp-2 cells, whereas class II EPEC (EAF)
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exhibit either DA or no adherence at all to HEp-2 cells. Both class I and class II EPEC 
are associated with diarrhoeal disease. An ELISA using antiserum to EAF plasmid- 
associated factors has subsequently been developed for the detection of classic EPEC 
displaying LA (Albert et al., 1991). In diarrhoeagenic E. coli strains exhibiting the DA 
phenotype at least two different adhesins have so far been identified. Bilge et aL (1989) 
have characterised a region of chromosomal DNA coding for a fimbrial adhesin. More 
recently the cloning and expression of a 6 Kb DNA fragment from a 100 Kb (2 MDa) 
plasmid harboured by EPEC clinical isolate 2787 which confers the DA phenotype to 
recipient E. coli K12 strains, as well as the identification of a 100 KDa protein (AIDA-I- 
adhesin involved in diffuse adherence) as the DA-mediating adhesin has been described 
(Benz & Schmidt, 1989, 1992). Serologically related proteins of similar size were 
detected by Western blotting in other DA+ diarrhoea-associated EPEC strains (Benz & 
Schmidt, 1992).
HEp-2 cell adherence was originally suggested to be a good model of in vivo EPEC 
adherence (Baldini et al., 1983). However, in the original description of HEp-2 cell 
adherence by Cravioto et aL (1979), 29% of 17 non-EPEC, non-ETEC strains that were 
possible causes of five diarrhoeal outbreaks were adherent to HEp-2 cells. Mathewson 
et aL (1985) reported that nontoxigenic, HEp-2 cell adherent strains of E. coli displaying 
LA or DA and which did not belong to the recognised EPEC serogroups were an 
important cause of travellers' diarrhoea. They proposed, therefore that HEp-2 cell 
adherence may be a virulence factor in E. coli strains independent of serogroup, and for 
this reason Mathewson proposed that HEp-2 cell-adherent E. coli strains be referred to 
as enteroadherent E. coli (EAEC), in order to avoid reference to and confusion with 
strains belonging to EPEC serogroups. More recently evidence suggests that EAEC are 
identifiable by a particular pattern of adherence to Hep-2 cells that is clearly 
distinguishable from both LA and DA (Levine, 1987).
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1.6 . 1.2 Attaching and effacing activity
In vivo studies have shown that EPEC strains adhere avidly to the mucosa of the small 
intestine with local destruction of microvilli and pedestal formation (Moon etal., 1983). 
The characteristic attaching and effacing (A/E) lesion produced is thought to be 
responsible for the diarrhoea associated with EPEC (Robins-Browne, 1987) and strains 
producing this type of lesion have been referred to as attaching and effacing E. coli 
(AEEC).
Levine et al. (1985) showed that a 94 KDa outer membrane protein was detected in wild 
type EPEC strains but not in EAF plasmid-cured derivatives of these strains, suggesting 
that the 94 KDa membrane protein of EPEC may be encoded for by the EAF plasmid. 
However, an isogenic EPEC strain cured of the pMAR2 plasmid continued to 
demonstrate A /E adherence to HEp-2 cells (Knutton et aL, 1987a) and enterocytes in 
organ culture (Knutton et al., 1987b). Others have also indicated that adherence of 
EPEC to HEp-2 cells does not depend on the expression of fimbrial adhesins (Scotland 
et aL, 1983b). Knutton et al. (1987a, b) provided evidence that the LA to HEp-2 cells 
and the A /E  adherence are two genetically distinct phenomena. They proposed a two 
stage model for EPEC adherence with a fimbrial mediated initiation step (plasmid 
encoded and responsible for HEp-2 LA) and a subsequent phase of A /E adherence 
(encoded for by genes on the chromosome). It was evident that the second stage can 
occur in the absence of the first stage, but the presence of plasmid-encoded adhesins 
appears to greatly enhance the ability of EPEC to colonise the mucosa (Tzipori et a t, 
1989). In addition to enabling initial colonisation, the EAF adherence plasmid may 
provide tissue specificity for human epithelial cells (Jerse et aL, 1991). Studies using 
TnphoA mutagenesis indicated that the 94 KDa outer membrane protein was encoded 
by a chromosomal locus (eae - E. coli A /E). Furthermore the eae gene has been shown 
to be necessary for A /E activity on human tissue culture cells (Jerse et aL, 1990) and to 
share significant homology to invasin, a known virulence factor of Yersinia
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pseudotuberculosis (Jerse & Kaper, 1991). Expression of the eae gene was found to be 
positively regulated by the EAF plasmid (Jerse & Kaper, 1991). This may explain the 
earlier observations that in vivo (Knutton et aL, 1987b) and in vitro (Tzipori et al., 1989), 
increased numbers of A /E lesions are produced by EPEC strains that possess the EAF 
plasmid.
1.6.2 Adherence in VTEC
Before 1987 the surface antigens which mediate adherence of E. coli 0157:H7 to 
epithelial cells had not been defined, although adherence of E. coli 0157:H7 to the 
colons of orally infected gnotobiotic piglets (Tzipori et aL, 1986), infant rabbits (Pai et 
aL, 1986) and chickens (Beery et aL, 1985) had been described. E. coli 0157:H7 had 
also been shown to adhere to the surface epithelial cells in the intestines of postweaning 
rabbits (Sherman et aL, 1988). VTEC of multiple serotypes have been shown to possess 
the ability to cause A /E lesions (Sherman et aL, 1988), however, bacterial A /E activity 
caused by these VTEC strains has not yet been shown to be an important virulence 
factor in the large bowel in humans, since it would require biopsies to be taken from the 
ileocaecal region during acute infection.
Sherman et aL (1987) found that VTEC 0157:H7 strains exhibit LA and/or DA to 
HEp-2 cells and to Henle 407 gut-derived epithelial cells in tissue culture. In later 
studies they provided evidence that specific constituents of 0157:H7 outer membranes 
rather than 0157 LPS or H7 flagellin, mediated adherence of the organisms to HEp-2 
cells in tissue culture (Sherman & Soni 1988; Sherman et al., 1991). In this study a 94 
KDa outer membrane protein was implicated as a bacterial adhesin involved in A/E  
activity. The similarity in size and cellular location between this protein and the 94 
KDa eae protein of EPEC suggests that the protein described by Sherman et aL (1991) 
may be the eae protein of that strain (Jerse & Kaper, 1991). Jerse et al (1990, 1991) 
showed that all EPEC and EHEC displaying A/E activity possess chromosomally
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encoded sequences homologous to a 1 Kb eae probe. Although these proteins may 
serve similar functions in the production of A /E  lesions, they differ antigenically.
In contrast to Sherman et a l (1987), adherence of VTEC 0157:H7 strains to Henle 407 
cells but not to HEp-2 cells has been reported (Karch et al., 1987). Evidence was 
provided that adherence to the Henle 407 cell line was determined by non- 
haemagglutinating, mannose-resistant fimbriae encoded for by genes on a 60 MDa 
plasmid. In addition, small numbers (typically two to four) of 0157:H7 bacteria were 
shown to attach to Henle 407 cells in a central location, whereas plasmid-cured 
derivatives failed to adhere. This data conflicts with evidence that a plasmidless 
derivative of an E. coli 0157:H7 strain adhered to Henle 407 cells three times better 
than the parent strain (Junkins & Doyle, 1989) and a plasmidless derivative of serotype 
0157:H7 caused typical A /E lesions in the piglet intestine (Tzipori et al., 1987, 1989). 
In addition, a plasmid cured derivative of E. coli 0157:H7 strain 933, which lacks a 60 
MDa plasmid but contains other plasmids, colonised streptomycin treated mice in high 
numbers when fed to mice (Wadolkowoski et a l, 1990a). However E. coli 0157:H7 
strain 933 colonised better than its plasmid-cured derivative when the organisms were 
fed simultaneously to streptomycin-treated mice. These results suggest that the 60 MDa 
plasmid may encode a factor or factors required for E. coli 0157:H7 strains to colonise 
in the presence of other bacteria. This factor may be the plasmid-encoded fimbriae 
which mediate attachment to Henle 407 intestinal cells in vitro. The inconsistency of 
these observations would seem to suggest that the genetic basis for adherence to 
epithelial cells in tissue culture is very variable (Hall et aL, 1990) and may be different 
from that reported for strains of serotype 0157:H7 published by Karch et a l (1987). 
Use of a 3.4 Kb segment of this plasmid as a DNA probe, termed CVD419, in a survey 
showed that VTEC strains commonly harbour this plasmid, (hybridisation with 99% 
VT+ 0157:H7,77% VT+ 026:H11 & 77% other VT+ E. coli), whereas commensal E. 
coli and strains belonging to other classes of pathogenic E. coli gave a negative reaction 
(Levine et al., 1987), making it a useful screening test for epidemiologic and diagnostic
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purposes. Levine et al. (1987) also showed that VTEC 0157:H7 strains, unlike class I 
EPEC strains, are EAF probe negative.
1.63 Flagella
Flagella are filamentous protein appendages that protrude from the cell surface of 
many bacteria and confer motile properties to the organisms. As a result of motility, 
flagella may permit increased bacterial penetration of the surface mucous gel and thus 
promote increased colonisation by enteric pathogens at the mucosal surface. In 
addition to virulence associated with motility properties of bacteria, certain flagella may 
also function as bacterial attachment factors or adhesins that promote binding of 
pathogenic organisms to receptors present on the surface of enterocytes and 
colonocytes. Although Sherman & Soni (1988) showed H7 flagella not to be important 
in adherence to human epithelial cells, H7 antigens nevertheless appear to be an 
important factor in the pathogenesis of human disease because nonmotile, afiagellar E. 
coli strains of the 0157 serogroup are much less frequently isolated in stool specimens 
from symptomatic patients than are E. coli strains of the 0157:H7 serotype.
From the early days of the 1940's when E. coli were first convincingly associated with 
human diarrhoea, much has been discovered about the several categories of 
diarrhoeagenic E. coli, including information on their clinical features, epidemiology, 
0:H  serotypes, and most particularly their pathogenesis. New virulence factors are 
constantly being discovered which can be found to span several diarrhoeagenic E. coli 
serogroups. Johnson & Lior (1988) described a new heat-labile E. coli toxin, cytolethal 
to Vero, HeLa, HEp-2 and CHO cells and negative in Y1 cells in the culture filtrates of 
43 E. coli strains associated with diarrhoeal disease. The toxin, termed a cytolethal 
distending toxin (CLDT) was distinct from the classic LT and ST enterotoxins, VTs and 
hemolysins. However VT and LT were found in combination with CLDT in a few E. 
coli strains. As knowledge has grown it has become increasingly evident (Guth et aL,
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1989), that the ability of E. coli to cause intestinal infection is associated with 
bioserotypes rather than with O serogroups. It has been observed that the same E. coli 
serogroup may harbour enterotoxigenic and enteroadherent serotypes (Guth et aL, 
1985), enterotoxigenic and invasive serotypes (Gross et al., 1983), cytotoxigenic and 
enteroadherent serotypes (Bopp et al., 1987) and cytotoxigenic and enterotoxigenic 
serotypes (Marques et al., 1986; Katouli et al., 1989). An 0138 strain has been shown to 
harbour the genes for cytotonic ST in addition to VTe (Meyer & Karch, 1989). 
Coexpression of two potent toxins may enhance the virulence of these strains in the 
host.
1.7 Clinical and public health significance of VTEC infections
Evidence that VTs are involved in the pathogenesis of diarrhoeal disease is 
predominantly circumstantial. There is, however, strong epidemiological evidence for 
this and in a substantial review of VTEC, Karmali (1989) documents numerous 
published studies of outbreaks and sporadic cases of VTEC infection, due in most cases 
to serotype 0157:H7 that indicate the spectrum of illness includes asymptomatic 
infection, mild uncomplicated diarrhoea, HC, HUS and thrombotic thrombocytopaenic 
purpura (TTP), a syndrome that is closely linked to HUS. The severe features of HC, 
HUS and TTP characterise VTEC as more important pathogens than the other types of 
EPEC.
1.7.1 Haemorrhagic colitis (HC)
HC was defined as a clinically distinct entity approximately 20 years ago. It is 
distinguished from inflammatory colitis by a natural progression from watery to bloody 
diarrhoea over the course of a few days and a relative lack of the usual signs of 
inflammation such as fever and large numbers of pus cells in the stool. The cause of the 
syndrome was unknown until 1982 when two separate outbreaks of HC in Michigan and
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Oregon were investigated by the Centers for Disease Control and led to the discovery of 
a particular serotype of E. coli, 0157:H7, as an etiologic agent (Riley et al., 1983). 
Historically, 0157:H7 has been a serotype that was rarely isolated from humans and 
animals. The Centers for Disease Control (Atlanta) detected only a single strain of 
0157:H7 in more than 3000 isolates serotyped in the period from 1973 to 1982 (Riley et 
a l, 1983); the E. coli Reference Center at Pennsylvania State University reported no 
serotype of 0157:H7 in more than 20,000 serotyped cultures isolated from animals 
(Riley et al., 1983); and in Great Britain, only one 0157:H7 strain was identified in 
more than 15,000 strains serotyped before 1983 (Day et a l, 1983). The study by Riley et 
al. (1983) attracted widespread attention and set the stage for several additional studies 
to understand better the magnitude of the problem. It soon began to emerge that E. 
coli 0157:H7 was by no means a rare serotype as initially thought but rather was a fairly 
common isolate from patients with HC and unspecified bloody diarrhoea. A survey in 
England and Wales showed that VTEC were responsible for 39% of sporadic cases of 
HC (Smith et al., 1987) and of these, 25% belonged to serotype 0157:H7. Studies have 
shown however, that VTEC associated with HC include atypical 0157 strains and other 
serotypes.
Although the precise role of VTs in HC is not fully understood there is substantial 
evidence that the toxins are important virulence factors in the development of bloody, 
oedematous vascular lesions of the colon (Fontaine et al., 1988). The toxins may also 
participate in the direct killing of colonic epithelial cells and may provoke fluid 
secretion and diarrhoea in the host (O’Brien & Holmes, 1987).
1,72 Haemolytic uraemic syndrome (HUS)
First described in 1955 as a distinct clinical entity, HUS is characterised by acute renal 
failure, thrombocytopaenia and haemolytic anaemia. The disease may present in 
several forms but in most cases a prodromal illness of bloody diarrhoea precedes the
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onset of the disease. HUS occurs in all age groups but represents the commonest cause 
of acute renal failure in children. In recent years increasing numbers of cases have been 
observed in localised epidemics during the summer months. HUS is rare in adults but it 
is not exclusively a disease of childhood (Crosse & Naylor, 1990). It has been reported 
in a variety of clinical and epidemiological settings and several different agents, 
including drugs, chemicals, toxins and microbes have been postulated as potential 
causes.
In a preliminary communication, Karmali et al. (1983) first reported that VTEC as well 
as free VT were present in the stools of some patients with HUS. Further studies 
indicated that VTEC have a close and probably causal association with HUS (Karmali 
et al., 1985a), a finding which has subsequently been corroborated by many investigators 
(Karmali, 1989). In Britain, E. coli 0157:H7 has commonly been associated with 
outbreaks and sporadic cases of HUS (Taylor et aL, 1986; Scotland et al., 1988; Milford 
& Taylor, 1990; Milford et al., 1990). In the states of Minnesota and Washington VT2 
producing E. coli 0157:H7 are the most common isolates from HUS patients (Ostroff et 
al., 1989; Martin et al., 1990). In contrast, in Buenos Aries which probably has the 
highest reported incidence of HUS in the world, approximately equal numbers of non- 
0157:H7 VTEC producing VT1, VT2 and both toxins are the principal causative 
organisms (Lopez et al., 1989). This last study underscores the importance of looking 
for VTEC strains in patients with HUS using a technique which is not specific for 
serotype 0157:H7.
An interesting situation which adds to the epidemiological base suggesting a possible 
role of VTs in HUS is that of cancer-associated HUS (C-HUS). This entity has been 
linked to the use of the drug mitomycin C as a chemotherapeutic agent (Lesesne et al., 
1989). Mitomycin is known to induce bacteriophages in bacteria and has been shown to 
dramatically increase the level of VT1 and VT2 produced in vitro (section 1.4.4.5). It is 
possible therefore, that therapeutic levels of mitomycin C during cancer treatment may
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also exert a similar inductive effect on VTEC that may be present in the gut flora 
(Acheson & Donohue-Rolfe, 1989). If so, then in situ induction of VT production may 
initiate or contribute to development of C-HUS, whereas in the absence of the inducing 
agent these organisms do not produce sufficient toxin to be pathogenic. Individual 
susceptibility may also be important and the value of antimicrobial treatment during 
illness remains conflicting. Studies by Ryan et al. (1986) suggested that antimicrobial 
therapy was ineffective, whereas some authors have found that antimicrobial treatment 
during the prodromal illness was associated with a mild clinical course and a good 
outcome (Martin et al., 1990). Others have reported a detrimental effect of 
antimicrobial use before hospitalisation for cases of HUS associated with infection with 
E. coli 0157:H7 (Carter et al., 1987). Also laboratory evidence suggests that some 
antimicrobial agents (such as trimethoprim-sulfamethoxazole) enhance the release of 
VT from E. coli (Karch et al., 1985). It has also been suggested that use of antimotility 
agents in the treatment of VTEC infections may result in increased mortality and 
morbidity (Ryan et al., 1986). Decreased intestinal motility may allow multiplication of 
the organism and increased production of VT.
The mechanism by which VT may be involved in the pathogenesis of HUS is at present 
unknown, although accumulating evidence suggests that the toxins may have a direct 
cytotoxic effect on endothelial cells (Obrig et al., 1988; Milford & Taylor, 1990). One 
study reports that VT decreases prostacyclin synthesis by endothelial cells (Karch et al., 
1988). Prostacyclin is important in regulating intravascular hemostasis and platelet 
aggregation. Furthermore, VT2 was seen to reduce prostacyclin synthesis more than 
VT1 and may reflect the relative potencies of these toxins in cell toxicity. 
Histopathologic studies of the kidneys of HUS patients have shown profound alterations 
in the glomeruli and it has been hypothesised that VTs produced by the VTEC strains 
are disseminated from the gut by the blood system and targeted to the kidneys where 
they generate damage to the glomerular endothelial cells (Wadolkowski et al., 1990b). 
Human vascular endothelial cells have been shown to be relatively resistant to ShT and
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V T s (Tesh et al., 1991). This may be due to reduced toxin binding, as low levels of Gt>3 , 
the VT1 and VT2 toxin-specific receptor (section 1.3.3.1), were found in human 
vascular endothelial cell membranes whereas Gb3 is a predominant neutral glycolipid 
in human renal tissue (Boyd & Lingwood, 1989). Boyd & Lingwood (1989) have also 
shown that except for the pig, renal tissue from various animals lack Gb3. This is 
consistent with the lack of renal lesions in animals given VT or VTEC.
1.7.3 Thrombotic thrombocytopaenic purpura ( TI P)
First described by in 1924, TTP is an uncommon disease of young adults and closely 
resembles HUS in its clinicopathological features but differs in that neurological signs 
and fever are more prominant in TTP. A pentad of clinical features are associated with 
TTP. These include, fever, thrombocytopaenic purpura, microangiopathic haemolytic 
anaemia, neurological manifestations which are often remittent and renal dysfunction. 
Most cases of TTP present without an antecedent illness, whereas a prodromal 
diarrhoeal illness is an essential feature of classical HUS. Recently two cases of TTP 
have been associated with E. coli 0157:H7 infection where, unlike the usual form of 
TTP, the patients had an antecedent bloody diarrhoeal illness and the disease therefore 
resembled classical HUS (Karmali, 1989).
1.7.4 Outbreaks of VTEC infection
VTEC strains of different serotypes are increasingly isolated from cases of human and 
animal diseases. Most of them belong to the serotype 0157:H7 and surveys have 
revealed that E. coli 0157:H7 is responsible for up to 40% of acute infectious 
diarrhoeas in some areas (Riley, 1987). Following the initial outbreaks of E. coli 
0157:H7 associated HC in Oregon and Michigan, numerous additional outbreaks have 
been reported and these have provided new insights into the natural history and 
epidemiology of VTEC infection.
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It has become evident from outbreak studies that VTEC infection results in a highly 
variable rate of complications with E. coli 0157:H7-related HUS and TTP more 
common at the extremes of age. The reasons for this are unclear and may be a function 
of several host and parasite factors including age, underlying condition (e.g 
gastrectomy), previous antibiotic treatment, presence or absence of specific antitoxic 
immunity, the inoculum size of the organism and strain characteristics may also play a 
role (see sections 1.4.4.1 & 1.7.2), (Carter et al., 1987). Other potential host factors to 
be investigated include the presence or absence of specific receptors on target cells and 
blood group status.
1.7.4.1 Influence of blood group status
The cellular receptor for both VT and ShT has been shown to require a terminal 
disaccharide, galactose-a(l-4)-galactose (section 133.1), which in man is linked to 
ceramide and paragloboside as the blood group antigens Pk and PI respectively 
(Lindberg et al., 1987). Approximately 75-80% of the normal Caucasian population 
express blood group PI on RBC but with varying degrees of antigenic strength and it 
has been found that there is a tendency for HUS patients, and especially those with 
more severe disease to be negative or only weakly positive for PI antigen expression. 
Additionally expression of various blood group antigens is age related and PI positive 
individuals have reduced expression both in their pre-school years and in senescence. It 
has been hypothesised therefore that in patients exposed to VT, adsorption of free toxin 
onto RBC may reduce the burden of VT to other target cells. Once internalised within 
the RBC the toxin will be relatively innocuous as there is no ribosomal activity for the 
active A subunit to interrupt. The early transfusion of PI positive RBC cells (or a 
specifically designed ligand) to bind and thus neutralise circulating toxin may prove to 
be a rational approach to treatment (Peter Rose, Warwick Hospital, personal 
communication).
41
1.7.4.2 Influence of toxin type
Recent studies from Britain and the U.S.A, in which the association of HUS and VTEC 
were examined, have shown that the majority of E. coli isolates produced VT2 either 
alone or together with VT1 (Scotland et al., 1988). In Washington state, 
epidemiological studies indicate that E. coli 0157:H7 strains with only VT2 genes are 
more likely to cause diarrhoeal disease that later progresses to HUS and TTP than 
organisms containing genes for VT1 or both VT1 and VT2 (Tarr et al., 1989; Ostroff et 
al., 1989). This finding was independent of age and antimicrobial use and correlates 
well with data indicating a critical role for VT2 but not VT1 in renal damage associated 
with E. coli 0157:H7 infection of streptomycin-treated mice (Wadolkowski et al., 
1990a). Perhaps isolates with only VT2 genes produce greater quantities of VT2 in vivo 
than do isolates with both toxin genes. Another possibility is that the VT2 genotype acts 
as a marker for other as yet unrecognised virulence characteristics.
It has become clear that the clinical presentation of VTEC infection spans a spectrum, 
ranging from asymptomatic infection, mild uncomplicated diarrhoea, HC, HUS and 
TTP to death. In Thailand, VTEC have been found in small numbers in a similar 
proportion of children with bloody diarrhoea in whom other pathogens were not 
identified and in controls without diarrhoea (Brown et al., 1989a). It is unclear why 
VTEC are found in as many well children as ill children but perhaps other cryptic 
virulence factors in addition to the toxin and adherence factors may be necessary to 
cause disease. Future studies may identify other factors necessary for VTEC to produce 
diarrhoea.
1.7.5 Epidemiology of VTEC infection
Most outbreaks of VTEC infection have been associated with serotype 0157.-H7. 
Results of multilocus enzyme electrophoresis studies indicate that 0157:H7 isolates
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from North America are interelated, forming a clonal group that has evolved relatively 
recently (Whittam et al., 1988). A second major finding by Whittam and colleagues was 
that the 0157:H7 clonal genotypes are only distantly related to other VTEC strains. 
One implication of the clonal relationship of 0157:H7 isolates is that there exists an 
effective mechanism for the widespread, geographic dispersal o f these organisms.
Symptomatic and symptom-free human carriers are presumed to be the principal 
reservoir of EPEC, EIEC and ETEC strains that cause human illness. These bacteria 
are present in the intestinal tract of carriers and are excreted in their faeces. Infected 
foodhandlers with poor personal hygiene or water contaminated by human sewage are 
sources of food contamination. VTEC however, are widely distributed in the intestines 
of animals and most outbreaks of E. coli 0157:H7 have been linked epidemiologically 
to the consumption of undercooked ground beef, and to a lesser extent to drinking of 
unpasteurised milk. Studies by Wells et al. (1991) suggest that dairy cattle, a source of 
both raw milk and beef products are a major reservoir of E. coli 0157:H7 and other 
VTEC. This data corroborates earlier studies by Montenegro et al. (1990) that 
apparently healthy cattle carry VTEC. In Sri Lanka however, VTEC were recovered 
significantly more often from cattle and water buffalo calves with diarrhoea than from 
healthy control animals, suggesting that VTEC may cause illness in cattle as well as in 
humans (Mohammad et al., 1985,1986).
Studies by Beery et al. (1985) revealed that E. coli 0157:H7 can readily colonise the 
caecae of chickens and can be excreted in the faeces for several months. This suggests 
that chickens may serve as hosts and possibly as reservoirs for E. coli 0157:H7. In 
surveys of retail raw meats and poultry (Doyle & Schoeni, 1987), 3.7% of ground beef, 
1.5% of pork, 1.5% of poultry, and 2.0% of lamb samples were found to be 
contaminated with 0157:H7, indicating that the bacterium is associated with foods 
particularly of animal origin and not specifically with beef. Additionally, in a report of 
the first community outbreak of HC in the UK due to E. coli 0157:H7, vegetables were
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thought to have been the source of infection (Morgan et al., 1988). Raw foods o f animal 
origin may be contaminated with the organism via faecal contact during slaughter or 
milking procedures and most human infections probably occur as a result of 
consumption of these foods when undercooked. Ground meats are thought to be more 
at risk if incompletely cooked and outbreak strains have been recovered from 
implicated beef products in two outbreaks (Wells et al., 1983; Hockin et al., 1987). The 
organism is believed to be a surface contaminant and the grinding of the meat would 
introduce the pathogen to the inside of the patty where undercooking is more likely.
Information currently available indicates that human VTEC infections occur most 
commonly in the summer among children under five years of age and in the geriatric 
population (Pai et al., 1988). Because of the disease's sharp summer peak in incidence 
and the association of the organism with hamburger meat, a common assumption is to 
link the disease with common summer food preparation practices. Thus the lay press 
has referred to it as "hamburger syndrome" or "barbecue syndrome".
In October 1988, an outbreak of E. coli 0157:H7 HC occurred among students 
attending a Minnesota school (Belongia et al., 1991). This outbreak was unusual 
because it was the first documented foodborne outbreak associated with consumption of 
heat-processed meat patties, a product that should be pathogen-free. Large-scale 
production and distribution for precooked meat products creates a potential for 
widespread illness and in reponse to this outbreak, specific requirements have been 
proposed for the manufacture of heat-processed uncured meat patties. In a study of the 
risk factors for E. coli 0157:H7 infection in an urban community (Bryant et al., 1989), 
proper food cooking (and handling) of all animal products, rather than the avoidance of 
these particular food products was found to be the primary prevention strategy.
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While VTEC infection in most cases is probably foodbome there is increasing evidence 
that VTEC infection can also be acquired through person-to-person transmission 
(Carter et al., 1987; Karmali et al., 1988).
1.8 Laboratory diagnosis of VTEC infection
The major obstacle in large-scale epidemiological investigations of the incidence of 
VTEC in diarrhoeal stools, is the lack of a rapid, simple and specific test to detect 
VTEC and their toxins. The purpose of the clinical microbiology laboratory is to 
rapidly and accurately provide the clinician with information concerning the presence or 
absence of a microbial agent that may be involved in an infectious disease process. 
Traditionally, this involves the isolation of a suspected pathogen from a clinical 
specimen followed by the identification of the organism by serological or biochemical 
methods. Depending on the organism, the entire identification process can take 
anywhere from several days to weeks.
Diagnosis of VTEC infection requires either the isolation of VTEC from stools, the 
demonstration of neutralisable free faecal VT (FVT) activity in stool filtrates or the 
detection of rising titres of neutralising antibodies (NAb) to VT in persons suffering 
from these illnesses. The available detection methods are discussed in detail in the 
following sections 1.8.1 to 1.8.8 and are summarised in figure 1.4.
1.8.1 Isolation of VTEC from stools
Considerable difficulty has been experienced in isolating VTEC from stools of patients 
with HUS and HC because the organisms have been present in low numbers. The low 
or undetectable numbers of VTEC in the stools of some of these patients can partly be 
explained by the fact that the first stool for investigation is usually received after HUS 
has been diagnosed and this typically occurs about 1 to 2 weeks after the start of an
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acute diarrhoeal disease (Karmali et al., 1985a). Also, findings suggest that faecal 
VTEC decline in numbers rapidly after the onset of symptoms (Karmali et al., 1985a, 
1985b; Wells et al., 1983) and that toxin can be detected in the stool long after the 
organism has disappeared (Pai et al., 1984).
Figure 1.4 A summary of the main tests available to diagnose VTEC infections
Diagnosis of VTEC infection requires either the isolation of VTEC from stools using 
selective media, the demonstration of neutralisable free faecal VT (FVT) activity in 
stool filtrates or the detection of rising titres of neutralising antibodies (NAb) to VT in 
persons suffering from these illnesses. Apart from a close association with 
enterohemolysin production, the majority of VTEC lack a common phenotypic marker 
to enable direct detection on selective media. 0157:H7 strains however, exhibit 
characteristics atypical of the E. coli group, non-sorbitol fermentation (NSF) and the 
inability to cleave the substrate 4-methylumbelliferyl-/3-D-glucuronide (MUG) to a 
fluorescent end product, methylumbelliferone. Consequently, MacConkey agar which 
contains D-sorbitol in place of lactose (SMAC) and SMAC-MUG medium have been 
used to aid in the detection of E. coli 0157:H7. Confirmation of presumptive VTEC is 
made using biologiacl or immunological assay methods to screen for the presence of 
VT. In addition genetic assay methods have been developed to demonstrate the 
presence of the genes coding for VTs. The various detection methods outlined are 
discussed in more detail in sections 1.8.1 to 1.8.8.
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Lack of a common phenotypic marker among the many different serogroups of E. coli 
said to produce VTs has hampered direct detection of these pathogens in clinical 
specimens and foods. Beutin et al. (1989) has since found that there is a close 
association, 89%, with VT production and enterohemolysin production in strains of E. 
coli, making enterohemolysin suitable as an epidemiological marker for the rapid 
detection of potential VT+ E. coli strains. Enterohemolysin is unrelated 
morphologically, serologically and genetically to a-hemolysin which is found frequently 
among human faecal E. coli strains and predominates in strains causing extraintestinal 
infections in humans.
Detection of VTEC on routine enteric media is time consuming and expensive. 
Biological or immunological assay methods have been employed to screen VTEC 
strains in mixed stool cultures for the presence of VT either in culture supernatants or 
directly in stool filtrates. In addition, genetic assay methods have been developed to 
demonstrate the presence of the genes coding for VTs in VTEC. However, the perfect 
solution - a simple, accurate, reproducible, cheap and sensitive analytical procedure is 
yet to be devised.
1.8.2 Screening media for the detection of E. coli 0157:H7
E. coli 0157:H7 has been found to exhibit characteristics atypical of the E. coli group of 
organisms. These traits have been used as strain markers and have facilitated detection 
of 0157:H7 in mixed flora from faeces on the appropriative selective media.
In 1982, in the two outbreaks in the U.S.A, it was noted that E. coli 0157:H7 failed to 
ferment sorbitol for 48 hours or more (Wells et al., 1983). March & Ratnam (1986) 
subsequently evaluated the usefulness of MacConkey agar which contained D-sorbitol 
in place o f lactose (SMAC) as a strain marker to aid in the detection of E. coli 0157:H7 
in stool cultures. Non-sorbitol fermenters (NSF) yield colourless colonies on SMAC
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(similar in appearance to non-lactose-fermenting colonies on MacConkey agar) and 
contrast well with the bright pink colonies of sorbitol-fermenting/positive (sor+ ) 
organisms of the faecal flora. They found that only 15% of faecal enterobacteria are 
NSFs and as 93-95% of all E. coli are sor+ , this led to the widespread use of SMAC for 
screening stool specimens. There has however, been one published report of a sor+ 
isolate of a VT producing 0157 from a patient with HC (Farmer & Davis, 1985). Also, 
prior exposure to sorbitol is known to induce sor+ mutants among E. coli 0157:H7. 
This however, does not pose a problem in the primary isolation of E. coli on SMAC 
medium.
Haldane et al. (1986) reported that all of their isolates of 0157:H7 produced lysine and 
ornithine decarboxylase and that this characteristic could be used with NSF as an 
improved biochemical screen for E. coli 0157:H7. A lysine negative 0157:H7 has 
however been described (Tison, 1990).
96% of E. coli isolates produce the enzyme /3-D-glucuronidase which cleaves the 
substrate 4-methylumbelliferyl-/J-D-glucuronide (MUG), providing a fluorescent end 
product, methylumbelliferone, that is detectable under a long wave UV light source. 
Very few organisms other than E. coli are MUG positive (MUG+ ). E. coli 0157:H7 on 
the other hand, has been reported to be uniformly MUG negative (MUG"), (Krishnan 
et al., 1987; Ratnam et al., 1988) and furthermore all 0157 serotypes which were VT+ 
were MUG". Thompson et al. (1990) developed a rapid MUG procedure (RM-MUG) 
to identify VT+ strains of E. coli serotype 0157. SMAC-MUG medium was very useful 
in isolating E. coli 0157:H7 from enrichment cultures of both ground beef and dairy 
products. However, problems were encountered with growth of Enterobacter, Proteus, 
and Hafnia colonies with characteristics similar to those of E. coli 0157:H7 on SMAC- 
MUG (i.e. sor" & MUG").
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A fluorescein-labeled polyclonal, affinity-purified goat antibody to E. coli 0157:H7 has 
been developed that enables rapid direct immunofluorescent identification of E. coli 
0157:H7 isolated from faecal specimens on SMAC agar (Tison, 1990). Specific typing 
of 0157:H7 can be achieved through slide agglutination using 0157 and H7 antisera. A 
screening medium containing H7 antiserum in sorbitol fermentation medium has also 
been developed (Farmer & Davis, 1985) and a latex agglutination test for the rapid 
presumptive identification of sor' colonies from SMAC has recently been described 
(March & Ratnam, 1989). Another problem is that another sor" Escherichia species, E. 
hermannii, may agglutinate some 0157 antisera (March & Ratnam, 1989). E. hermannii 
can be differentiated from E. coli 0157:H7 by cellobiose fermentation (Ratnam et al., 
1988) and it has been found useful to screen samples on cellobiose-MacConkey 
(CMAC) medium in addition to SMAC medium.
Many other serotypes of VTEC however, have been associated with clinical disease 
(Ritchie et al., 1992). Studies have shown that other serotypes of VTEC are sor+ 
(Krishnan et al., 1987) and therefore there is no obvious reason why the absence of 
sorbitol fermentation should be linked genetically to VT production. If total reliance is 
placed on SMAC medium there is a likelihood that serotypes other than 0157:H7 will 
be missed. The overall diagnostic strategy, therefore must be directed towards 
detecting VTEC in general, rather than detecting a single serotype. At present 
however, there are no differential markers for non-0157 VTEC and identification must 
be based solely on demonstration of VT.
1.8.3 Screening VTEC for VT production and detection o f free faecal VT (FVT)
Primarily, identification of strains producing different types of VT involved cytotoxicity 
assays and neutralisation with specific antibodies which use Vero and HeLa cell 
monolayers in tissue culture. A direct faecal VT assay to screen stool samples for VT1 
and VT2 has been developed (Ritchie et al., 1992). It involves screening stool
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supernatants for verocytotoxicity and the use of a neutralisation step for confirmation of 
positive results. When compared with stool culture for E. coli 0157:H7 on SMAC for 
the laboratory diagnosis of VTEC infections, results indicated that neither test detected 
all positives. Also, some specimens can be SMAC culture positive yet negative by direct 
FVT assay. These specimens tended to be collected early in the course of the illness 
and it is thought that the free toxin levels were not yet high enough to be detected in the 
stools. In an earlier study, Petrie et al. (1987a) showed that addition of the protein 
synthesis inhibitor cycloheximide, at concentrations of less than 32 ng ml*1, to Vero cell 
monolayers 1 day before the addition of VT significantly enhanced H30 VT activity in 
Vero cells. The reason for this is unknown. Perhaps if Ritchie and coworkers had used 
the enhancing effect of cycloheximide to improve the sensitivity of their Vero cell 
monolayers, those specimens which were negative by direct faecal assay but positive by 
SMAC culture might have been detected.
Whilst these bioassays are highly sensitive, they are slow, expensive, labour intensive 
and difficult to standardise. Maniar et al. (1990) has shown that the use of Vero cell 
suspension culture is as reliable as the use of Vero cell monolayers and provides 
detection of VT 24 to 48 hours earlier. However, tissue culture facilities may not be 
available in many clinical laboratories, especially those in underdeveloped and 
developing countries and therefore these assays have proved unsuitable for the 
screening of large numbers of bacterial isolates for epidemiological purposes.
A counter-current immunoelectrophoresis (CIE) method has been described to test for 
free FVT (Maniar et al., 1990). This method is easy to perform and takes only two 
hours to complete. The test however, gave 14.4% false-negative and 6.3% false-positive 
results. False-positives were thought to be the result of an antibody component against 
the somatic antigen 0157 in the antitoxin used, whereas false-negatives suggested that 
the minimum concentration of VT required to produce a positive result in the Vero cell 
system is insufficient to form a line of precipitation by the CIE test.
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1.8.4 Enzyme-linked immunosorbent assay (ELISA) methods to detect VT1 
and VT2
ELISA for use in diagnostic laboratories have been developed to detect many kinds of 
toxin such as cholera toxin, E. coli LT and ShT (Donohue-Rolfe et al., 1986). ELISAs 
for detection of VTs have also been developed (Kongmuang et al., 1987; Oku et al., 
1988; Downes et al., 1989). This technique has advantages over the Vero cell assay in 
being more accurate, simpler, rapid and less expensive. Identification and selection of 
VTEC strains typically can be performed within 24 hours making ELISA suitable to test 
large numbers of strains or colonies efficiently and economically. At present however, 
these assays lack sensitivity. Programmes per ml (pg ml'1) of toxin can be detected by 
the cytotoxic assay whereas nanogrammes per ml (ng ml'1) of toxin were required for 
positive ELISA results. Only those strains producing high to moderate levels of VT can 
therefore be detected, whereas those strains producing low VT levels and faecal extracts 
containing low levels of toxin cannot.
1.8.5 Colony blot assay with VT monoclonal antibodies to detect VTEC
Attempts to develop immunochemical tests to detect toxin-producing bacteria were 
hampered by the presence of cross-reacting antibacterial antibodies in polyclonal 
antitoxin and normal sera. It was proposed therefore, that the use of MAb rather than 
polyclonal antisera should improve the specificity of immunochemical tests for the 
detection o f VT. The limiting factor in the development of MAb against VT was the 
availability o f purified toxin for immunisations, screening assays and characterisation 
studies. The purification of VT routinely took 3 weeks and the yield of pure toxin from 
an 8 litre culture was approximately 200 microgrammes (/zg). Also, a major difficulty in 
detecting VTEC is that even for high level toxin producers the amount of VT 
synthesised is estimated to be less than 0.01% of total cellular protein (Karch et al., 
1986). Strockbine et al. (1985) first described the production and characterisation of
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three MAb against VT. One of these antibodies to VT1 was used in the development of 
a colony blot ELISA to detect V'l'EC producing VTl, VT1 and VT2. In the 
development of the colony blot assay, subinhibitory concentrations of the antibiotics 
trimethoprim and sulfamethoxazole were incorporated into the culture media, since 
they dramatically increased the production of toxin by several VTEC strains, as well as 
ShT by S. dysenteriae type 1 (Karch et al., 1986). At growth inhibitory doses, 
trimethoprim is a competitive inhibitor of dihydrofolate reductase and 
sulfamethoxazole is a structural analogue of paraminobenzoic acid. However, the 
mechanism by which trimethoprim-sulfamethoxazole stimulates toxin synthesis was not 
investigated. The strains tested in the colony blot assay had previously been tested for 
the levels of VT in the sonic lysates using the cytotoxicity assay (Marques et al., 1986). 
When analysed with respect to the level of toxin produced, the colony blot assay 
appeared to be sensitive for the identification of high VT-producing strains only. VTEC 
strains that were classified as low to moderate or trace toxin producers were negative in 
the blot assay. The MAb to VT2 developed by Perera et al. (1988) permitted the colony 
ELISA of Strockbine et al. (1985) to be upgraded to also detect most strains of E. coli 
which produce VT2 alone. The existance of antigenic variants among the VT2 
subfamily will necessitate the generation of MAb to each one to fulfill the goal of 
detecting all high-to-moderate level VTEC.
1.8.6 Receptor-based ELISA (RELISA) for VTs
Basta et al. (1989) reported a receptor-specific ELISA (RELISA) technique for the 
detection of VTl based on the binding affinity of VTl for Gb3 (section 133.1). Lyso- 
Gb3 (deacylated Gb3) which is more polar than Gb3 but retains VTl binding, was used 
as the capture molecule. The sensitivity of this assay made it possible to detect very low 
levels of VTl (down to 5 pg). The RELISA has overcome the shortfall in sensitivity by 
effectively concentrating the toxin from the sample for subsequent immunological 
detection. It is still not quite as sensitive as the cell culture cytotoxicity procedure,
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which can detect purified toxin down to levels of 1 pg. The RELISA was found 
however, to be as sensitive as the cell culture cytotoxicity assay when used to assay VT 
in the culture supernatants of various VTEC strains. The assay only detected VT1 but 
use of anti-VT2 instead of anti-VTl would render the assay capable of detecting VT2 
and a mixture of both antibodies would detect both toxins. Another RELISA has been 
developed using PI glycoprotein from hyatid cysts (Acheson et al., 1990). This assay 
detects ShT, VT1 and VT2 and is sensitive in the subnanogramme level.
Even with these sensitive tests there are some cases where VTEC cannot be isolated 
and no faecal VT found. An alternative test in this situation is to demonstrate a serum 
antibody response to VT. A modification of the RELISA developed by Basta et al. 
(1989) has recently been described (Boulanger et al., 1990) for the detection of NAb to 
VT1 (NEUTRELISA). This assay can be performed in 6 hours as opposed to the 
cytotoxicity neutralisation assay, which requires up to three days. The NEUTRELISA 
will be useful in the diagnosis of HUS, particularly for those patients who present late in 
their illnesses and whose stools do not demonstrate VT. Future modifications of the 
RELISA technology are expected to result in the development of rapid assays for the 
detection o f  VT2 and its NAb. Application of such a battery of assays would provide 
comprehensive seroepidemiologic data on VTEC infections.
1.8.7 Immunoassay detection methods for VTEC from food
Isolation and detection methods first used for detection of VTEC in foods concentrated 
on the isolation of E. coli 0157:H7 by plating foods on selective media modified to 
allow the growth of 0157 strains (incubation temperature less than 45°C), and to 
demonstrate their typical biochemical reactions (inability to ferment sorbitol, lack of 
fluorescence in the presence of MUG and production of indole). Doyle & Schoeni 
(1987) have used a hydrophobic grid membrane filter (HGMF) immunoblot technique 
and PAb raised against a crude VT preparation to identify all VT1 and VT2 producing
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bacterial strains in retail meats. Todd et al. (1988) later used HGMF to isolate and 
enumerate E. coli 0157 from food with specific identification by an anti-0157 MAb. 
They found that use of a MAb rather than a less specific polyclonal avoided cross­
reaction with non-0157 strains that had yielded false positives in other identification 
schemes (e.g E. hermannii). Group N Salmonellae however could not be excluded and 
required further investigation with antisera to identify any group N Salmonella spp. 
present. The sensitivity of this HGMF method was 10 E. coli per gramme (g) which was 
not as great as the more laborious research enrichment method of Doyle & Schoeni 
(1987), (1.5 E. coli 0157:H7 per g). Recently a MAb raised using a rough strain of E. 
coli 0157:H7 has been produced that is specific for E. coli 0157:H7 and 026:H11 
(Padhye & Doyle, 1991a). This MAb reacted specifically with two chromosomally 
encoded outer membrane proteins of apparent MW of 5000 to 6000 which appeared to 
be markers specific for EHEC strains of serotypes 0157:H7 and 026:H11. This MAb, 
because of its specificity has been now used in an enrichment-sandwich ELISA for the 
rapid and sensitive detection, (0.2-0.9 E. coli 0157:H7 per g), of these types of EHEC 
isolates in food (Padhye & Doyle, 1991b).
1.8.8 VT1- and VT2- specific DNA probes
DNA or RNA hybridisation with probes derived from virulence genes has previously 
been demonstrated to be an alternative technique which can facilitate detection of 
bacteria containing similar pathogenic characteristics (Moseley et al., 1980).
A DNA probe for the detection of a 60 MDa plasmid typically carried by 0157:H7, that 
promotes epithelial cell attachment of VTEC has been prepared by Levine et al. (1987). 
However, because plasmids of E. coli may be lost during isolation, this probe would not 
detect EHEC isolates that no longer carry the 60 MDa plasmid. Specific DNA probes 
have been developed to identify DNA sequences that code for VT1 and VT2. These 
probes have advantages in that the hybridisation test is specific and sensitive and that a
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large number of test samples can be processed at one time. In addition gene probing is 
considerably faster than, and probably as specific as testing culture supernatants or 
sonic lysates in tissue cultures for cytotoxicity and inhibiting their effect with antibodies 
to VT1 and VT2. DNA probes however, do not give an indication of the level of toxin 
expression, which has been shown to be important in studies of pathogenesis (Marques 
et al., 1986).
1.8.8.1 Cloned DNA fragments as probes
Willshaw et al. (1987) reported identifying restriction fragments from VT1 and VT2 
clones that may be purified and used as VT gene probes. Newland & Neill (1988) also 
developed two pairs of DNA probes to identify and distinguish those strains which 
encode VT1 and VT2. The first pair consisted o f  internal restriction fragments cloned 
from the structural genes for VT1 and VT2. The VT2 probe in this study also functions 
as a probe for VTe because the VT2 fragment was chosen from a region of the VT2 
gene which contains sequences homologous to those present in VTe. These cloned 
DNA probes however, are not able to differentiate between the genes coding for VT2 
and VT2v. The second pair of probes consisted o f restriction fragments not associated 
with VT synthesis and are used to assess the association of phage type with VT type.
DNA probes have been used to detect VTEC in food and calf faecal samples 
(Samadpour et al., 1990). Enrichment cultures prepared from food or faecal samples 
were probed for VTEC by colony hybridisation or by dot blot. VTEC were detected at 
concentrations as low as 1.3 colony forming units (CFU) per g of sample. The dot blot 
technique yielded results within 48 hours, whereas the colony hybridisation technique 
takes 3 to 4 days but permits recovery of the positive colonies when desired. Gene 
probing can be performed with ease and sensitivity to the screening of food and 
environmental samples for the detection of organisms bearing the VT genes. This 
technique has two definite advantages. First of all VTEC, regardless of serotype, can be
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detected and recovered and cross-reactive organisms that could be detected by the 
antibodies to the 0157 antigen are avoided. Also after hybridisation and exposure to X- 
ray film the colony hybridisation and dot-blot filters can be washed and reprobed. This 
makes the method suitable for detection of a wide range of pathogens for which specific 
DNA probes are available and which would grow well in the enrichment media.
Gene probes are a useful diagnostic technique but are not available to most clinical 
laboratories due to the cost of reagents with short shelf lives, concerns of handling and 
disposal of radionucleotide-labeled DNA. Gicquelais et al. (1990) describe a simple 
and economical method for using biotin-labeled DNA probes with bacterial colony blots 
to identify diarrhoea-causing E. coli. The biotinylated probe method exploits the high 
affinity of streptavidin for biotin-labeled molecules in a sandwich system analogous to 
an indirect ELISA. A streptavidin-alkaline phosphatase conjugate is used to 
colorimetrically detect biotin-labeled DNA probes which have hybridised to target 
DNA present on the filter paper. Biotinylated DNA probes as well as their ease and 
safety in handling have a long shelf life. Laboratories with limited budgets and those 
that do not have the facilities to use radioisotopes will benefit from this technique.
1.8.8.2 Synthetic oligonucleotide probes
Analysis of the nucleotide sequences of VT1 (Jackson et al., 1987a) and VT2 (Jackson et 
al., 1987b) suggested that oligonucleotide probes could be constructed and used to 
identify VTEC. The structural genes of VT1 and VT2 are 58% homologous in overall 
nucleotide sequence, although there are localised regions of much lower or much higher 
homology. A sequence of high homology might be used as a probe to detect E. coli 
producing VT1, VT2 and VTe, while a region of low homology could be used as a probe 
to differentiate between E. coli producing different forms o f  VT. A number of 
oligonucleotide probes have been synthesised to enable detection of the different types 
of VT by DNA hybridisation. Details of these are shown in table 1.7.
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T a b le  1 .7 S y n t h e t i c  o l ig o n u c l e o t id e  p ro b e s  f o r  VT DNA h y b r i d i s a t i o n
Oligo­
nucleotide
probe
Toxin
type
detected
Oligonucleotide sequence (5 * -3 ') Location
within
genee
Reference
777* VT1 GAT GAIC T CAGT GGGCG1T C 772-791 Kerch t  Meyer (1969a)
M9h VT2, VTe TCIGAAACTGCTCCTGTGTA 849-868
428-Ib VT1 GATAGTGGCICAGGGGA1AA 428-447 Kerch ft Meyer (1989b)
428-l l b VT2, VT2v AACCACACCCACGGCAGIIA 428-447
I* VT1 ACTGCAAAGACGT A1GT AGAT1CGCT GAATGT CAT1CGC1C 250-290 Meyer et a l. (1989)
II* VT1 TGATCTCAGTGGGCGTTCTT 774-79Î
III* VT1 CTTACATTGAACTGGGGAAGGI1GAGTAGCGTCCTGCCTGA 820-860
iv - VT1 ACCTTTACAGTTAAAGTGGGTGATAAAGAATTATTTACCAA 1231-1271
yh VT2, VTe TCTGAAACTGCTCCTGTGTATACGATGACG 849-878
Alb VT1 ATACTGAATTGTCAICAICA 1013-1032 Brown et a l. (1989b)
■ l l b VT2, VTe AAGT ATAATGAGGATGACACAt T T ACAGTG 1297-1326
E5135b VT2 CCCGTCAACCTTCACTGTAAATGTGTC 1312-1338 Hii et a l. (1991).
AB157c,d VT2v GATACAT T CACAGIAAAAGT GGCCGGA 1312-1338
a DNA sequences of genes according to De Grandis et a i. (1967). 
b DNA sequences of genes according to Jackson et a (. (1987b)
c Oligonucleotide A6157 has the sequence of the sense (♦) strand. Utile 15 1 » has the science of the antisense ( - )  strand. 
d Sequence of A6157 is based on the sequence derived froai Nii et a l. (1991).
• Location corresponds to the position of bases in the previously published nucleotide sequences of the i U - l *  and i ü - l l b genes.
1.8.8.3 Synthetic oligonucleotide primers
DNA hybridisation with specific polynucleotide (Willshaw et al., 1987; Newland & Neill, 
1988) and oligonucleotide (table 1.7) probes complementary to VT gene sequences has 
been shown to facilitate detection of VT producers. However, several problems must 
be faced before standard immunological or DNA hybridisation detection methods for 
VTEC can be introduced for routine laboratory use. One of these difficulties is 
serological and genetic heterogeneity among VTs. In the VT operons sequenced to 
date there are conserved regions especially in the genes that encode A subunits (Karch 
& Meyer, 1989b). If these regions are several hundred base pairs apart from each other 
they are suitable targets for oligonucleotides used as primers to amplify the DNA 
segment between these nucleotide sequences by PCR. Different sets of oligonucleotide 
primers have been devised and used to detect the different types of VT by PCR. Base 
sequences, locations and predicted sizes of amplified products for these VT-specific 
oligonucleotide primers are shown in table 1.8.
Karch & Meyer (1989b) produced a single pair of oligonucleotide primers designed to 
amplify a segment of the VT genes by PCR which were nonidentical to sequences 
published for genes for VT1 and VT2. These so-called degenerated primers contained 
intentionally introduced sequence ambiguities from highly conserved regions among 
genes for VTs to efficiently amplify sequences from VTEC strains irrespective of the 
type of toxin produced. Furthermore they synthesised two additional oligonucleotides 
with the capacity to determine whether the amplified segments are derived from VT1 or 
VT2 genes. Pollard et al. (1990a) designed a set of four synthetic oligonucleotide 
probes derived from the sequences of the VT1 and VT2 genes and used these in a PCR 
amplification procedure to detect these genes in some enteric pathogens. The 
oligonucleotide probes clearly distinguished VT1 and VT2 strains of E. coli and did not 
give specific amplification with nucleic acid from VTe-producing E. coli. Johnson et al. 
(1990) further synthesised a set of oligonucleotide primers specific for the VTe A
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Table 1.8 Base sequences, locations and predicted sizes of amplified products for 
VT-specific oligonucleotide primers
Primer Toxin type 
(5 '-3 '>
Oligonucleotide sequence 
sequence*1’ 5
Location 
within gene
Size and location of 
aaplified product (bp)
Reference
MCI ShT, VT1, VT2, TTTACGATAGACTTC1CGACb 311-330 227 (VT1A)e Kerch t  Meyer (1989b)
MK2 VT2v, Vie CACATATAAATIATTTCCCTCb 515-535 224 (VT2A)
Vila ShT, VT1 GAAGAGTCCGTGGGATTACG*1 1191-1210 130 (VT16) Pollard et a l. (1990a)
VI 1b AGCGAIGCAGC TAT T AAT AA*1 1301-1320
VT2a VT2 TIAACCACACCCACGGCAGT*3 426-445 346 (VT2A)
VT2b GCTCTGGATGCATCTCTGGT*5 752-771
VTIc VT1 ACCCTGTAACGAAGTTTGCG*2 31-50 140 (VT1 promoter) Pollard et al. (1990b)
VTId ATCTCATGCGACTACTTGAC*2 151-170
VTe-a VTe CCTTAACTAAAAGGAATATA*4 217-236 230** •* Johnson et a l. (1990)
VTe-b CTGGTGGTGTATGATTAATA*4 427-446
VT2-C VT2, VT2va t  b AAGAAGATGTTTATGGCGGT*5 1210-1229*:1213-1232* 285 Tyler et e l. (1991)
VT2-d CACGAATCAGGTTATGCCTC*5 1475-1494*:1478-1497*
VT2v-1 VT2va 1 b CAT TCACAGTAAAAGTGGCC*5 1319-1338* 385
VT2v-2 GGGTGCU CCCGGTGAGT TC*5 1684-1703*
stx/sltl S' ShT, VT1 GACAGGATTTGTTAACAGG*2 460-478 680 Jackson (1991)
stx/slt1 3' TTCCAGTTACACAATCAGGC*2 (VTIA/ShTA)
• Primers desisted on published OtU sequences for VT1 (Calderuood et e l. .  19871 ; Strockbine et >1. .  19682) ,  VT2 (Jackson et a l. .  1967b5) ,  Vie 
(Weinstein ct at..  1968a4) .  VT2v (Ito  et a l. .  19905).
b Primers MCI and MK2 are nonidentical to the gen* sequences for VT1 and VT2 but contain intentionally introtfcjced aafciguities such 
that they shou at least 90X homology to their target sites for both VIIA and VT2A. 
c VT1A gene se*aent is longer by 3 bases because it contains an additional trip le t at position 449 that is not present in the VT2A subunit gene.
•* Encompasses regions for the proposed promoter and a portion of the A subunit of the Vie operon.
••* Encompasses regions for VT2* and VT2va l  b* ■ subunits respectively.
subunit gene which when used in association with the primers for VT2 (Pollard et al., 
1990a), will rapidly and specifically distinguish VT2 and VTe genes in VTEC. Although 
VT2 and VTe share extensive DNA sequence homology they can be differentiated and 
clearly distinguished by varying the degrees of stringency in the PCR protocol. Use of 
these PCR protocols allowed the definitive characterisation of strains originally 
suspected to be human VTe isolates because of their low cytotoxicity to HeLa cells, as 
VT2 and not VTe producers. None of the biological, immunological or other molecular 
techniques described previously could differentiate ShT from VT1. Although it is 
impossible to distinguish the gene products, a unique sequence in the promoter region 
of the sit-1 gene has allowed genetic differentiation of VT1 from ShT using PCR 
technology (Pollard et al., 1990b). As mentioned in section 1.4.3.4, Tyler et al. (1991) 
designed a set of synthetic oligonucleotide primers for use in the PCR protocol that can 
specifically detect the B subunit genes in vtx2ha and vtt2hb. An additional set of 
primers amplified a fragment common to the B subunits of the VT2 and VT2v genes. 
Subsequent restriction endonuclease digestion of this amplicon permitted prediction of 
specific VT2 and variant genotypes on the basis of predetermined restriction fragment 
length polymorphisms.
The PCR technique is relatively simple and combined with its superior sensitivity and 
specificity should enable rapid screening for the presence of VTEC in clinical specimens 
and food samples. The ability to analyse specimens without the isolation of specific 
organisms should facilitate rapid diagnosis and treatment. Subsequent to extraction of 
DNA, the PCR protocol yields in 4 hours, data that would require several days by 
traditional tissue culture assays. Furthermore, as no correlation exists between the 
intensity of amplification products observed in the PCR and cytotoxin titres, the 
application of the VTl-specific PCR protocol (Pollard et al., 1990b) to a larger group of
E. coli isolates should clarify the significance of low-level VT1 production previously 
reported in some strains. However, because these PCR methods may require purified 
DNA, visualisation of the amplified product by agarose gel electrophoresis, or Southern
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blot hybridisation with a radioactive DNA probe, they are not entirely appropriate for 
screening large numbers of samples in diagnostic laboratories. Olive (1989) adapted 
the PCR technique for the identification of ETEC strains and used an alkaline 
phosphatase (PhoA)-labeled DNA probe in a spot blot assay to detect amplified 
products, making it better suited to clinical laboratories. More suited to rapidly 
screening large numbers of clinical isolates, Jackson (1991) describes a PCR technique 
to detect ShT and VT1 in which individual colonies from solid medium were inoculated 
directly into the PCR mixture. The PCR products from liberated target DNA were 
amplified with stxA/sltl gene primers and labeled by direct incorporation of the non- 
radioactive TTP analogue, digoxigenin-ll-dUTP (DIG) in the reaction mixture. DIG- 
labeled PCR products were then hybridised to homologous DNA immobilised on a 
nitrocellulose membrane and detected immunologically by using an PhoA-conjugated 
antibody to digoxigenin. In future studies, the feasibility of this non-radioactive PCR 
detection method may be assessed using additional primer pairs capable of detecting 
strains which produce other VT types.
1.9 Vaccines to VTs
A toxoid form of whole ShT has been used in the past as an immunogen and shown to 
produce a protective antibody response to ShT in rabbits (Donohue-Rolfe et al., 1984). 
Specifc antibodies to the B subunit were affinity purified from this serum and shown to 
neutralise the cytotoxic activity of ShT towards HeLa cells (Donohue-Rolfe et al., 1984). 
Boyd et al. (1991) developed a vaccine candidate against the effects of ShT and VT1 in 
humans by immunising rabbits with VT1 B subunit. They avoided the issue of residual 
toxicity this way and obtained sera with high neutralising titres against VT1. No 
neutralising activity against VT2 was observed in the Vero cell assay. In an attempt to 
develop an effective vaccine against ED, Gordon et al. (1992), using oligonucleotide- 
specific site-directed mutagenesis have identified an amino acid in the A subunit that 
drastically reduces the enzymatic activity of VTe. Pigs vaccinated with this mutant
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toxin, designated SLT-IIvE167Q, developed a NAb titre of 1:512, 21 days postinjection 
and their tissues were free of ED lesions. These data suggest that SLT-IIvE167Q may 
represent an effective vaccine against ED. As yet, no potential vaccine candidates have 
been described for use in immunisation against the potentially fatal VTEC associated 
syndromes of HC and HUS.
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1.10 Aims of the project
A pathogen is often defined as a microorganism that has the capacity to cause disease in 
a particular host (Falkow, 1990) and not unexpectedly, a good deal of research effort 
has been and is, directed at the treatment and prevention of these diseases. Ever since 
bacteria were first recognised as causing diseases, investigators have been intent on 
understanding how they do so and major advances, fueled largely by application of a 
genetic approach, have been made in the biochemistry, immunology and cell biology of 
the host-parasite interaction. For many years the only bacteria that could be studied at 
the molecular level were those in which one or more genetic systems for the transfer of 
DNA were available. This allowed the mapping of a few bacterial genomes and the 
identification of genes whose products regulated other genes in trans. The advent in the 
last decade of recombinant DNA and gene cloning techniques, as well as rapid DNA 
sequencing methods has resulted in an explosion of research on the molecular 
mechanisms of regulation of virulence determinants in bacterial pathogens.
Microbial pathogenesis is usually complex and multifunctional. The host 
microenvironment varies considerably during the course o f infection and a successful 
pathogen must be capable of regulating many different factors both coordinately and 
sequentially to prevent the host from eliminating it and to enable it to grow and 
multiply. Study of this phenotypic modulation of virulence gene expression in response 
to environmental stimuli converts the extraordinarily complex host-parasite relationship 
to the more tractable task of studying bacterial physiology and can offer insights into the 
strategies of pathogenesis.
There is considerable clinical, genomic and pathogenic information relating to VTs, but 
little pertinent to the physiological state of the bacterium. This project was initiated to 
examine the physiology of VT production by E. coli. Control of expression of genes 
encoding virulence determinants is usually at the level of transcription (Mekalanos,
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1992). Consequently it was necessary to develop an assay to enable quantification of 
VT1 and VT2 gene expression at the molecular level, as no rapid and specific assay of 
this type was available at the time. Subsequently this assay could be used to attempt to 
elucidate the relationship between the various nutritional and physical parameters that 
control VT1 and VT2 synthesis in laboratory culture and then correlate these with 
potential signals that may trigger toxin synthesis during the infection cycle.
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2 Materials and methods
2.1 Bacterial strains and plasmids
The bacterial strains and plasmids used in this study are listed in tables 2.1 and 2.2 
respectively.
Table 22 Plasmids
Plasmid Phenotype Source Reference
NTP705 Knr j/i-IB' B. Rowe Willshaw et al. (1985)
NTP707 Tcr s/MI B. Rowe Willshaw et al. (1987)
pSC105 Apr Knr, 
slt-lA'vJTnphaA
S. Calderwood Calderwood & Mekalanos (1987)
pSLF22 Knr,
slt-U::TnphoA
This study
pSLF34 Knr,
slt-Tl::TnphoA
This study
2 2  Bacteriophage
The bacteriophage used in this study are listed in table 2.3.
Table 2.3 Bacteriophage
Phage Source Reference
Lambda Vir P. Reeves, Warwick University
Lambda TnphoA P. Reeves, Warwick University Manoil & Beckwith (1985)
65
Table 2.1 Bacterial strains
Strain Genotype Source Reference
E. coli 0157:H7 - ATCC
35150
Wells (1983)
E. coli 026:H11 - NCTC
8781
Parker, M.T. 
(1953). PHLS 
Manchester
E. coli 0157:H7 
Clinical isolate
- Warwick
Hospital
-
E. coli K12 - Warwick
University
-
E. coli 026.H U  
(E3787/H19)
- S. Scotland Willshaw et aL 
(1987)
E. coli 0157:H* 
(E32511)
- S. Scotland Willshaw et al. 
(1987)
E. coli 
C600(933J)
- T. Meyer Meyer et aL (1989)
E. coli 
C600(933W)
- T. Meyer Meyer et aL (1989)
E. coli K12 
60R746
- B. Rowe Willshaw et al. (1985)
E. coli K12 
60R363
- B. Rowe Willshaw et al. (1987)
E. coli DH1 F , recAl, endAl, 
gyrA96, thi-1, 
hsdK.il, (n[‘Mic+ ), 
supE44,k'
P. Reeves Hanahan (1983)
E. coli CC118 F , (¿ara-leu)!691 
araD139, (/ac)X74, 
ph oA  20, ga/E, ga/K, 
thi,rpsE, rpoB, 
arg E(Am), recAl
P. Reeves Manoil & 
Beckwith (1985)
E.coli TGI (pro-lac)?supE, 
thi, F ,  (raO,
D. Cardy Carter et aL 
(1985)
S. dysenteriae 
Type 1
'
S. Colby
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2 3 Media
All media, unless otherwise stated, was sterilised by autoclaving at 121°C for 15 minutes 
(min). Solid media was prepared by the addition of 1.5% weight by volume (w/v) Difco 
Bacto Agar. Soft media was prepared by the addition of 0.5% (w/v) Difco Bacto Agar. 
For use as top agar in the preparation of bacterial lawns (2.11.2), the agar was remelted 
and kept at 50°C in a water bath.
23.1 D D A
Bacto tryptone 
NaCl
per litre
20 g
8 g
After sterilisation and once cool, MgSC>4 was added to 10 mM from 1 M stock.
2 3 3 LB (Luria Bertani)
per litre
Bacto tryptone 10.0 g
Bacto yeast extract 5.0 g
NaCl 10.0 g
(PH 7.5)
2 3 3 Iron limited media
For growth under low iron conditions, LB media was supplemented with 0 .2  mM 2,2'- 
dipyridyl (Sigma) from a 0.1 M 50% volume by volume (v/v) ethanolrwater stock, as 
described by Calderwood & Mekalanos (1987).
23.4 LB/Mal/Mg2 * media
To sterile LB was added: Maltose to 0.2% (w/v) from 20% (w/v) stock and Mg2 + to 
10' 2 M from 1 M MgS0 4  stock.
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2.3.5 Low phosphate media. (Roeder & Collmer, 1985)
per litre
MgSC>4.7H20 0.1 g
(NH4 )2SC>4 1.0 g
Na citrate 03  g
Tris 12.1 g
(pH 7.4)
After sterilisation and once cool, KH2PO4 was added to 100 from 100 mM stock 
and glucose to 0.2% (w/v) from 20% (w/v) stock.
23.6 Minimal salts media
Minimal Salts (x4)
20% (w/v) Glucose
Minimal salts solution (x4).
NH4CI 20.0 g
NH4NO3 4.0 g
Na2S0 4  anhydrous 8.0 g
K2HPO4 anhydrous 12.0 g
KH2PO4 4.0 g
MgS04 .7H20  0.4 g
Each salt was added in the order indicated to 1 litre of distilled water (DW).
per litre 
250 ml 
10 ml
23.7 M9 minimal media
M9 salts (xlO) 
CaCl2 10 mM 
MgSQ4
per litre 
100 ml 
10 ml 
0.1 M
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M9 salts (xlO)
per litre
Na2HPC>4 anhydrous 60 g
KH2PO4 anhydrous 30 g
NH4CI 10  g
NaCl 5 g
(pH 7.4)
2.3.8 Penassay media
Penassay broth (Difco Antibiotic Medium No.3) was prepared according to the 
manufacturer's instructions.
23.9 TYE
Bacto tryptone 
Bacto yeast extract 
NaCl
2.4 Antibiotics
Antibiotic stock solutions were prepared as described in Maniatis et al. (1982) and used 
at the following concentrations (unless otherwise stated).
per litre
10  g 
10  g
5g
Antibiotic Stock concentration 
(mg ml'*)
Final concentration 
(Mi ■*"*)
Ampicillin (Ap) 100 100
Chloramphenicol (Cm) 35 10
Kanamycin (Kn) 25 50
Tetracycline (Tc) 123 15
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2.5 General chemicals and m aterials used in this study
Chemicals Supplier
32p-dcrp Amersham
DNA sequencing nucleotides Pharmacia
DNA sequencing materials 
(acrylamide, bisacrylamide, AMPS, 
SDS and urea)
BioRad Labs
General materials BDH/Sigma or 
Fisons
^S-methionine Amersham
Nitrocellulose filters (Hybond-C) Amersham
Organic acids and Solvents May & Baker, 
Fisons or BDH
Restriction enzymes and buffers Amersham or BRL
X-ray film Fuji Photo Film 
Co. Ltd.
2.6 General soIutions/bufTers
These solutions are referred to in the text of this chapter. Their compositions and 
where appropriate, the procedures for their preparation are described below.
Aniline reagent A  universal vial (calibrated to 11 ml) was washed
with concentrated HC1, rinsed thoroughly with 
sterile DW (SDW) and dried in an oven. 0.5 ml 
glacial acetic acid, 7 ml SDW and 1 ml redistilled 
aniline were added and the pH adjusted to 4.5 with 
glacial acetic acid. This solution was stored in the 
dark at 4°C.
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Chloroform
(for DNA extraction)
24:1 (v/v) chloroform:isoamyl alcohol
Denhardts solution
(x50)
5 g Ficoll
5 g Polyvinylpyrrolidone 
BSA (Pentax fraction V) 
DW to 500 ml
ENDO buffer (x2) 25 mM Tris-HCl pH 7.6 
25 mM KC1 
5 mM MgCl2
Formaldehyde loading 
buffer (FLB)
50% (v/v) Formamide
6% (v/v) Formaldehyde
lx MOPS Buffer
10% (v/v) Glycerol
100 fig ml' 1 Ethidium Bromide
0.025% (w/v) Xylene Cyanol
0.025% (w/v) Bromophenol Blue
Formamide
(for ricin assay)
deionised by addition of 1 g of 
Duolite MB6113 (BDH) resin to 100 ml formamide. 
This was stirred for 1 hour, filtered through 
Whatman No.l filter paper and 0.5 M NaOH added 
to pH 7.0. This was stored in the dark at 4°C.
Formamide
(for RNA extraction)
deionised by addition of 5 g mixed 
bed resin (Bio-Rad AG501-X8, 20-50 mesh) to 50 ml 
formamide. This solution was stirred for 30 min, 
filtered through Whatman No.l filter paper and 
stored in aliquots at -20°C.
Kinase buffer (xlO) 700 mM Tris-HCl pH 8.0 
100 mM MgCl2
Loading buffer type IV
(x6)
0.25% (w/v) Bromophenol Blue 
40% (w/v) Sucrose
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Loading buffer (x5) 
(for Western Blotting)
0.125 M Tris-HCl pH 6.8 
10% (w/v) Sucrose 
4% (w/v) SDS
0.25% (w/v) Bromophenol Blue
Lysis mix 0.05 M Tris 
0.0625 M EDTA 
2% (w/v) Bri j58 (Sigma) 
0.4% (w/v) Na deoxycholate
MOPS buffer (x5) 5 mM EDTA pH 8.0 
50 mM Na Acetate 
200 mM MOPS pH 7.0
Phage buffer 10 mM Tris pH 7.4 
10 mM MgS04 
0.01% (w/v) Gelatin
Phenol
(for DNA extraction)
Neutralised with 1 M Tris-HCl pH 8.0, 
and containing 0.1% (w/v) 8-hydroxyquinoline
Phenol
(for RNA extraction)
100 g BRL ultra pure phenol melted at 
68°C. 0.1 g 8-hydroxyquinoline was added and the 
mixture left overnight to equilibrate in 20 mM Na 
Acetate buffer, pH 5.6
Potassium phosphate 
buffer (pH 7.0)
30.5 ml Na2HP0 4  (0.2 M)
19.5 ml NaH2P0 4 .2H2 0  (0.2 M) 
To 100 ml with SDW
SAE 0.5% (w/v) SDS 
1 mM EDTA pH 8.0 
20 mM Na Acetate pH 5.6
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Salmon sperm DNA
(denatured)
The DNA (Type-III sodium salt, Sigma) 
was dissolved in water (10  mg ml'*) and sheared by 
passing several times through an 18-gauge 
hypodermic needle. After boiling for 10 min 
aliquots were stored at -20°C.
Sequencing buffer
(x5)
200 mM Tris-HCl pH 7.5 
50 mM MgCl2 
250 mM NaCl
Sodium acetate
(3 M pH 6.3)
3 M Na Acetate brought to pH 6.3 with 
acetic acid.
SSC (x20) per litre
1753 g NaCl
88.2 g Trisodium citrate
pH 7.0
SSPE (x20) per litre 
174 g NaCl
27.6 g NaH2P 0 4 .H20  
7.4 g EDTA 
pH 7.4
STET 8% (w/v) Sucrose 
50 mM Tris-HCl pH 8.0 
50 mM EDTA 
5% (w/v) Triton X-100
Sucrose solution 36 mM Tris-HCl pH 7.8 
40% (w/v) Sucrose 
2 mM EDTA
Tris borate (TBE) 0.089 M Tris-borate 
0.089 M Boric acid 
0.002 M EDTA
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TE 10 mM Tris-HCl pH 8.0, 
1 mM EDTA 
pH 8.0
Tris-phosphate (TPE) 3.6 mM Tris 
3 mM NaH2P 0 4 
0.2 mM EDTA
Tris-sucrose 0.05 M Tris
(for DNA extraction) 25% (w/v) Sucrose 
pH 8.0
Western transfer buffer per litre
(WTB) 14 g Glycine 
2.42 g Tris 
200 ml Methanol
2.7 Growth and maintenance of bacterial cultures
2.7.1 Organism maintenance
All strains (with the exception of E.coli TGI) were maintained on LB agar plates 
containing the appropriate antibiotics where required, for up to 6 weeks at 4°C. E. coli 
TGI was maintained on M9 minimal agar plates containing 0.1 ml, 0.1% (w/v) thiamine 
per litre. For longer term storage, an overnight culture was mixed with an equal volume 
of sterile glycerol in a glass vial and stored at -20°C and -70°C.
2.72  Growth conditions
Strains were routinely grown at 37°C in a Gallenkemp Orbital Shaker (250 rpm). 
Liquid cultures were propagated overnight by inoculating 10 ml LB (plus appropriate
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antibiotics) in 25 ml universal bottles, with a single colony from an agar plate. A variety 
of glass culture vessels were employed with capacities ranging from 25 ml to 2 litres.
2.7.3 Spectrophotometry
Routine determinations of culture optical density (OD) were performed at a wavelength 
of 600 nanometres (nm) through a 1 cm light path cell using a Shimadzu UV-150-02 
double beam spectrophotometer.
2.7.4 Viable count determinations
Routine determinations of culture viability were performed by plating 100 p \ of serial 
dilutions in sterile phosphate buffered saline (PBS) onto the appropriate agar plates. 
After overnight incubation at 37°C, colony counts were made and the colony forming 
units per ml (CFU ml'1) determined.
2.7.5 Cell size distribution analysis by Coulter Counter
A Coulter Counter model 256 and Coulter Counter Channelyser C l000 connected to a 
BBC microcomputer were used to determine size distribution and cell counts. Samples 
were diluted in 20 ml balanced salt electrolyte (Isoton-Coulter Electronics Ltd.) and the 
total particle count and cell size distribution profiles obtained using a 30 /xm orifice 
probe. Subtraction of background count (isoton alone) enabled the corrected count for 
the samples to be calculated. Latex particles of known size were used as calibration 
standards for cell volume analysis and the mean volume of particles (/¿m^), estimated 
from the size distribution profiles.
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2.8 API20E profiles
The API20E system (Bio Mérieux, France) is a standardised, miniaturised version of 
conventional procedures for the identification of Enterobacteriaceae and other Gram 
negative bacteria. A  single colony of each strain to be tested was resuspended in 5 ml of 
SDW and used to inoculate the API20E strips, which were then incubated at 37°C for 
18-24 hours. The addition of reagents and the interpretation of reactions were done 
according to the manufacturer’s directions. The pattern of reactions was then coded 
into a numerical profile and identification made with the computer based API Profile 
Recognition System.
2.9 Serological identification of E. coli 0157:H7
A latex agglutination test (Oxoid Diagnostic Reagents) was used as described by the 
manufacturer to determine whether the E.coli Clinical Isolate (table 2.1) belonged to 
the 0157 serogroup. In addition, 10 /A of a single colony of the Clinical Isolate, 
resuspended in 100 n1 of sterile PBS, was mixed on a slide by tilting with 10 /ri of E. coli 
H7 antiserum (Difco). Agglutination with the latter was observed when small clumps of 
cells became visible. In both tests a negative control of E. coli K12 and positive control 
of E. coli 0157:H7 (ATCC 35150) were used to provide comparisons.
2.10 Determination of auxotrophic requirements
Amino acid, vitamin and purine/pyrimidine pools were used in the determination of 
auxotrophic requirements as described by Clowes & Hayes (1968).
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2.11 Phage production and phage challenge
2.11.1 Preparation of phage lysates
Exponential cultures were grown in LB/Mal/Mg2 + media (section 2.3.4). Mitomycin 
C (Sigma) was then added to 1 ng ml*1 from 1 mg ml' 1 stock and cultures were further 
incubated overnight. Cultures were pelleted in an MSE Chilspin (5,280g, 10 min) and 
the supernatant removed. A few drops of chloroform were added, the supernatant 
vortexed, pelleted and stored at 4°C.
2.11.2 Preparation of lawns and phage challenge
The strain to be used as a lawn was grown overnight in 10 ml LB/Mal/Mg2 + . 0.2 ml 
was then added to 3 ml LB/Mal/Mg2 + top agar, gently mixed and poured onto a fresh 
LB/Mal/Mg2 + plate. 10 /d of the phage lysate to be tested was spotted onto the 
prepared lawn, the plates incubated at 37°C overnight and examined for evidence of 
cell lysis/plaque production, indicative of phage.
2.11.3 Preparation of high titre lambda vir lysate
E. coli LE392 was grown overnight in 10 ml LB/Mal/Mg2 + . 200 ft\ volumes were then 
aliquoted into sterile bijouxs and 10 /d of a range of dilutions of lambda vir (table 2.3) in 
phage buffer (section 2.6) added. 4 ml LB/Mal/Mg2+ soft agar was added, gently 
mixed and poured onto solid LB/Mal/Mg2+ plates which were incubated overnight at 
37°C. Two individual plaques were removed with a glass pipette and resuspended in 1 
ml of phage buffer. 10, 50 and 100 fi\ aliquots were mixed with 200 /d of a fresh LE392 
overnight culture, added to 3 ml soft DDA (section 2.3.1) and overlayed onto fresh 
DDA plates. After overnight incubation, phage were harvested from the plate which 
showed confluent lysis by scraping off the top agar with a sterile glass loop into a sterile
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universal. The plate was washed with 2 ml phage buffer and the washings added to the 
top agar. 0.5 ml chloroform was added and the mixture vortexed until a soft slurry had 
formed. This was then pelleted in an MSE Chilspin (5,280g, 10 min) and the 
supernatant collected into a sterile universal. A further 0.5 ml chloroform was added 
and the lysate stored at 4°C.
2.11.4 Phage titre determination
The phage titre was determined by spotting 10 fi\ of a range of dilutions of phage lysate 
in phage buffer onto a fresh lawn of E. coli LE392. After incubation at 37°C overnight 
the number of plaques were counted and the plaque forming units per ml (PFU ml'1) 
determined.
2.12 Chromosomal DNA extraction
(a) Method 1
Chromosomal DNA extraction was carried out using the technique described by Alley 
(1987) with the following modifications. A  500 ml overnight culture grown on Penassay 
was harvested by centrifugation in a Beckman 6x250 rotor (22,100g, 10 min, at 4°C). 
The pellet was resuspended in 10 ml of Tris*sucrose and once resuspended, 5 ml of TE 
plus 150 mg of lysozyme (Sigma) were added. After incubation at 37°C for 10 min, 15 
ml of 0.25 M EDTA pH 8.0 was added and the cells incubated for a further 50 min at 
37°C. Sarkosyl was then added to a final concentration of 2%  (w/v) and the mixture 
incubated for a further hour at 50°C. It was found unnecessary to add proteinase K 
(BCL) to improve lysis at this point. 30 g of caesium chloride (CsCl) were added and 
dissolved before adding 1 ml of 10 mg ml' 1 ethidium bromide. The resulting mixture 
was centrifuged in a Beckman 8x50 rotor (27,200g, 15 min, at 15°C) to remove cell 
debris. The supernatant was decanted, placed in a Vti50 self-seal tube and spun in a
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Beckman L8-70 (196,400g, 16 hours, 20°C). The DNA in the middle of the gradient 
was removed (approximately 5 ml) using a hypodermic needle and extracted 3 times 
with water saturated butanol (to remove ethidium bromide). 3 M Na Acetate pH 6.3 (2 
ml), 1 % (w/v) sarkosyl (2 ml), TE (11 ml) and isopropanol (10 ml) were added to the 
5ml DNA solution. This was placed at -20°C for 2 hours and centrifuged in a Beckman 
8x50 rotor (39,200g, 10 min, 4°C). The DNA pellet was washed with 70% (v/v) ethanol 
and dried under vacuum. The dried pellet was dissolved in 1 ml TE and stored at 4°C.
(b) Method 2 (alkaline lysis)
Chromosomal DNA extraction was carried out using the technique described by Cardy 
(1989) with the following modifications. Cells were harvested from a 500 ml overnight 
culture grown on Penassay by centrifugation in a Beckman 6x250 rotor (22,100g, 10 min, 
4°C). The pellet was resuspended in 6 ml TE to which 3.75 ml of 0.25 M EDTA pH 8.0 
and 50 mg lysozyme were added and gently mixed. After incubation at 37°C for 15 min, 
proteinase K (125 of 20 mg ml"1 stock) was added, followed slowly by 3.25 ml 10% 
(w/v) SDS and further incubated at 37°C until lysis occurred. 4 ml of 5M sodium 
perchlorate were added to aid membrane separation and placed at 60°C for 15 min 
with occasional stirring. An equal volume of TE saturated phenol:chloroform:iso- 
amylalcohol (25:24:1) was added and mixed gently. To facilitate complete separation of 
aqueous and organic phases, centrifugation was performed in a Beckman 8x50 rotor 
(39,200g, 30 min, 4°C) and the upper aqueous layer transferred to a fresh Oakridge 
tube. An equal volume o f chloroform was added, mixed gently and centrifuged as 
before to separate aqueous and organic phases. Extraction was repeated twice and 
after the final extraction, the aqueous phase was transferred to a polycarbonate 250 ml 
centrifuge pot. NaCl (5 M stock) was added to 0.1 M followed by 2 volumes of ice cold 
ethanol. DNA was gently removed with a heat sealed pasteur pipette and washed 
several times with 70% (v/v) ethanol. The washed DNA was dried under vacuum for 
30-60 min and then slowly resuspended overnight in 10 ml TE. Ribonuclease (RNase),
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(20 mg ml’* stock. Sigma) was added to 100 n\ ml"* and the solution incubated at 37°C 
for 30 min. The RNase treated DNA solution was then made up to 30 ml with TE into 
which 30 g CsCl were dissolved. Finally 3 ml of ethidium bromide (10 mg ml"1 stock) 
were added and the resulting mixture was placed in a VtiSO self-seal tube and 
centrifuged in a Beckman L8-70 centrifuge (196,400g, 16 hours, 20°C). The resulting 
DNA band was extracted and the ethidium bromide removed as previously described. 2 
volumes of SDW and 6 volumes of ethanol were added and the DNA precipitated at - 
20°C overnight. The precipitate was pelleted in a Beckman 8x50 rotor (39,200g, 15 
min, 4°C) and the pellet dried under vacuum. The dried DNA was resuspended in 1 ml 
TE and stored at 4°C.
2.13 Isolation of plasmid DNA
2.13.1 Large scale
(a) Method 1
A 250 ml overnight culture in Penassay was harvested by centrifugation in a Beckman 
6x250 rotor (22,100g, 10 min, 4°C). The pellet was resuspended in 16.5 ml Tris-sucrose 
pH 8.0, 5 ml of lysozyme (5 mg ml’* in 0.25 M Tris-HCl pH 8.0) was added and left on 
ice for 5 min. After addition of 0.25 M EDTA pH 8.0 (4.5 ml) and a further 5 min 
period on ice, 18 ml Lysis Mix were added and the mixture incubated at 42°C with 
occasional inversion until cleared. The cell debris was then removed as described 
previously (section 2.12(a)). 30 g of CsCl were added to 30 ml of supernatant and this 
was dissolved before adding 1 ml (10 mg ml’*) ethidium bromide and loading in a VtiSO 
self-seal tube. The DNA was then purified by CsCl gradient centrifugation and the 
ethidium bromide removed, as previously described (section 2.12(a)). To the 5 ml DNA 
solution was added 1% (w/v) Sarkosyl (1.2 ml), 3 M Na Acetate pH 6.3 (1.2 ml), TE 
(4.6 ml) and 2 volumes of 96% (v/v) ethanol. The DNA was precipitated at -20°C
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overnight or at -70°C for 3 hours. The DNA was then pelleted, dried under vacuum 
and resuspended in 500 fi\ of TE.
(b) Method 2
The alkaline lysis technique of Birnboim & Doly (1979) was used as described by 
Maniatis et al. (1982) except that the volumes were reduced by 20% to allow the use of 
Oakridge tubes. Additionally, solution II (alkaline SDS solution) was not placed on ice 
prior to use (as the SDS precipitates) and a centrifugation step (39,200g, 30 min, 15°C) 
was included prior to the CsCl gradient centrifugation to remove cell debris. After 
removal of ethidium bromide (section 2.12(a)), plasmid DNA was directly precipitated 
from CsCl as described previously (2.12(b)) and resuspended in 500/11 of TE.
2.13.2 Small scale (mini-prep)
A scaled down version of the large scale prep (2.13.1 (b)), working with 1.5 ml of 
culture, instead of 1 litre, was used. Solution II was again not placed on ice prior to use 
and also the 70% (v/v) ethanol wash of the DNA pellet was omitted as this resulted in 
loss of plasmid.
2.14 Restriction endonuclease digestion
Restriction endonucleases and restriction endonuclease buffers (xlO) were obtained 
from Amersham or BRL, and used according to the manufacturer's instructions.
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2.15 Agarose gel electrophoresis
To prepare horizontal slab gels, 1% (w/v) agarose, unless otherwise stated, was melted 
in TBE electrophoresis buffer and cooled slightly before pouring. DNA samples, 
restricted as appropriate, were mixed with 1/61*1 volume of Loading Buffer Type IV and 
loaded into the gel slots. Electrophoresis was carried out with the gel completely 
submerged in buffer at 100-120 volts (V) or 60 V overnight. As DNA molecular weight 
(MW) markers, 10/d of lambda+ (bacteriophage DNA (50 ng ml'*), digested with the 
restriction endonuclease HindlU, was used. This generated fragment sizes : 23.17, 9.46, 
6.75, 4.26, 2.20, 1.92 and 0.58 kilobases (Kb). DNA was stained within the agarose gel 
with ethidium bromide (0.5 n\ ml"*) as described by Maniatis et al. (1982), and 
visualised by transillumination with short-wave UV light and photographed using 
Polaroid Type 665 black and white film.
2.16 Quantification of DNA
The concentration of DNA in a given sample was measured spectrophotometrically as 
described by Maniatis et al. (1982).
2.17 Oligo-labelling of DNA fragments by hexadeoxynucleotide primers
Purified DNA of recombinant plasmids, NTP705 and NTP707 (table 2.2), was prepared 
as described in section 2.13.1 (b) and the DNA probe fragments obtained by restricting 
the vector plasmids with the appropriate enzymes (Willshaw et al., 1985, 1987). The 
digests were run on a 1% (w/v) low gelling temperature agarose (BRL) gel and the 0.75 
Kb VT1 and 0.85 Kb VT2 fragments excised. To label the fragments to high specific 
activity, without prior purification from the gel slice, the procedure described by 
Feinberg & Vogelstein (1984) was followed with the following modifications. To 16.25 
n\ of DNA fragment was added in the following order 5 n\ OLB buffer ; 1 fi\ BSA (10
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mg ml'1) ; 0.5 n\ DNA Polymerase 1 (Amersham, Klenow-large fragment, cloned) and
2.5 fi\ 32P-dCl P. The mixture was then incubated at room temperature for at least 5 
hours or overnight. No stop buffer was added and the unincorporated nucleotides were 
removed using a spin column as follows
The end o f a 1 ml syringe was plugged with a little siliconised glass wool and filled with 
Sephadex G50 (Pharmacia-equilibrated in TE pH 8.0 containing 0.1 M NaCl) through a 
long form pasteur pipette to within 5-10 mm of the top. A  small bore needle, inserted 
into a 1.5 ml Eppendorf was added and the column placed, through a hole in the lid, 
into a plastic universal. The columns were centrifuged at 470g for 30 seconds (sec) in a 
MSE Mistral 1000 universal centrifuge and a fresh Eppendorf was added. 75 n\ TE was 
added to the probe reaction and the mixture heated at 65°C for 2 min to melt any 
agarose. This was then added to the column and centrifuged at 470g for 1 min. A 
further 100 fil TE was added and the column centrifuged as before. The Eppendorf was 
tested with a Geiger counter and if the probe had not been removed a further 100 fil TE 
was added and the column recentrifuged. 0.1 ml (10  mg ml*1) sheared, heat treated 
Salmon Sperm DNA was added to the labelled probe, the mixture boiled for 10 min and 
kept on ice for 5 min before use.
2.18 Southern transfer of DNA
This method followed the basic protocol of Southern (1975), as adapted by Maniatis et 
al. (1982). Denaturation and neutralisation of DNA in the gel matrix were both carried 
out for 30 min at room temperature. The transfer buffer was 20 x SSC instead of 10 x 
SSC. Before placing the nitrocellulose on it, the neutralised gel was wetted with 2 x SSC 
to remove excess salt. The transfer of DNA was allowed to proceed overnight. When 
the filter was removed from the gel, it was soaked in 2 x SSC for a few min before being 
dried and baked, under vacuum at 80°C for 2 hours.
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2.19 Hybridisation of Southern filters
The procedure described by Maniatis et al. (1982) was essentially followed with the 
following modifications. Nitrocellulose filters were placed in heat-sealed Sterilin bags 
containing 40 ml pre-hybridisation solution (5 x SSPE, 5 x Denhardts, 0.1% (w/v) SDS), 
laid flat in a plastic container and incubated in a 65°C water bath for 4-8 hours with 
shaking at 100 rpm. The pre-hybridisation solution was then replaced with 20 ml of 
fresh solution supplemented with the ^P-labelled probe. Hybridisation was carried out 
for a minimum of 18 hours at 65°C, 100 rpm followed by several stringent washes of 0.1 
x SSC, 0.1% (w/v) SDS (250 ml) for 30 min at 65°C, 100 rpm (unless otherwise stated). 
Filters were allowed to dry at room temperature, covered in cling-film and examined by 
autoradiography at -70°C.
2.20 Autoradiography
Autoradiography was carried out at -70°C for ^ P -la b e lle d  material and at room 
temperature for 35S-labelled material using Harmer film cassettes (with intensifying 
screens for 3^P) and Fuji RX X-Ray film. Autoradiograms were developed in Kodak 
LX-24 developer and fixed in Kodak FX-40 according to the manufacturer's 
instructions.
2.21 Determination of toxin production
2.21.1 Polymyxin B release of Verotoxin. (Karmali et al., 1985b)
0.5 ml of an overnight culture was used to inoculate 100 ml of Penassay which was then 
incubated at 37°C with shaking for 5 hours. 30 ml of culture, transferred to an 
Oakridge tube was pelleted in a Beckman 8x50 rotor (16,000g, 10 min, 4°C) and the 
supernatant discarded. The pellet was washed twice in sterile PBS, resuspended in 1 ml
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Polymyxin B Sulphate (Sigma, 1 mg ml"* in PBS) and incubated for 30 min at 37°C. 
After centrifugation in a MSE MicroCentaur (ll,600g, 10 min) the supernatant was 
filtered through a 0.22 /¿m filter (Sartorius) and stored at 4°C.
2.21.2 Use of the Ricin Assay
Yeast ribosomes isolated from a culture of ABYS 1, and the recombinant ricin A chain 
used in these experiments were a gift from Dr. Martin Hartley, Department of Plant 
Biochemistry, Warwick University. These were stored at -70°C and 4°C respectively.
2.21.2.1 Treatment of RNA with ribosome inhibiting protein (RIP)
It was found necessary to pretreat Polymyxin B released VT samples (section 2.21.1) 
with /S-mercaptoethanol (BME) to ensure formation of active A fragments. Typically, 
10/¿I of crude extract was mixed with 1 /d of BME (100 mM) and incubated for 1 hour 
at 30°C. Following this, 2 /A was muted with 2 n  1 yeast ribosomes, 9 /d 2x ENDO buffer, 
4 fil SDW, 2 /d 100 mM BME and 1 /d of a 1:5 dilution in DW of Vanadyl 
Ribonucleoside Complex (VRC), (BRL). This solution was incubated at 30°C for 20 
min. As a positive control 2 (A of yeast ribosomes were incubated at 30°C for 20 min in 
the presence of 2 pA of recombinant ricin A chain, 8 /d SDW and 8 /d 2x ENDO buffer. 
To precipitate the RNA, 0.1 volume of 10% (w/v) SDS was added and the mixture 
extracted with an equal volume of phenohchloroform (1:1). The aqueous layer was 
retained and the RNA precipitated overnight at -20°C after addition of 0.1 volume 2 M 
Na Acetate pH 6.0 plus 2.5 volumes ethanol. The precipitate was collected by 
centrifugation in a MSE MicroCentaur (ll,600g, 20 min, 4°C,), the pellet washed in 
70% (v/v) ethanol, repelleted as before and vacuum dried for approximately 15 min. 
The pellet was then dissolved in 10/d SDW.
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2.21.2.2 Aniline cleavage of depurinated RNA
The cleavage o f ricin A chain-depurinated rRNA was first described by Endo et al. 
(1987). The method used here was essentially as described by May et al. (1989) with 
some modifications. 1 fi\ of RNA, treated as described in section 2.21.2.1 was incubated 
at 60°C for 2 min with 20 fi\ 1 M aniline/acetic acid (pH 4.5), 0.1 volume 7 M NH4 
Acetate and 2.5 volumes of ethanol were added and the RNA precipitated on dry ice in 
the dark for 30 min. The RNA was then pelleted in a MSE MicroCentaur (ll,600g, 
4°C, 15 min), the pellet washed in 70% (v/v) ethanol, dried under vacuum and 
dissolved in 20 /xl of 60% (v/v) de-ionised formamide in 0.1 x Tris-phosphate (TPE) 
buffer. As a control an equivalent amount of non-aniline treated RNA sample was 
added to 20 n\ 60% (v/v) formamide/TPE mixture. Samples were incubated for 5 min 
at 65°C to denature the RNA and then cooled on ice. 3 n\ of 50% (v/v) glycerol, 0.1% 
(w/v) bromophenol blue was added to the samples.
2.21.2.3 Electrophoresis of depurinated RNA
Samples (+ or - aniline treatment), prepared as described in section 2.21.2.2 were 
loaded onto a 1.2% (w/v) agarose, 0.1 x TPE buffer, 50% (v/v) formamide gel (100 ml 
on 15 x 12 cm plates). The gel was electrophoresed at 20 mA constant current in 
Leicester Biocenter gel tanks for 2-3 hours in 0.1 x TPE buffer. To visualise the RNA, 
the gel was soaked for 10-20 min in 2 n g ml*1 ethidium bromide, destained in DW for 
10 min and viewed on a UV transilluminator.
2.21.3 Use of the Vero cell cytotoxicity assay. (Konowalchuk et al., 1977)
Stocks of Vero (African Green Monkey Kidney) cells, provided by Dr Iftihar Urabi 
(Warwick University) were grown as monolayers at 37°C (5 % (v/v) CO2 atmosphere), 
in medium 199 supplemented with 2 mM glutamine, 10% (v/v) fetal calf serum and the
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antibiotics, penicillin and streptomycin, to avoid contamination. Toxin activity was 
assayed in 6 well plastic tissue culture dishes into which approximately 10  ^cells per well 
in growth medium (2 ml) had been seeded, 1-2 days before. Samples for investigation 
were prepared essentially as decribed in section 2.21.1. except that Polymyxin B release 
of VT was from a 10ml overnight culture and this was pelleted in an MSE Mistral 1000 
universal centrifuge (2,940g, 5 min). 200 /*1 of sample was added to the monolayer and 
the morphological and cytotoxic effects were recorded over the next 48 hours.
2.22 Determination of protein concentration
The Bio-Rad Protein Assay System (Bio-Rad Labs Ltd.) was used essentially as 
described by Bradford (1976). This assay is based on the observation that the 
absorbance maximum for an acidic solution of Coomassie Brilliant Blue G-250 shifts 
from 465nm to 595nm when binding to protein occurs. This assay was routinely used in 
the determination of soluble protein concentration as it was much easier to use than the 
Lowry method, requiring 1 reagent and 5 min to perform as compared to 3 reagents and 
30-40 min typical for the Lowry assay. Samples were diluted in SDW as required and 
Bovine Serum Albumin (BSA) was used as a standard. For each assay protein 
concentrations were determined by reference to a plot of protein concentration against 
the absorbance at 595nm (A595nm), prepared using a range of dilutions, (1-25 ng ml"1, 
Microassay Procedure; 20-140 ng ml"1, Standard Assay Procedure), of a 1 mg ml*1 BSA 
stock solution.
2.23 Preparation of cell free extracts
Typically (unless otherwise stated), 100 ml culture was centrifuged in a Beckman 6 x 250 
rotor (22,100g, 10 min, 4°C), the cell pellet resuspended to a high cell density in 1 ml 
ice-cold 10 mM Tris-HCl pH 7.0 and transferred to a 1.5 ml Eppendorf tube. Cells 
were then disrupted by sonication (Amplitude 12 //m peak to peak, 3 x 30 sec bursts
87
with 30 sec cooling inbetween) and the debris and unbroken cells removed by 
centrifugation in a MSE MicroCentaur (ll,600g, 15 min, 4°C). The supernatant was 
filtered through a 0.22 fim membrane filter (Sartorius) frozen on dry ice and stored at - 
20°C.
2.24 Preparation of culture supernatants
2.24.1 Ammonium sulphate precipitation
Culture supernatant was obtained by centrifugation of a 100 ml culture in a 6 x 250 
Beckman rotor (22,100g, 10 min, 4°C). NH4SO4 was added to 40% (w/v) and after 
stirring at 4°C for 20-30 min the mixture was pelleted (12,100g, 20 min, 4°C). NH4SO4 
was added to the supernatant to 60% (w/v) and after further stirring at 4°C for 20-30 
min, the mixture was pelleted as before. The pellet was resuspended in a small volume 
(2 ml) of Tris-HCl pH 7.0 and dialysed overnight with stirring at 4°C against 2 litres 
Tris-HCl pH 7.0 with 3 changes. The dialysed sample was then filter sterilised and 
stored as described in 2.23.
2.24.2 Concentration with an Amicon concentrator
Culture supernatant obtained as described in section 2.24.1. was dialysed overnight, with 
stirring at 4°C, against 2 litre volumes of Tris/glycine running buffer with 3 changes. 30 
ml of dialysed supernatant was then concentrated to a small volume in an Amicon 
Micro-Ultrafiltration System (Model 8MC) using a YM-10 membrane (Amicon Corp.) 
to ensure that only macrosolute remained in the ultrafiltration chamber as concentrate. 
The concentrate was filter sterilised and stored as described in section 2.23.
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2.25 Polyacrylamide gel electrophoresis (PAGE)
2.25.1 Slab gels
Proteins were analysed on 11% (w/v) denaturing, SDS polyacrylamide gels using a 4.5% 
(w/v) stacking gel (Laemmli, 1970). The constitution of buffer and acrylamide solutions 
for SDS-PAGE are shown in table 2.4.1. Table 2.4.2 gives the composition of the SDS 
polyacrylamide resolving and stacking gels. Samples for SDS-PAGE were mixed with 
an equal volume of sample buffer (table 2.4.1), boiled for 4 min, cooled and loaded onto 
the gel with a Hamilton syringe. Ammonium persulphate (AMPS) was always freshly 
prepared and the gel, once poured, was overlaid with water saturated butan-l-ol. 
Electrophoresis was carried out using a LKB 2001 Vertical gel system at a constant 
current of 40 mA, for approximately 3 hours or 8 mA overnight.
Table 2.4.1 Stock solutions for SDS-PAGE
Stock Solutions Composition
Resolving Gel Buffer 0.75 M Tris-HCl pH 8.8 
0.2% (w/v) SDS
Stacking Gel Buffer 0.25 M Tris-HCl pH6.8 
0.2% (w/v) SDS
Acrylamide Stock 44% (w/v) Acrylamide 
0.8% (w/v) Bisacrylamide
Ammonium Persulphate (AMPS) 1% (w/v)
TEMED As supplied by manufacturer
Electrophoresis Buffer 0.025 M Tris 
0.129 M Glycine 
0.1% (w/v) SDS
Sample Buffer (x2) 0.025 M Tris-HCl pH 6.8 
0.8% (w/v) SDS 
10% (v/v) Glycerol 
5% (v/v) /3-mercaptoethanol 
Bromophenol Blue
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Table 2.4.2 Composition o f  SDS-PAGE resolving & stacking gels
Stock Solution Resolving Gel Stacking Gel
11% 4.5%
Resolving Gel Buffer 27.00 ml .
Stacking (3el Buffer - 10.00 ml
Acrylamide Stock 13.60 ml 3.00 ml
Double Distilled Water 12.00 ml 7.00 ml
AMPS 1.90 ml 0.50 ml
TEMED 0.13 ml 0.04 ml
2.25.2 Silver staining
The method of Wray et al. (1981) was used as it is both relatively simple and rapid. 
Gels were soaked in 50% (v/v) methanol for a minimum of 8 hours with 3 changes. 1.6 
g of silver nitrate was dissolved in 8 ml DW and slowly added to a solution containing 42 
ml 0.36% (w/v) NaOH and 2.5 ml NH3 . The volume was made up to 200 ml with DW 
and this was then used to stain the gel for 15 min. After 2 washes in DW for 5 min each, 
the gel was soaked in developer (2.5 ml 1% (w/v) citric acid, 0.4 ml formaldehyde, 
made up to 500 ml with DW) until the bands appeared. The reaction was stopped with 
a solution containing 10% (v/v) acetic acid and 45% (v/v) methanol.
2.25.3 Destaining
Polyacrylamide gels were destained when necessary by soaking overnight in a solution 
containing 10% (v/v) Kodafix and 30% (v/v) methanol. The gels could then be 
restained as described in section 2.25.2.
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2.26 Photography
Stained gels and autorads were routinely photographed from above using a Pentax 
SP500 camera with Kodak Panatomic X film (ASA 32).
2.27 Determination of ^ S-methionine incorporation into cell cultures
The method used was essentially as described by Swoboda et al. (1982) with the 
following modifications. To a 1.5 hour culture of E. coli 0157:H7, grown on a 100 ml 
Penassay, was added -^S-methionine (1300 Ci mM"') to a final concentration of 1 / i d  
ml' 1 or 2 f i d  ml'1. Duplicate 0.5 ml samples were immediately removed and every 5 
min thereafter, unless otherwise stated. Unlabelled L-methionine (100 mM stock) was 
added to 1 mM to prevent further incorporation of radiolabel, 2 ml ice-cold 5% (w/v) 
trichloroacetic acid (TCA) was added and the samples were left on ice for a minimum 
of 30 min to precipitate the cells. Samples were dried onto GF/C glass microfibre 
filters (Whatman), washed twice with ice-cold 5% (w/v) TCA, once with ice-cold 
ethanol and finally with a mixture of ethanol and ether (1:1). Filters were dried and 
counted in 5 ml Beckman EP Scintillation Cocktail in a LKB Minibeta Scintillation 
Counter. Efficiency of counting was 95% for -^S methionine.
2.28 Pulse labelling of cultures with ^S-methionine
7.7 /¿I o f  10 /iM L-methionine was added to growing cultures of E. coli 0157:H7, one 
hour prior to the addition of radiolabel, to prime the cells for methionine uptake. At 
known time intervals, -^S-methionine (1300 Ci ml'1) was then added to a final 
concentration of 3 nC i ml'1. After 10 min, incorporation was stopped by addition of 
unlabelled L-methionine to a final concentration of 1 mM and the cultures centrifuged 
to pellet the cells. Cell free extracts and culture supernatants were prepared and 
assayed for protein as peviously described (sections 2.22, 2.23 and 2.24.2). 15 fi\ of each
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sample was filtered through GF/C glass microfibre filters and scintillation counted as 
previously described (section 2.27). Samples, adjusted to contain equal amounts of 
protein or counts of radiolabel, were electrophoresed on 11% (w/v) SDS 
polyacrylamide gels, silver stained, photographed and destained as described in sections
2.25 and 2.26. To increase the sensitivity of X-Ray film to -^S labelled proteins, gels 
were impregnated with flúor (Amplify-Amersham) according to the manufacturer's 
instructions and dried under vacuum at 60°C for 2 hours.
2.29 Protein markers
Protein MW markers of size range 14.4-94.0 KDa (Pharmacia) were reconstituted 
according to the manufacturer's instructions. Bromophenol blue was added and 5 fi\ 
routinely run on SDS-PAGE. 14C Methylated proteins of size range 14.3-200 KDa 
(Amersham) were used as protein markers in pulse labelling experiments (2.28). 
Labelled proteins were mixed with an equal volume of sample buffer (x2), (table 2.4.1) 
and 10 fú run on SDS polyacrylamide gels.
2 JO Extraction of RNA
All glassware used in the preparation of RNA was baked overnight at 180°C and all 
solutions were made using SDW previously treated with 0.1% (v/v)
diethylpyrocarbonate (DEPC, Sigma). Also, all tubes, tips and reagents (except phenol 
and ethanol) were autoclaved before use and after baking, and/or autoclaving, all 
equipment and reagents were handled with gloves.
RNA extraction was carried out using the technique described by Crickmore (1987), 
with some modifications. Typically, unless otherwise stated, the relevant strain was 
grown overnight in 10 ml Penassay plus antibiotics, where appropriate. 1.5 ml was 
removed to an Eppendorf tube and the cells pelleted in a MSE MicroCentaur (ll,600g,
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3 min, 4°C). The supernatant was removed and the cells were resuspended in 450 /A of 
SAE (section 2.6). BRL ultra pure phenol (450 /A, equilibrated with 20 mM Na 
Acetate, pH 5.6) was added and an emulsion formed by vortexing. The mixture was 
then incubated at 65°C with regular mixing. After centrifugation (ll,600g, 10 min), the 
phenol extraction was repeated on the aqueous phase, after which the RNA in the 
aqueous phase was precipitated at -70°C for 30 min by the addition of 1 ml of ethanol. 
The RNA was then pelleted (ll,600g, 10 min), resuspended in 333 /A of SAE and 
precipitated as before. After pelleting for the second time the RNA was dried and 
resuspended in 200 /A of SAE, before being stored at -70°C.
2.31 Quantification of RNA
The concentration of RNA in a given sample was measured spectrophotometrically as 
described by Maniatis et al. (1982).
2.32 Electrophoresis of RNA
The RNA to be probed was electrophoresed on a formaldehyde denaturing gel. The gel 
(1.5% (w/v) agarose) was prepared by boiling 2.25 g of agarose in 93 ml DEPC treated 
water. When the agarose had dissolved, 30 ml of 5x MOPS was added followed by 27 
ml of formaldehyde and the gel was then immediately poured. Typically, unless 
otherwise stated, 10 ng of RNA in a known volume was mixed with 3 volumes of 
formaldehyde loading buffer (FLB) and denatured by heating at 68°C for 3 min before 
loading. 5 /A of RNA MW markers (Gibco, BRL) of size range 0.24-9.49 Kb and 8 /A 
each of unlabelled VT1 and VT2 DNA probe fragments were also denatured in FLB 
and loaded onto the gel. The gel was run at 80 V during the day or at 30 V overnight in 
lx MOPS buffer.
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2 3 3 Northern blotting
After electrophoresis the gel was washed in water, photographed, then soaked twice in 
lOx SSC for 20 min. The RNA was then transferred to nitrocellulose exactly as for 
Southern Blotting (section 2.18) and probed as follows:-
(a) Method 1
Northern filters were routinely probed exactly as for Southern filters (section 2.19). 
However, filters were washed gradually with increasing stringency, typically being, 
(unless otherwise stated)
(1) 2 washes for 20-30 min at room temperature (2x SSC, 0.1% (w/v) SDS).
(2) 2 washes for 20-30 min at room temperature (lx SSC, 0.1% (w /v) SDS).
(3) 2 washes for 20-30 min at room temperature (O.lx SSC, 0.1% (w/v) SDS).
(b) Method 2
Nitrocellulose filters were probed as described in section 2.19 for Southern filters with 
the following modifications. Filters were incubated in pre-hybridisation solution (5x 
SSC, 50% (v/v) formamide, lx Denhardts) at 42°C. Hybridisation was carried out at 
42°C and washes consisted of :-
(1) 2 washes for 20-30 min at room temperature (2x SSPE,0.1% (w/v) SDS).
(2) 2 washes for 20-30 min at room temperature (O.lx SSPE, 0.1% (w/v) SDS).
(3) 2 washes for 20-30 min at 50°C (O.lx SSPE, 0.1% (w/v) SDS).
2.34 Treatment of RNA with DNase
DNase buffer was made by dissolving 0.203 g MgCl2 (100 mM) in 10 ml of 100 mM Na 
Acetate pH 5.6. To 50 ftl of RNA, extracted as described in section 2.30 was added 350
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H\ DNase buffer and 1 fi\ of DNase-RNase free (BRL). This was incubated at 37°C  for 
30 min then phenol extracted and ethanol precipitated for 1 hour at -70°C. The dried 
pellet was dissolved in 40 ftl of SAE.
2.35 RNA half-life determination
50 ml Penassay was inoculated with 250 n1 of an overnight culture of the relevant strain 
and incubated at 37°C with shaking until the late exponential phase was reached 
(OD600nm of approximately 1.5). Rifampicin (Sigma, 30 mg ml'* in methanol) was 
added to a final concentration of 100 ng m l'\ the time noted and 1 ml immediately 
removed to ice and pelleted in a MSE MicroCentaur (ll,600g, 3 min, 4°C). The 
supernatant was removed and the pellet frozen on dry ice. Further 1 ml samples were 
removed after 5,10, 20,30, 40, 50, 60 min incubation with rifampicin and the cell pellets 
collected as described above. When all the cell pellets had been obtained, RNA was 
extracted from them as described in section 2.31, except that the RNA was Anally 
resuspended in 100 n 1 of SAE before being stored at -70°C. Samples, adjusted to 
contain 10 ng of RNA, were denatured in FLB, divided into two and loaded onto two 
formaldehyde gels so that they were identical. Gels were run overnight, Northern 
blotted and subsequently probed with either/or ^^P-dCTP labelled VT1 and VT2 probe 
fragments as described in sections 2.32 and 2.33(a).
2.36 Preparation of RNA from the growth cycle
200 ml Penassay plus appropriate antibiotics was inoculated with 1.0 ml of an overnight 
culture of E. coli 60R746 or 60R363. At known time intervals, 3 ml of culture was 
pelleted and RNA extracted as described in section 2.30. Samples were resuspended in 
increasing amounts of SAE (50-200 /d) and the concentration of RNA in each sample 
determined (section 2.31). Samples adjusted to contain 15 ng RNA were denatured in
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FLB, loaded onto a formaldehyde gel in duplicate and Northern blotted as previously 
described (sections 2.32 and 2.33(a)).
2.37 Bacterial transformation
Two methods were employed to introduce DNA into bacterial cells:- Electroporation 
and the induction of "Pseudocompetence" by pretreatment with Ca^ + .
2.37.1 Electroporation
Electroporation, one of the most recent advances for the introduction of DNA into 
cells, involves the application of a brief, high voltage pulse to a suspension of cells and 
DNA, resulting in a transient membrane permeability and the subsequent uptake of 
DNA.
Cells for electroporation were propagated in 100 ml LB and harvested at an OD600nm 
of 0.6-0.8. Cells were pelleted in a Beckman 6x250 rotor (22,100g, 10 min, 4°C), the 
supernatant discarded and the cell pellet washed twice in 50 ml ice-cold SDW. The 
pellet was then washed in 25 ml ice-cold sterile 10% (v/v) glycerol, repelleted and 
resuspended in 200 pA of the latter. The cells were frozen on dry ice and stored at - 
70°C.
Electroporation was carried out using a Gene P u lser ^  (Bio-Rad Labs USA), set to
2.5 KV, a capacitance of 25 fi¥ and a resistance of 200 ohms. 1 /A of CsCl density 
gradient purified plasmid DNA was mixed with 40 pA of electroporatable cells and left 
on ice for 1 min before being transferred to an ice-cold 0.2 cm electroporation cuvette. 
The cell/DNA mixture was spread evenly across the bottom between the chilled 
electrodes, the cuvette placed in the safety chamber and the pulse applied. Following 
the pulse, 1 ml of LB was added and the mixture transferred to an Eppendorf tube and
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incubated at 37°C for 1 hour to allow for expression of the antibiotic resistance genes. 
100 fil aliquots were then plated onto selective agar to screen for transformants.
237.2 The calcium chloride procedure
The technique used was essentially that described by Holland (1983). 0.5 ml of
overnight culture was used to inoculate 50 ml of LB in a 100 ml flask. This culture was 
grown to an OD600nm of approximately 0.5 and the cells were then held on ice for 10 
min. From this point, all operations were carried out on ice and using ice-cold 
solutions. The cells were pelleted by minimal centrifugation in a multex angled 
centrifuge, the supernatant carefully removed and the pellet resuspended in 0.5 volume 
of CaCl2 (100 mM). After a further 10 min on ice, the culture was repelleted, 
resuspended in 0.05 the original volume (2.5 ml) of 100 mM CaCl2 and was held on ice 
for a minimum of 1 hour (Dagert & Ehrlich, 1979).
200 p i of competent cells were aliquoted into a 1.5 ml Eppendorf tube and 1 pi DNA 
added to the cells, mixed gently and then left on ice for 30 min. This was then heat 
shocked at 42°C for 2 min and returned to ice for 15 min. Two volumes of LB were 
added, incubated for 1 hour at 37°C, to allow expression o f antibiotic resistance genes 
after which 100 p \ aliquots were plated onto selective media.
2.38 Transduction with lambda TnphoA
Lambda TnphoA (table 2.3) was provided by Dr. G. Salmond, Dept, of Biological 
Sciences, Warwick University. A single transformant of E. coli CC118 (pNTP707) was 
grown overnight in LB/Tc and 100/d used to inoculate 10 ml fresh LB/Tc. This was 
grown to exponential phase at 37°C with shaking (250 rpm). The culture was pelleted 
in a MSE Mistral 1000 universal centrifuge (2,940g, 5 min, room temperature), the 
pellet resuspended in 1 ml of LB/Mal/Mg^+ /Tc and 100 p \  of lambda TnphoA was
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added. After static incubation at 37°C for 30 min to allow for phage adsorption and 
infection, 10 ml LB/Tc was added and the culture incubated for 1 hour at 37°C (250 
rpm) to allow for expression of Knr. The culture was pelleted as before, resuspended in 
1 ml LB/Tc and 100 fi\ aliquots spread on LB plates containing Tc, Kn (300 ftg ml'1) 
and XP (Sigma, 40 fig ml' 1 in DMSO) and incubated at 37°C for two days. Mini 
plasmid preparations (2.13.2) of blue colonies were used to transform freshly competent 
E.coli CC118 as described in section 2.37.2. Individual blue colonies on LB plates 
containing Tc, Kn (30 fig ml'1) and XP after 2 days at 37°C, contained in frame fusions 
of TnphoA to secreted gene products on plasmid NTP707.
2.39 DNA Sequencing
To determine the site of insertion of TnphoA within pSLF22 and pSLF34 two methods 
were employed
(1) Dideoxynucleotide chain termination method of DNA sequencing (Sanger et al., 
1977; Sanger et al., 1980) - section 2.39.2.
(2) Direct plasmid sequencing - section 2.39.3.
239.1 Preparation of fragments from agarose gel
(a) Method 1
The excised fragment was placed in dialysis tubing (prepared as described by Maniatis 
et al., 198?) with a small volume of 0.5 x TBE (approximately 200 fi\). All air bubbles 
were removed and a current of 40 mA was applied across the dialysis tubing in a minigel 
tank buffered with 1 x TBE for 20 min. The polarity was then reversed for 30 sec to 
remove any DNA from the side of the dialysis tubing and the DNA in solution removed 
to an Eppendorf tube. The solution was extracted twice with phenol, once with TE 
saturated chloroform and the DNA precipitated at -20°C for a minimum of 3 hours
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upon addition of 0.1 volumes 3 M Na Acetate and 2 volumes ethanol. DNA was 
recovered by centrifugation in a MSE MicroCentaur (ll,600g, 10 min, 4°C), washed 
with 70% (v/v) ethanol, repelleted and dried under vacuum for 5 min. The dried pellet 
was resuspended in 20 /A of TE.
(b) Method 2 (Gene Clean)
The excised fragment was weighed and the DNA purified from the gel slice using the 
Gene Clean II Kit (Bio 101) as described by the manufacturer. The DNA fragment was 
contained within a final volume of 10 /d TE.
2.39.2 Dideoxynucleotide chain termination method of DNA sequencing
2.39.2.1 Ligation of DNA
1 /d M13mpl9 RF DNA (Gibco BRL) was digested with the appropriate restriction 
endonucleases, gene cleaned and resuspended in 10 /d TE. 5 /d of purified DNA 
fragment containing the fusion joint was ligated with 1 /d M13mpl9 digest using T4 
DNA ligase (Amersham) according to the recommendation of the supplier, at 15°C for 
a minimum of 18 hours.
2.39.2.2 Isolation of M13 recombinants
Competent E.coli TGI cells were transformed with between 1-3 /d of ligation mix using 
the method described for plasmid transformation (section 2.37.2), except that following 
heat shock, cells were added to 3 ml, 0.7% (w/v) TYE soft agar to which had been 
added 60 /d of 2% (w/v) X-gal (20 mg ml"1 in DMF) and 30 /d  of 2.5% (w/v) IPTG (25 
mg ml'1). This was immediately poured onto fresh TYE plates and allowed to set. 
After overnight incubation at 37°C, lawns were examined for plaque formation. Clear
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plaques were indicative of TGI infection with recombinant M13 vectors, whereas 
transfection with non-recombinant M13 vectors generated blue plaques.
2.39.2.3 Template preparation
Template preparation was essentially as described by Bankier et al. (1986), except that 
E. coli TGI was used as the host for M13 recombinant propagation. After propagation 
of phage for 5 hours, cultures were transferred to 1.5 ml Eppendorf tubes and 
centrifuged in an MSE MicroCentaur (ll,600g, 20 min), to precipitate the bacteria. 
Supernatants were removed to a fresh Eppendorf tube, 200 /d of PEG (6,000 MW, 20% 
(w/v)) was added and the mixture briefly vortexed and left standing at room 
temperature for 10-15 min. The mixture was centrifuged for a further 20 min and the 
supernatant removed. Any residual supernatant was removed after a brief 30 sec spin. 
The resulting phage pellet was resuspended in 100 fi\ TE, allowed to stand at room 
temperature for 10 min and 50 /ri of TE saturated phenol was then added, vortexed well 
and centrifuged for 5 min at room temperature. To 80 n\ of the aqueous phase, placed 
in a fresh Eppendorf was added, 40 /il of 7.5 M NH4AC and 200 /ri ethanol. This was 
vortexed and placed at -20°C overnight. After centrifugation, the pellet was dried 
under vacuum, resuspended in 20 fil TE and stored at -20°C.
2.39.2.4 Dideoxy sequencing
The extended method of DNA sequencing with Klenow fragment was used as described 
by Cardy (1989). The primer used corresponded to a 19 bp portion of the IS50L of Tn5 
and was provided by Dr D. Hodgeson, Dept, of Biological Sciences, University of 
Warwick. For the template-primer annealing reaction, 2 fi\ of template DNA was 
mixed with 2 n 1 sequencing buffer (x5), 2 fx\ of Tn5 primer and SDW up to 10 fi\ final 
volume and incubated for 1 hour at 55°C. All subsequent steps (sequencing reactions 
and denaturation) were carried out in microtitre trays. The products of the
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primer extension reactions were denatured in an oven (Mini/696/Clad) at 80°C for 15 
min and placed immediately on ice prior to loading the whole of each reaction mixture 
on a 6 % (w/v) polyacrylamide, tris-borate-urea sequencing gel (section 2.39.4).
2.39.3 Direct plasmid sequencing
2.39.3.1 End labelling of primer
3 /A o f Tn5 primer was mixed with 1 /A 0.1 M DTT, 2 /ri kinase buffer (xlO), 4 /¿I (80 
fiCV) -^P-dATP, 2 fil T4 polynucleotide kinase and 8 /x\ SDW in a 0.5 ml Eppendorf 
tube. This was incubated at 37°C for 40 min after which the enzyme was inactivated by 
heating the mixture in a dry block at 68°C  for 10 min. 40 /¿I of SDW was added 
followed by 240 n\ of 5 M NH4 Acetate and mixed well. 750 /¿I of ice-cold ethanol was 
then added, mixed well and left at -20°C for a minimum of 1 hour. The precipitate was 
pelleted in a MSE MicroCentaur (ll,600g, 20 min, 4°C) and the supernatant totally 
removed. The pellet was dried under vacuum for 10 min and resuspended in 4 /ri of 
SDW.
239.3.2 Denaturation of DNA
5-10 n g of plasmid DNA, in a total volume of 8 fi\ was mixed with 2 n\ 5x denaturing 
solution (1 M NaOH, 1 mM EDTA pH 8.0) and incubated at 37°C for 30 min. Salts 
were then removed from the denatured DNA using a spin column as follows:-
The lid of a 0.5 ml Eppendorf tube was removed, the base pierced twice with a small 
bore needle and the bottom plugged with a small amount of glass wool. The Eppendorf 
was filled completely with Sepharose CL4B (Pharmacia) and placed in a 1.5 ml 
Eppendorf tube, the lid of which had also been removed. This was centrifuged a total 
of 4 times in a MSE MicroCentaur (ll,600g, 30 sec) and after each centrifugation any
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buffer present in the base of the 1.5 ml Eppendorf was discarded. The column was then 
washed with 10 n\ of SDW in a further 30 sec centrifugation step. The prepared column 
was placed in a fresh 1.5 ml Eppendorf tube, the denatured DNA was added and the 
column centrifuged as before for approximately 40 sec. 6 fi\ of the denatured DNA 
solution which passed through the column was immediately removed to primer/reaction 
buffer mix (2 fil Sequenase reaction buffer and 2 fil endlabelled Tn5 primer - section 
2.39.3.1) and incubated at 37°C for 30 min.
2.39.3.3 Plasmid sequencing using Sequenase Version 2.0
The Sequenase Version 2.0 kit (US Biochemical Corp.) was used as described by the 
manufacturer, except that no labelling step was performed. To 10 fil of template-primer 
mix was added 1 f i l  DTT (0.1 M), 2.5 f i l  SDW and 2.0 f i l  dilute Sequenase enzyme 
(diluted 1:8 with ice-cold dilution buffer). This was immediately split into 4, 3.5 fil 
amounts in 4 Eppendorf tubes each containing a single prewarmed 2.5 f i l  volume of one 
of the dideoxynucleotide termination mixes G,A,T and C. The 4 mixes were placed at 
37°C for 3-5 min, 4 f i l  of stop solution was added, the mixtures placed in an 80°C water 
bath for 2.5 min and then immediately removed to ice. Reaction mixes were loaded 
onto a 6% (w/v) polyacrylamide tris-borate-urea sequencing gel, electrophoresed and 
fixed as described in section 2.39.4.
239.4 Sequencing gel electrophoresis
A stock solution of 38% (w/v) acrylamide, 2% (w/v) N,N'-methylenebisacrylamide 
(Bisacrylamide) was used to prepare the working solution for the gels. Typically a 6% 
(w/v) polyacrylamide wedge gel was made by dissolving 46 g of urea in 15 ml 40% (w/v) 
acrylamide (19:1 Bis) stock, 10 ml lOx TBE and SDW up to 100 ml final volume. The 
acrylamide was polymerised by the addition of 667 fil freshly prepared 10% (w/v) 
AMPS plus 40 fil TEMED and immediately poured. Electrophoresis was carried out at 
55 W in lx TBE after which gels were fixed in 10% (v/v) methanol, 10% (v/v) acetic
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acid for 15 min, transferred to Whatman 3 MM paper and dried under vacuum at 80°C 
for a minimum of 2 hours.
2.39.5 Sequence analysis
Autoradiography was carried out at -70°C as described in section 2.20. All DNA 
sequence derived from this work was recorded and the site of insertion of Tnp/ioA 
determined by comparison with published sequence data for VT2 (Jackson et al., 
1987b).
To determine the level of plasmid stability in each strain, 50 fil aliquots of an overnight 
of each was used to inoculate 10 ml volumes of LB containing decreasing concentrations 
of antibiotics (table 2.5). Cultures were then incubated overnight at 37°C with shaking 
(250 rpm), after which serial dilutions in PBS were plated on LB and LB/Kn/Ap 
(pSC105) or LB/Kn/Tc (pSLF22) agar plates. These were incubated overnight and 
colony counts made to determine the level o f plasmid retention.
Table 2.5 Plasmid stability - Antibiotic concentrations
Number Kanamycin Ampicillin Tetracycline
2.40 Assessment of plasmid stability
1
2
3
4
5
50.0
25.0 
12.5
6.25
0.0
100.0
50.0
25.0 
12.5
0.0
15.0
7.5
3.75
1.875
0.0
Strain E3787 (pSCl05) antibiotic combination = Kn + Ap 
Strain E32511 (pSLF22) antibiotic combination = Kn + Tc
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2.41 Plasmid curing under phosphate limitation. (Roeder and Collmer, 1985)
Strains E3787 (pSC105) and E32511 (pSLF22) were grown overnight in 10 ml LB plus 
appropriate antibiotics at 37°C with shaking (250 rpm). 10 ft\ of each was used to 
inoculate 5 ml o f low phosphate media (section 2.3.5) which was then incubated at 37°C 
with shaking (250 rpm) for 48 hours, selecting for maintenance of Knr. After this time 
10 /A of each culture were used to inoculate a further 5 ml of low phosphate media 
containing Kn and incubated for a further 48 hours as before. After each 48 hour 
incubation, serial dilutions in PBS were plated onto LB/Kn and LB/Ap or LB/Tc as 
appropriate. 50 colonies of each culture displaying Knr were replica plated onto 
LB/Ap or LB/Tc plates to screen for Aps or Tc5 isolates. Additionally colonies 
displaying Apr or Tcr were replica plated onto LB/Kn plates. All plates were incubated 
at 37°C overnight.
2.42 Preparation of periplasmic proteins
Periplasmic proteins were released from cultures in response to cold osmotic shock 
treatment according to the method of Neu and Heppel (1965). Typically, 5 ml of an 
overnight culture was buffered by addition of 0.5 ml Tris-HCl (0.5 M, pH 7.8) and 
incubated at room temperature for 10 min. The cells were then pelleted in a MSE 
Chilspin (5,280g, 5 min), the pellet resuspended in 800 /<1 sucrose solution and 
transferred to 1.5 ml Eppendorf tubes. After 10 min incubation at 30°C, cells were 
repelleted in a MSE MicroCentaur (ll,600g, 1 min) and the supernatant carefully 
removed. Cells were rapidly resuspended in 0.5 ml ice-cold SDW and left on ice for 10 
min. Shocked cells were then removed by centrifugation (ll,600g, 5 min) and the 
resulting shock fluid used in Western blot analysis.
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2.43 Western blotting
2.43.1 Transfer of proteins separated by PAGE to nitrocellulose
Periplasmic proteins (section 2.42) were assayed for protein as described in section 2.22 
and samples, adjusted to contain equal amounts of protein were mixed with 1/51*1 
volume of Loading Buffer (x5, boiled for 4 min and electrophoresed on 11% (w/v) SDS 
polyacrylamide gels as described in section 2.25. 5 ftl of 1 mg ml'* bacterial alkaline 
phoshatase (E.coli Type IIIL, Sigma) was also loaded on the gels. After electrophoresis 
the stacking gel was removed, the gel soaked in Western Transfer Buffer (WTB) for 10- 
15 min and the proteins transferred to nitrocellulose as follows. A nitrocellulose filter 
was cut to the size of the polyacrylamide gel, soaked in WTB and placed on top of the 
gel with care being taken to remove air bubbles between the gel and the nitrocellulose. 
Using a BioRad Transblot tank and power supply according to the manufacturer's 
instructions, transfer of proteins from gel to nitrocellulose was carried out at 40 V for 3 
hours. After transfer the nitrocellulose filter was rinsed in DW to remove excess salt 
and the filter stained to visualise protein bands by washing for 10 min in Ponceau S 
(0.5% (w/v) in 5% (v/v) TCA). The position of the slots and protein markers was 
noted and the stain was then removed by washing in 20 ml PBS for 10 min, followed by 
addition of 10 ml fresh PBS containing 2% (w/v) dried milk (Marvel). The filter was 
washed in the latter for a minimum of 1 hour to allow protein to bind non-specifically to 
the nitrocellulose. The PBS:2% (w/v) Marvel was replaced with a fresh 10 ml volume 
of PBS:2% (w/v) Marvel containing the primary antibody, rabbit antibacterial alkaline 
phosphatase (NBL), at a dilution of 1:500. The filter was allowed to shake in this 
solution overnight at room temperature and was then washed three times for 10 min 
each time in 10 ml PBS containing 0.1% (v/v) Tween 20.
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colour reaction
Peroxidase conjugated goat anti-rabbit IgG (Sigma) was used as secondary antibody and 
4-chloro-l-naphthol (Sigma) as the colour reaction agent. After the washes in 
PBS:0.1% (v/v) Tween 20 described in section 2.43.1 the filter was transferred to fresh 
PBS:0.1% (v/v) Tween 20 (10 ml) containing a 1:300 dilution of secondary antibody and 
was left shaking for 1-2 hours at room temperature. After two 10 min washes in 10 ml 
PBS:0.1% (v/v) Tween 20 and two washes in 10 ml PBS, the filter was transferred to a 
solution containing 1.5% (w/v) NaCl, 1% (v/v) 1M Tris-HCl (pH 7.5), 0.03% (w/v) 4- 
chloro-l-naphthol and 10% (v/v) methanol. 50 fA H2O2 (Fisons) was then added to 
initiate the staining reaction. Before the reaction reached completion the filter was 
washed with DW (3 changes in 30 min), air dried, photographed and stored in the dark.
2.44 Enzyme assays
2.44.1 Sample preparation
(a) Method 1 (sonication of cells)
5 ml of culture (of known OD600nm) was pelleted in a MSE Chilspin (5,280g, 5 min).
A sample of the supernatant was transferred to a 1.5 ml Eppendorf and immediately 
frozen on dry ice and stored at -20°C. The cell pellet was resuspended in 5 ml Tris- 
HCl, pH 8.0 and the OD600nm was taken. Cells were then disrupted by sonication in a 
25 ml glass beaker (Amplitude 6 /im peak to peak, 3 x 30 seconds bursts with 30 seconds 
cooling in between) and the cell debris removed by centrifugation in a MSE Chilspin as 
before. The cell free extract was then frozen on dry ice and stored at -20°C.
2.43.2 Detection o f antigen-antibody complexes using a horseradish peroxidase
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(b) Method 2 (permeabilisation of cells)
5 ml of culture (of known OD600nm) was pelleted in an MSE Chilspin (5,280g, 5 min). 
A sample of the supernatant was transferred to a 1.5 ml eppendorf, immediately frozen 
on dry ice and stored at -20°C. Cells were resuspended in 5 ml Tris-HCl pH 8.0 and 1 
ml aliquots immediately frozen on dry ice and stored at -20°C. For enzyme assays cells 
were thawed and permeabilised essentially as described by Michaelis et ai. (1983), 
except that 10 fj\ 10% (w/v) SDS and 20 fil chloroform were added and the mixture 
incubated at 37°C for 5 min.
2.44.2 Alkaline phosphatase
Alkaline phosphatase (PhoA) activity was assayed according to the method of Brickman 
and Beckwith (1975). A 0.1 ml aliquot of sample to be assayed was mixed with 0.9 ml 
Tris-HCl (pH 8.0) and the reaction started by addition of 0.1 ml freshly prepared Sigma 
104 (4 mg ml‘* in 1 M Tris-HCl pH 8.0). The mixture was incubated at 37°C and the 
time monitored until a yellow colour appeared. The reaction was stopped by addition 
of 0.1 ml of 1 M KH2PO4 and the OD550nm and OD420nm were read against a water 
blank. PhoA activity was expressed in units per OD600nm of bacterial cells using the 
following formula.
Enzyme Activity (U) = 1000 x OD420 - n.75xOD55Q) x Dilution 
time x OD600nm Factor
2.44.3 Beta-lactamase
/3-lactamase activity was assayed according to the method of O'Callaghan et al. (1982) in 
1 ml microcuvettes. Assay mixtures contained 20-100 ftl of sample made up to 800 fi\ 
with 0.1 M potassium phosphate buffer (pH 7.0). 20 n  1 of Nitrocephin (4 mg ml"* in
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DMSO) was added and the ASOOnm at 30°C followed using a PYE Unicam SP1800 
spectrophotometer. Enzyme activity in milli-units (mU) was expressed as the rate of 
hydrolysis of nitrocephin per minute per ml sample, normalised to the OD600nm of 
bacterial cells using the following formula:
Enzyme Activity (mU) = 1000 x (A500/min) x Dilution factor 
OD600nm
2.45 Verotoxin expression during growth
E.coli strains CC118, CC118 (pSC105), E32511 and E32511 SLF22/1 were grown 
overnight in 10 ml of LB plus the appropriate antibiotics. Overnight cultures were then 
pelleted in a MSE Mistral 1000 (2,940g, 5 min), the supernatant discarded and the 
pellet resuspended in 10 ml of Tris-HCl pH 8.0. 1 ml of each overnight was inoculated 
into a 200 ml volume of LB containing the appropriate antibiotics. Cultures were then 
incubated at 37°C with shaking (250 rpm). Every hour samples were taken to 
determine the OD600nm of each culture. Additionally, every 2 hours (unless otherwise 
stated) samples of cultures CC118 and CC118 (pSC105) were taken and prepared as 
described in section 2.44.1(a) and samples of cultures E32511 and E32511 SLF22/1 
were taken and prepared as described in section 2.44.1(b). Samples of CC118 and 
CC118 (pSC105) were assayed for PhoA and /3-lactamase activity (sections 2.44.2 and
2.44.3), whereas samples of E32511 and E32511 SLF22/1 were assayed for PhoA 
activity alone (section 2.44.2).
2.46 Verotoxin expression under iron limitation
E.coli strains CC118, CC118 (pSC105), E32511 and E32511 SLF22/1 were grown 
overnight in 10 ml of LB plus the appropriate antibiotics. Overnight cultures were then 
pelleted in a MSE Mistral 1000 (2,940g, 5 min), the supernatant discarded and the
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pellet resuspended in 10 ml of Tris-HCl pH 8.0. Cultures were split into two, 
recentrifuged and the pellets resuspended in either 5 ml prewarmed (37°C, 250 rpm, 
overnight) iron replete LB (section 2.3.2) or 5 ml prewarmed iron limited LB (section
2.3.3). Kanamycin had been added to the LB at the prewarming stage where required. 
1 ml of each overnight culture resuspended in iron replete LB was inoculated into a 200 
ml volume of prewarmed LB containing the appropriate antibiotics whereas, 1 ml of 
each overnight culture resuspended in iron limited LB was inoculated into a 200 ml 
volume of prewarmed iron limited LB containing the appropriate antibiotics. Cultures 
were then incubated at 37°C with shaking (250 rpm). Every hour, samples were taken 
to determine the OD600nm of each culture. Additionally, every 2 hours (unless 
otherwise stated), samples of cultures were taken for enzyme assay as described in 
section 2.45.
2.47 Expression of VT1 under iron limitation in a glass universal
Overnight cultures of CC118 and CC118 (pSC105) were resuspended in either iron 
replete or iron limited LB as described in section 2.46. 50 ftl of each overnight culture, 
resuspended in iron replete LB was inoculated into 6 x 5 ml volumes of iron replete LB 
in glass Universals, whereas 50 fi\ of each overnight culture resuspended in iron limited 
LB was inoculated into 6 x 5ml volumes of iron limited LB in glass universals. 
Antibiotics were included where appropriate. Cultures were incubated at 37°C with 
shaking (250 rpm). After 8 and 24 hours incubation, triplicate 5 ml cultures of each 
strain grown under iron replete and iron limited conditions were pelleted in a MSE 
Mistral 1000 and prepared for enzyme assay as described in section 2.44.1(a). Samples 
were assayed for PhoA and /3-lactamase activity as described in section 2.44.2 and 
2.44.3.
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2.48 VT expression under anaerobic conditions
500 ml Quickfit subaseal flasks were specially made with a pyrex test-tube side arm. For 
growth under anaerobic conditions, 2 ml of saturated pyrogallol was added to the side 
arm of a flask containing 100 ml of LB and the flask and side arm air spaces gased with 
sterile nitrogen gas for 5 min. 2.5 ml of a solution containing 10% (w/v) NaOH and 
15% (w/v) K2CO3 was then added to the side arm to ensure total anaerobiosis. Flasks 
containing the appropriate antibiotics were inoculated with 0.5 ml of an overnight 
culture and incubated at 37°C with shaking (250 rpm). For comparison purposes, 
strains were cultured under aerobic conditions (no nitrogen purging or pyrogallol) in 
parallel. Every hour, samples were taken to determine the OD600nm of each culture. 
Additionally, every 2 hours (unless otherwise stated) samples were taken for enzyme 
assay as described in section 2.45.
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3. Characterisation of Verotoxin producing strains
3.1 Introduction
The aim of this project was to examine the regulation of verotoxin (VT) production in 
laboratory culture. The strains used in this study and their source have been presented 
in table 2 .1 .
Strains C600(933J) and C600(933W) are E. coli C600 strains lysogenised with the VT1 
encoding phage 933J of E. coli 0157:H7 strain 933 and the VT2 encoding phage 933W 
of strain 933 respectively. E. coli strains E3787/H19 (026:H11) and E32511 (0157:H*) 
were isolated from cases of diarrhoea and HUS respectively. Production of VT1 by 
strain E3787 and VT2 by strain E32511 has been reported previously (Willshaw et al., 
1987). The E. coli strain termed Clinical Isolate (Cl) was of unknown serotype and was 
isolated from a case of bloody diarrhoea at Warwick Hospital.
The disease association of E. coli strains 0157:H7 (ATCC 35150) and 026:H11 (NCTC 
8781) is unknown but both serotypes are commonly associated with haemorrhagic 
diarrhoeal disease and have been classified as enterohaemorrhagic E. coli (EHEC), as 
opposed to VTEC by Levine (1987), (section 1.5.4).
3.1.1 Aims
As a prerequisite for the development of an assay system to specifically quantify VT1 
and VT2 gene expression, the strains described above (unless otherwise stated), were 
subjected to routine studies to define growth characteristics and nutritional 
requirements. Additional studies to define/confirm toxin genotypes, presence of phage 
and toxin production were also performed. The results from these studies are described 
in this chapter.
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Growth characteristics o f VTEC
Growth of all the strains described in section 3.1.1, including E. coli K12, was followed 
by recording the optical density at 600nm (OD600nm) at known time intervals (section
2.7.3). The viable count (section 2.7.4), total cell count and cell volume were also 
determined (section 2.7.5).
All strains displayed very similar growth characteristics and therefore only the data 
obtained for E. coli 0157:H7 (ATCC 35150) is shown (figure 3.1). Under the 
conditions employed, growth was characteristically exponential (log phase) with a 
growth rate, determined as described by Prescott et al. (1990), of 0.98 generations per 
hour. After approximately 4 hours incubation, the culture entered stationary phase and 
the cells became smaller, as a result of dividing faster than they grew. Throughout the 
time course of the experiment there was no drop in viability of the culture (results not 
shown).
Konowalchuk et al. (1978) originally found Evans medium (Evans et al., 1973), to be 
optimal for VT production. However, Penassay broth was chosen for routine laboratory 
culture of VTEC strains in this project, as this easily available commercial medium has 
been reported to result in fast growth rates, a high cell yield, and levels of VT 
equivalent to those produced in Evans medium (Karmali et al., 1985b).
It should be noted that laboratory culture is not the normal environment that these 
pathogenic organisms find during infection, when growth rates are often restricted by 
nutrient limitation and host defenses. In order to gain a true understanding of the role 
of toxin production in the pathogenesis of VTEC associated diseases, it will be 
necessary to use in vitro growth conditions that mimic the in vivo condition as closely as 
possible. Direct comparison of in vitro virulence gene expression to the in vivo condition 
must therefore be made with caution.
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Figure 3.1 Growth characteristics of a batch culture of E. coli 0157:H7 (ATCC 
35150)
100 ml Penassay medium was inoculated with 0.5 ml of an overnight culture of E. coli 
0157:H7 (ATCC 35150) and incubated at 37°C  in a Gallenkemp orbital shaker (250 
rpm). At the time intervals shown, the optical density at 600nm (OD600) was 
monitored spectrophotometrically. The total cell count and mean cell volume of the 
culture were also determined using an electrical particle analyser (Coulter Counter) as 
described in section 2.7.5.
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Biochemical characteristics
The performance of each strain in 21 biochemical tests was determined using the 
API20E identification system (Bio Mdrieux, France) as described in section 2.8. The 
results obtained are shown in table 3.1. The API20E system is a standardised, 
miniaturised version of conventional physiological procedures for the identification of 
Enterobacteriaceae and other Gram negative bacteria. The pattern of reactions were 
converted into a numerical profile and identification made using a computer based 
profile recognition system. All profiles were identified as E. coli., however, comparison 
of individual strain reactions with the percentage of positive reactions normally 
observed for E. coli resulted in information on atypical biochemical characteristics.
E. coli K12 showed no atypical characteristics and was almost identical biochemically to 
E. coli C600(933J) and C600(933W), except that the latter two strains were unable to 
ferment melibiose. E. coli strains 026:H11 (E3787) and 026:H11 (NCTC 8781) also 
showed very similar profiles, both atypically being unable to ferment rhamnose 
(typically 87% positive). E. coli 026:H11 (NCTC 8781) however, also displayed an 
additional atypical characteristic, that of urease production (typically 1% positive). E. 
coli strains 0157:H7 (ATCC 35150), E32511 (0157:H‘) and the Clinical Isolate all 
displayed identical profiles. Most notably, these strains were unable to ferment sorbitol 
(typically 90% positive). This atypical characteristic has been used as a strain marker to 
aid in the detection of E. coli 0157:H7 in mixed flora on MacConkey agar containing D- 
sorbitol in place of lactose (SMAC), and is discussed in detail in section 1.8.2. 
Presumptive E. coli 0157:H7 isolates on SMAC must be specifically typed through slide 
agglutination using 0157 and H7 antisera. Subsequent use of a latex agglutination test 
for the identification of E. coli serogroup 0157 and E. coli H antiserum H7 (section 2.9) 
identified the E. coli Clinical Isolate serologically as being 0157:H7 (section 2.9). The 
Clinical Isolate was subsequently termed E. coli 0157:H7 (Cl).
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Table 3.1 Biochemical characteristics of Escherichia coli strains using the API 20E identification system (Bio Herieux SA, France)
STBAIN ONPG AOH LDC ooc CIT H2S UBE 10A IND VP GEL GIU NAN INO SOB RHA SAC MEL ANY ABA 0X1
K12 .  - • .  .  . • . . . ♦ - ♦
0157:117 ♦ ♦ ♦ - ♦ ♦ « « » ♦
(ATCC 35150) 
0157:N7 (C l) •  - ♦ ♦ - .  . • • • ♦ • • -  .
026:1111 ♦ ♦ ♦ ♦ ♦ ♦ ♦ ♦ « ♦
(HCTC 8781) 
E3787 •  - . . .  .  - • • • ♦ * • .
E32511 •  - • • .  .  - • • • ♦ • • •  •
C600(933J ) •  • • .  .  - .  .  ■ ♦ ♦ • •
C600(933U) ♦ • • .  .  . • • ♦ ♦ - •
♦ » positive reaction ;  -  «  negative reaction
Kev to table
M I Reactions/Enzymes Test Reactions/Enzymes Test
ONPG beta-galactosidase TOA tryptophan desaninase SOR sorbitol fenaentation/oxidation
AOH arginine dihydrolase INO indole production RHA rhamnose fermentâtion/oxidation
LDC lysine decarboxylase VP acetoin production SAC sucrose fermentation/oxidation
OOC ornithine decarboxylase GEL gelatinase NEL melibiose fermentation/oxidation
CIT citrate utilisation GLU glucose fermentation/oxidation AMY amygdalin fermentation/oxidation
N2S production HAN mannitol fermentâtion/oxidation ARA arabinose fermentation/oxidation
URE urease INO inositol fermentât ion/oxidat ion OX cytochrome-oxidase
To confirm that the above strains had not mutated with respect to biochemical 
characteristics during repetitive subculturing, API20E identification profiles were 
repeated on two further occasions at later stages of the project and found to be identical 
to those obtained in table 3.1. Additional studies (section 2.10), in which growth of the 
strains on purine/pyrimidine, amino acid and vitamin pools was examined (section 
2.3.6), revealed that the strains associated with diarrhoeal disease were prototrophic 
and able to grow on minimal salts media.
3.4 Phage production and phage challenge
Production of VT1 and VT2 has been shown to result from infection by temperate 
bacteriophage carrying the structural genes for toxin production (section 1.4.1). 
Temperate bacteriophage, as well as undergoing a lytic cycle which causes bacterial 
lysis, may in certain circumstances, persist indefinitely in the host cell as an integral part 
of the host genome without phage production. This phenomenon is known as lysogeny. 
In order to determine/confirm the presence of lysogenic bacteriophage within the 
strains under investigation, phage lysates were prepared following addition of 
mitomycin C (1 ng ml"*) to the culture medium (section 2.11.1). Mitomycin C is 
thought to cause phage induction by the mechanism discussed in detail in section 
1.4.4.5. Such phage lysates were used to challenge lawns of the non-lysogenic E. coli 
strain DH1, as described in section 2.11.2.
Strains E3787, E32511, 0157:H7 (ATCC 35150), C600(933J), C600(933W) and K12 
contained lysogenic bacteriophage, as evidenced by production of zones of lysis on 
lawns of E. coli DH1 (table 3.2). The proportion of challenged cells that demonstrated 
lysogeny varied significantly with, for example, production of a zone of almost complete 
cell lysis by lysate from E. coli E3787 (i.e. few infected cells lysogenised), whilst other 
lysates produced turbid zones of lysis (i.e. large percentage of infected cells 
lysogenised). Strains 026:H11 (NCTC 8781) and 0157:H7 (Cl) showed no evidence of
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DH1 cell lysis. There are several possible explanations for the latter observation. 
Perhaps these strains do not contain lysogenic bacteriophage, E. coli DH1 may not have 
been sensitive to the phage produced by these strains, the strains may be lysogenised 
with unstable or defective phage, or the conditions used for induction or detection of 
phage were not optimum. An increase in the concentration of mitomycin C to 10 fig 
ml'l during phage lysate preparation from strains 026:H11 (NCTC 8781) and 0157:H7 
(Cl) were also negative.
Table 3.2 A summary of the results obtained by mitomycin C induction and 
challenge of the strains indicated with lambda vir.
Strain Phage production Lysis with lambda vir
E3787 Yes No
E32511 Yes No
0157:H7 (ATCC 35150) Yes No
0157:H7 (Cl)
026:H11 (NCTC 8781)
No No
No No
C600(933J)
C600(933W)
Yes
Yes
Yes
Yes
K12 Yes Yes
Culture supernatants after growth in the presence of mitomycin C (1 fig ml-1) were used 
to challenge lawns of E. coli DH1 to show presence of phage. In addition a lawn of 
each E. coli strain was challenged with a high titre lamda vir Tysate (2 x 10iU PFU ml'1) 
and plates examined for bacterial cell lysis.
At the same time, lawns of all strains were prepared and challenged with a lysate 
containing the bacteriophage lambda vir (table 2.3). A temperate bacteriophage 
maintains the lysogenic state by producing a repressor, specified by the cl gene, which 
binds to operator sequences of the phage DNA, preventing expression of lytic functions. 
The cl repressor is also responsible for immunity to exogenous infection, preventing 
infecting phage DNA from replicating. Lambda vir is a virulent (vir) mutant with a 
mutation in the operator binding site for the cl repressor, resulting in a constitutive lytic
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cycle. Once inside the cell, the lambda vir DNA does not recognise the cl repressor 
produced by the lysogenised phage genome, replication of the vir phage genome and 
subsequent cell lysis then occurs. It was observed that lambda vir caused lysis on lawns 
o f E. coli strains K12, DH1, C600(933J) and C600(933W) but no lysis of the wild type 
strains E3787, E32511, 0157:H7 (ATCC 35150), 0157:H7 (Cl) and 026:H11 (NCTC 
8781), (table 3.2). Challenge of bacterial lawns with a freshly prepared high titre 
lambda vir lysate (section 2.11.3), with a phage titre of 2 x 10*® PFU ml"* (section 
2.11.4), gave identical results. The reason for this is unclear but would imply inability of 
the phage to enter these strains for some reason. This may be due to 
alteration/modification of the phage receptors on the cell surface of these strains, 
leading to bacteriophage resistance, or inability o f the phage DNA to enter these cells. 
Alternatively, previous infection with phage carrying genes that led to the conversion of 
the surface antigens to prevent further adsorption of phage could have occurred. This 
would eliminate waste of phage on lysogenised cells. Investigation as to the reason for 
inability of lambda vir to cause lysis in these strains would require substantial 
investigation and as this was not an aim of this thesis, was not pursued.
3.5 Gene probing with polynucleotide probes
As mentioned in section 3.1, production of VT1 by strain E3787 and VT2 by strain 
E32511 has been reported previously (Willshaw et al., 1987). However, it was necessary 
to confirm that the received strains possessed the published genotypes and to determine 
the presence/type of VT gene sequences in the other isolates. At this time, there had 
been no publications on the existance of V Ts other than VT1, VT2 and VTe (table 
1.1); synthetic oligonucleotide probes (table 1.7) or VT-specific oligonucleotide primers 
(table 1.8) to detect VT gene sequences. Cloned DNA fragments had, however, been 
used as gene probes to identify and distinguish those strains carrying gene sequences for 
VT1 and/or VT2 (section 1.8.8.1) and two strains (table 3.3) were provided by Bernard 
Rowe, Central Public Health Laboratory, London, for the preparation of probe
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T a b le  3 .3 DNA p r o b e s  f o r  VT1 and VT2 g en e  s e q u e n c e s
Strain VT
production
Plasmid
carried
Vector
p(as*id
Inserted DNA 
fragment
Probe
fragment
Inference6
60R746
E. coli K12 F' No NTP705 pACVC177 0.75 Kb Hincll VT1 0.75 Kb (1)
H prototrophic Hincll
to
608363
E. coi i K12 f* Tes NTP707 pACYC184 4.7 Kb £ço*l VT2 0.85 Kb (2)
prototrophic Smal-Patl
b <1> U ilU h M  et »1 . (1985) 
(2 ) UiUshaw et a l. f 1967)
fragments for the detection o f VT1 and VT2 genes. Strain 60R746 carries the 
recombinant plasmid NTP705 which has a 0.75 Kb H indi fragment containing 
sequences of the B subunit gene of VT1, inserted into the ampicillin resistance (Apr) 
gene of vector plasmid pACYC177. Strain 60R363 contains the recombinant plasmid 
NTP707 which carries a 4.7 Kb fcoR I fragment encoding the VT2 operon, inserted into 
the chloramphenicol resistance (Cmr) gene of vector plasmid pACYC184 (figure 3.2). 
Double digestion of plasmid NTP707 with restriction enzymes Smal and Pstl or Aval 
and Pstl generates a fragment of 0.85 Kb containing sequences of the A subunit gene of 
VT2. Digestion with the latter two enzymes however, produces additional DNA  
fragments and therefore, Smal-Pstl digestion was chosen, it being technically easier to 
subsequently isolate the required fragment.
3.5.1 Preparation of VT1 and VT2 probe fragments
Large scale isolation of recombinant plasmids NTP705 and NTP707 was performed as 
described in section 2.13.1(b). To ensure maintenance of plasmids during preparation, 
strains 60R746 and 60R363 were cultured in LB containing the antibiotics, kanamycin 
(Kn) and tetracycline (Tc) respectively, at concentrations stipulated in section 2.4. To 
obtain the DNA probe fragments, the recombinant plasmids were restricted with the 
appropriate enzymes (table 3.3) and the digests run on a 1% (w/v) low gelling 
temperature agarose (BRL) gel (section 2.15). The VT1 and VT2 probe fragments 
(figure 3.3), were then excised under short-wave length UV and labelled to high specific 
activity, without prior purification from the gel slice, as described in section 2.17.
3.52 Probing of chromosomal and plasmid DNA
Large scale isolation of chromosomal and plasmid DNA from each strain was 
performed as described in sections 2.12(b) and 2.13.1(b) respectively. Samples of 
plasmid DNA were electrophoresed through 1% (w/v) agarose gels (section 2.15) whilst
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Figure 33. Restriction enzyme maps of (a) vector plasmid pACYC184 and
(b) a 4.7 Kb EcoRI fragment containing the VT2 operon
(b)
1 kb
The 4.7 Kb EcoRI fragment cloned from 032511 (VT2) was inserted into EcoRI 
digested vector plasmid pACYC184 to form recombinant plasmid NTP707 (Willshaw et 
al., 1987).
A, Aval; E, EcoRI; Ev, EcoRV; He, Hindi; P, Pstl; Pv, Pvull.
1 2 1
Figure 3 3 DNA probe fragments for VT1 and VT2
1% (w/v) low gelling temperature agarose (BRL) gel run in Tris-borate buffer. 
Key to tracks
1: Phage lambda DNA digested with Hindlll. This generated fragment sizes :
23.17, 9.46, 6.75. 4.26, 2.20, 1.92 & 0.58 Kb.
2 : Plasmid NTP705 digested with Hindi.
3 : Plasmid NTP707 digested with Smal and Pstl.
Arrowed fragments are those used as VT1 (0.75 Kb) and VT2 (0.85 Kb) probes.
122
chromosomal DNA samples were digested with EcoRI (section 2.14) and subjected to 
electrophoresis through 0.7% (w/v) agarose gels. Duplicate gels were then Southern 
blotted (section 2.18), hybridised with either the VT1 or the VT2 labelled probes 
(section 2.19) and the filters examined by autoradiography (section 2.20). The A  and B 
subunits of VT1 and VT2 show 57% and 60% overall nucleotide sequence homology 
respectively (table 1.4), however, no cross-hybridisation between the probes was 
observed after stringent washes in 0.1 x SSC, 0.1% (w/v) SDS, as detailed in section 
2.19. A summary of the individual strain reactions with the labelled gene probes is 
shown in table 3.4.
Table 3.4 Summary of the results obtained by probing chromosomal DNA of the 
strains indicated with 2^P-dCTP labelled VT1 and VT2 DNA probes
Strain VT1 probe Size of EcoRI 
fragment (Kb)
VT2 probe Size of £coRI 
fragment (Kb)
E3787 + 6.5 •
E32511 - + 4.9 & 4.3
0157:H7 
(ATCC 35150)
+ 6.5 + 43
0157:H7
(Cl)
* - + 133 & 5.8
026:H11 
(NCTC 8781)
- - - -
C600(933J) + 6.4 - -
C600(933W) - • + 4.4
K12 • • - •
S.dysenteriae 
typ« 1
+ 4.5 - -
*Shiga toxin producer.
+ = Hybridisation after stringent washing in 0.1 x SSC, 0.1% (w/v) SDS.
- = No hybridisation after stringent washing in 0.1 x SSC, 0.1% (w/v) SDS.
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There has been no published description of VT genes occurring on the natural plasmids 
found in some VTEC strains, similarity. Southern blots of plasmid DNA isolated from 
the strains examined in this thesis showed no hybridisation with either the VT1 or the 
VT2 labelled DNA probes (data not shown). Figure 3.4 shows photographs of the 
electrophoresed EcoRI restricted chromosomal DNA of the strains tested and the 
corresponding autoradiographs obtained upon probing with the 32P-dCTP labelled VT1 
probe. Figure 3.5 shows the corresponding autoradiographs obtained after probing with 
the 32P-d(_TP labelled VT2 probe. From the results it can be confirmed that strains 
E3787 and C600(933J) carry VT1 gene sequences and that strains E32511 and 
C600(933W) carry gene sequences homologous to VT2. In addition Ol57:H7 (ATCC 
35150) was found to contain VT1 and VT2 gene sequences whereas 0157:H7 (Cl) 
contained only VT2 gene sequences. A single £coRI fragment of Shigella dysenteriae 
type 1 chromosomal DNA was seen to hybridise with the VTl probe. This was not 
unexpected since S. dysenteriae type 1 contains the genes for Shiga toxin (ShT), which is 
almost identical to VTl, with only three nucleotide differences occurring in the A 
subunit (section 1.43.1). Strains 026:H11 (NCTC 8781) and K12 showed no homology 
with either of the DNA probes and as E. coli 026:H11 also did not appear to contain 
mitomycin C inducible phage (section 3.4), it is possible that loss of this phage, with the 
associated VT production, may have occurred during storage. It can be seen from the 
autoradiographs that two EcoRI fragments in the chromosomal DNA of E32511 and 
0157:H7 (Cl) hybridised with the VT2 gene probe under stringent conditions. This 
implied that these strains have two copies of VT2-related genes, since none of the sit 
operons sequenced to date have contained an £coRI site within or between the 
structural genes for the A and B polypeptides. E32511 has previously been documented 
to only produce VT2 (Scotland et al., 1985; Head et al., 1988a). Production of a VT2- 
variant toxin by E32511 may account for the discrepancies reported concerning the 
physical properties of the VT2 toxin purified from this strain (Head et al., 1988a), 
compared with that purified from the recombinant version in pEBl (Downes et al., 
1988). Antigenic differences have also been reported when antisera from these two
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strains were used in neutralisation assays (Head et al., 1988b). Also Dickie et al. (1989) 
found that antisera from VT2 producing strain 3657 (serogroup C157:H7) and K12 
(pEBl) could not completely neutralise the VT activity of E32511. It would have been 
necessary to clone and sequence these operons to determine their identity and 
relationship with VT2 and as this was not the aim of the project, was not pursued 
further. Oku et al. (1989) published evidence of a VT2 variant toxin, suspected as being 
VTe, being produced by an E. coli 091:H21 strain isolated from a patient with HUS. 
The subsequent cloning and sequencing of genes from E. coli 091:H21 identified two 
distinct genes, vtc2ha and vtc2hb, with almost identical nucleotide sequences, that were 
capable of producing a VT similar to VT2 (section 1.4.3.4). This was the first published 
demonstration of multiple copies of toxin genes related to VT2 within a single strain. 
Schmitt et al. (1991) also reported that E32511 contained two copies of VT2-related 
genes and published the nucleotide sequences of the two different operons. One was 
determined to be that of s/r-II while the other, termed r/f-IIc in essence contained A 
subunit sequences from slt-ll and B subunit sequences from vtx2ha (table 1.6). In 
Schmitts study, DNA from E32511 digested with EcoRI gave two bands of 
approximately 4.8 and 5.5 Kb which showed hybridisation with the VT2 probe. 
Willshaw et al. (1985) reported the cloning of VT2 (E32511) from a 4.7 Kb EcoRI 
fragment derived from phage DNA of E32511, whereas Rietra et al. (1989) reported 
that a 5.0 Kb EcoRI fragment from phage DNA of E32511 hybridised with VT2-specific 
sequences. The values obtained in this study (table 3.4) are slightly lower, being 4.9 and
4.3 Kb. Based on Schmitts results it was concluded that the 4.3 Kb EcoRI fragment 
observed in figure 3.5 carries the sit-II operon whilst the 4.9 Kb EcoRI fragment carries 
the j/f-IIc operon. The EcoRI fragment in E. coli 0157:H7 (ATCC 35150) that 
hybridised with the VT2 probe, comigrated with the 4.3 Kb EcoRI fragment of E32511 
(data not shown) and it is proposed therefore that this strain, in addition to VT1, also 
produces VT2.
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Figure 3.4 Examination of chromosomal DNA of E. coli strains for VTI gene 
sequences
Chromosomal DNA of the strains indicated was restricted with EcoRI, fractionated by 
agarose gel electrophoresis and Southern blotted onto nitrocellulose. The resulting blot 
was probed with a 32P-dCTP labelled VTI DNA probe cloned from the phage DNA of 
E. coli strain H19 (serotype 026:H11). Chromosomal DNA from S. dysenteriae type 1 
was also probed.
Key to tracks
A & K: Phage lambda DNA restricted with HindUl.
B to J: E3787, E32511,0157:H7 (ATCC 35150), 0157:H7 (Cl), 026:H11 
(NCTC 8781), K12, C600(933J), C600(933W) & S. dysenteriae type 1 
chromosomal DNA respectively - restricted with EcoRI.
Tracks L to U are autoradiographs of the corresponding tracks A to J probed with the 
32P-dCTP labelled VTI probe.
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Figure 3 .5 Examination o f chromosomal DNA o f E . co li strains for VT2 gene
sequences
A Southern blot of £coRI restricted chromosomal DNA of the strains shown in figure
3.4 was probed with a ^^P-dCTP labelled VT2 DNA probe cloned from the phage DNA 
of E  coli strain E32511 (serotype 0157:H*). Only tracks showing hybridisation are 
shown. All the other strains showed no evidence of hybridisation.
Key to tracks
A : E32511 chromosomal DNA
B : 0157:H7 (ATCC 35150) chromosomal DNA
C : 0157:H7 (Cl) chromosomal DNA
D : C600(933W) chromosomal DNA
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Most prophages are integrated at fixed locations on the bacterial chromosome. The 
VT1 EcoRI fragments of strains E3787, C600(933J) and 0157:H7 (ATCC 35150) are 
similar in size and presumably, this is due to the integration of the VT1 carrying phage 
at identical sites in the bacterial chromosomes of these strains. Similarity, the VT2 
carrying phage would appear to have integrated at identical sites in the chromosomes of 
E. coli strains E32511, C600(933W) and 0157:H7 (ATCC 35150). Neither of the EcoRI 
fragments that hybridised with the VT2 probe in 0157:H7 (Cl), comigrated with the 
EcoRI fragments in E32511 and the identity of the VT2-related operons in this strain 
remain to be characterised. E. coli 0157:H7 (Cl) did not appear to contain mitomycin 
C inducible phage (section 3.4), and it is possible that this strain may have obtained 
VT2-related sequences by a method of gene transfer such as conjugation. Transfer of 
genes coding for VTe from a field isolate to a K12 strain by conjugation has been 
reported (Williams Smith et al., 1983).
Studies have shown that E. coli 0157:H7 strains containing only VT2 genes are more 
frequently associated with HUS and TTP than strains containing VT1 or both VT1 and 
VT2 (Ostroff et al., 1989; Tarr et al., 1989). Scotland et al. (1987) also noted that strains 
producing VT2 alone were most frequently associated with HUS. The importance of 
multiple copies of s/MI operons in strains of E. coli associated with disease remains to 
be determined. So far there has been no evidence of multiple copies of VT1 related 
genes in a single strain.
3.6 Determination o f VT production using the ricin assay
The ricin assay was used to determine which strains were capable of producing active 
toxin. This assay makes use o f the fact that both ricin and VTs have exactly the same 
mode and site of action (sections 1.3.3 & 1.3.3.2). Treatment of eukaryotic ribosomes 
with these toxins results in cleavage of a specific N-glycosidic bond at adenine residue 
4324 in 28S ribosomal RNA (rRNA). Addition of aniline to the isolated RNA causes
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release of a distinctive fragment of 400 nucleotides which can be easily visualised on 
RNA gels.
Cell pellets were treated with polymyxin B (section 2.21.1), as polymyxin B has 
previously been found to be useful in extracting high titres of intracellular VT from cell 
pellets of VTEC (Karmali et al., 1985b). Polymyxin B extracts were reduced with BME 
(section 2.21.1) to ensure production of catalytically active Al fragments and used to 
treat yeast ribosomes (section 2.21.2) as described in section 2.21.2.1. As a positive 
control, yeast ribosomes were also incubated in the presence of recombinant ricin A 
chain, a gift from Dr. Martin Hartley, Warwick University. The recombinant protein 
contains an N-terminal methionine prior to isoleucine, the N-terminal amino acid in 
planta. Apart from this it is identical to the native, plant purified A chain in primary 
sequence. RNA was extracted from toxin-treated ribosomes (section 2.21.2) and 
treated with aniline as described in section 2.21.2.2. Toxin treated rRNA, before and 
after aniline treatment was electrophoresed through a 1.2% (w/v) agarose/50% (v/v) 
formamide gel and the RNA visualised after soaking in ethidium bromide (section 
2.21.2.3).
3.6.1 Requirement of a /?-mercaptoethanol incubation step
In an initial experiment, yeast ribosomes were treated with E3787 and E32511 
polymyxin B extracts to which no BME had been added. The distinctive 400 nucleotide 
fragment released upon aniline treatment was present in both ricin and E32511 treated 
RNA tracks, but was absent from the E3787 treated RNA track (gel not shown). When 
BME was included in the reaction mix (2 p\ of 100 mM stock), identical results were 
obtained (figure 3.6). In another experiment, in addition to inclusion of BME in the 
reaction mix (2 p \ of 100 mM stock), the polymyxin B cell extracts were also 
preincubated in BME (10 p \ extract + 1 p\ 100 mM BME, 30°C, 1 hour). On this 
occasion (figure 3.7), E3787 polymyxin B cell extracts contained active toxin, as
129
Figure 3.6 Analysis of yeast ribosomal RNA (rRNA) treated with E. coli E3787 and 
E32511 polymyxin B cell extracts and /?-mercaptoethanol (BME) in the 
reaction mixture.
All samples, except for the ricin control had 2 /d of 100 mM BME included in the 
reaction mixture as described in materials and methods. Electrophoresis of RNA was 
performed on a 1.2% (w/v) agarose, 50% (v/v) formamide gel. The gel was 
electrophoresed at 20 mA constant current in Leicester Biocenter gel tanks for 2-3 
hours in 0.1 x TPE buffer, stained in 2 ^g ml' 1 ethidium bromide for 20 minutes and 
destained in distilled water for 10 minutes.
Key to tracks
A : Yeast rRNA treated with recombinant ricin A chain (+  aniline).
B : Yeast rRNA treated with recombinant ricin A chain (- aniline).
C : Yeast rRNA treated with E. coli E3787 polymyxin B cell extract ( + aniline).
D : Yeast rRNA treated with E. coli E3787 polymyxin B cell extract (- aniline).
E : Yeast rRNA treated with E. coli E32511 polymyxin B cell extract ( + aniline).
F : Yeast rRNA treated with £. coli E32511 polymyxin B cell extract (- aniline).
A B C D  E F
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Figure 3.7 Analysis of yeast ribosomal RNA treated with £. coli E3787 and E32511 
polymyxin B cell extracts, pre-incubated with BME in addition to RME in 
the reaction mixture.
Polymyxin B cell extracts were pre-incubate 1 with 1 n\ of 100 mM BME for 1 hour at 
30°C in addition to the 2 fA of 100 mM BME included in the reaction mixture, except 
for the ricin control. Electrophoresis of RNA was performed on a 1.2% (w/v) agarose, 
50% (v/v) formamide gel. The gel was electrophoresed at 20 mA constant current in 
Leicester Biocenter gel tanks for 2-3 hours in 0.1 x TPE buffer, stained in 2 ng ml'T 
ethidium bromide for 30 minutes and destained in distilled water for 10 minutes.
Key to tracks
A : Yeast rRNA treated with recombinant ricin A chain (+ aniline).
B : Yeast rRNA treated with E. coli E3787 polymyxin B cell extract (- aniline).
C : Yeast rRNA treated with E. coli E3787 polymyxin B cell extract (+  aniline).
D : Yeast rRNA treated with £. coli E32511 polymyxin B cell extract (- aniline).
E : Yeast rRNA treated with £. coli E32511 polymyxin B cell extract (+  aniline).
A B C  D E
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evidenced by presence of aniline releasable fragment (arrowed in figures 3.6 and 3.7). 
These observations imply that strain E32511, which contains slt-ll and slt-llc operons 
(section 3.5.2), produces toxin(s) that does not require reduction to be catalytically 
active. Either the A subunit possesses N-glycosidase activity in the non-reduced form or 
it is very unstable and readily dissociates to form the active A1 fragment. VT1 
produced by strain E3787, on the other hand, requires reduction with BME and 
furthermore prolonged exposure to this reducing agent (1 hour, 30°C was found to be 
successful) before displaying N-glycosidase activity. Production of toxin which is readily 
active (VT2 by E32511) as opposed to a toxin which requires relatively lengthy 
reduction before displaying activity has important implications on the relative abilities 
of such organisms to cause disease in vivo, the former could presumably lead to a more 
sudden onset of symptoms.
3.6.2 Determination of toxin production by bacterial strains
The ricin assay was used as described above (section 3.6), to determine which strains, in 
addition to E. coli E3787 and E32511 were capable of producing active toxin. 
Polymyxin B cell extracts were preincubated in BME to ensure that no false negatives 
were obtained (section 3.6.1). The resulting gel is shown in figure 3.8. All strains were 
seen to produce active toxin except £. coli strains 026:H11 (NCTC 8781) and K12. 
This corroborates the gene probing data obtained in section 3.5.2.
3.63  Comparison of E. coli E3787 and E32511 polymyxin B and PBS cell
extracts in the ricin assay
Polymyxin B and PBS cell extracts were prepared from strains E3787 and E32511 as 
described in section 2.21.1 except that the cell pellets for PBS extraction were 
resuspended in 1 ml of sterile PBS instead of polymyxin B. Yeast rRNA was challenged 
with these extracts and the resulting gel is shown in figure 3.9. It can be seen that
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Figure 3.8 Analysis o f yeast ribosomal RNA treated with polymyxin B cell extracts of
E. coli strains.
Electrophoresis of RNA was performed on a 1.2% (w/v) agarose, 50% (v/v) formamide 
gel. The gel was electrophoresed at 20 mA constant current in Leicester Biocenter gel 
tanks for 2-3 hours in 0.1 x TPE buffer, stained in 2 n% ml"1 ethidium bromide for 15 
minutes and destained in distilled water for 30 minutes.
Key to tracks
A : Yeast rRNA treated with 
B : Yeast rRNA treated with 
C : Yeast rRNA treated with 
D : Yeast rRNA treated with 
E : Yeast rRNA treated with
F : Yeast rRNA treated with 
G : Yeast rRNA treated with 
H : Yeast rRNA treated with 
I : Yeast rRNA treated with
J : Yeast rRNA treated with
K : Yeast rRNA treated with 
L : Yeast rRNA treated with
M : Yeast rRNA treated with 
N : Yeast rRNA treated with
recombinant ricin A  chain (- aniline), 
recombinant ricin A  chain (+ aniline).
0157:H7 (ATCC 35150) cell extract (- aniline). 
0157:H7 (ATCC 35150) cell extract (+  aniline). 
0157:H7 (Cl) cell extract (- aniline).
0157-.H7 (Cl) cell extract (+ aniline).
026:H11 (NCTC 8781) cell extract (- aniline). 
026:H11 (NCTC 8781) cell extract (+  aniline). 
K12 cell extract (- aniline).
K12 cell extract (+  aniline).
C600(933J) cell extract (- aniline).
C600(933J) cell extract (+ aniline).
C600(933W) cell extract (- aniline).
C600(933W) cell extract (+ aniline).
A B C D E  F G H  I J K L M N
133
Figure 3.9 Analysis of yeast ribosomal RNA treated with either phosphate buffered 
saline (PBS) or polymyxin B cell extracts of E. coli strains E3787 and 
E32511.
Electrophoresis of RNA was performed on a 1.2% (w/v) agarose, 50% (v/v) formamide 
gel. The gel was electrophoresed at 20 mA constant currenLin Leicester Biocenter gel 
tanks for 2-3 hours in 0.1 x TPE buffer, stained in 2 ml' 1 ethidium bromide for 30 
minutes and destained in distilled water for 10 minutes.
Key to tracks
A : Yeast rRNA treated with recombinant ricin A  chain (+ aniline).
B : Yeast rRNA treated with E3787 polymyxin B cell extract (- aniline).
C : Yeast rRNA treated with E3787 polymyxin B cell extract (+  aniline).
D : Yeast rRNA treated with E3787 PBS cell extract (- aniline).
E : Yeast rRNA treated with E3787 PBS cell extract (+ aniline).
F : Yeast rRNA treated with E32511 polymyxin B cell extract (- aniline).
G : Yeast rRNA treated with E32511 polymyxin B cell extract (+ aniline).
H : Yeast rRNA treated with E32511 PBS cell extract (- aniline).
I : Yeast rRNA treated with E32511 PBS cell extract (+  aniline).
A B C  D E F G H I
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polymyxin B cell extracts of both strains contain active toxin (tracks C & G) whereas 
only strain E32511 has active toxin in PBS treated cell extracts (track I). The presence 
of VT in PBS treated cell extracts is compatible with the concept of a leaky outer 
membrane and, moreover, it would appear that only VT2 and not VT1 is able to leak 
from the periplasm. PBS and polymyxin B cell extracts from both strains had been 
prepared from late exponential phase cultures and it is unlikely that the appearance of 
toxin in PBS extracts was due to bacterial autolysis. These findings corroborate earlier 
studies by Karmali et al. (1985b) who proposed that VTl predominates in cell lysates 
with VT2 present in much higher titres than VTl in culture supernatants. Both findings 
imply significant differences in the secretion and localisation of the two different toxins 
and furthermore, the demonstration that VT2 readily leaks whilst V Tl does not may be 
important in the pathogenesis of VT2 associated diseases. Secretion of an active 
(section 3.6.1) toxin into the surrounding environment during growth could lead to a 
sudden onset of symptoms and additionally reduce the available time in which the body 
could raise a protective immune reponse. By this time the damage may have been done 
and indeed this hypothesis may be reflected in the findings of a number of groups which 
have shown that strains producing VT2 alone are most frequently associated with HUS 
(section 3.5.2).
3.7 Protein profiles of £. coli 0157:H7 (ATCC 35150) during growth on
Penassay broth
Earlier in the project, cell free extracts and culture supernatant samples were prepared 
at known time intervals during growth of E. coli 0157:H7 (ATCC 35150) on Penassay 
broth (sections 2.23 and 2.24 respectively). A protein concentration step was required 
in the preparation of culture supernatant samples and ammonium sulphate 
precipitation was initially used (section 2.24.1). It was found necessary however, to 
concentrate large volumes of supernatant, (typically 2 litres), due to protein losses 
during procedural steps. An Amicon Micro-Ultrafiltration System (Amicon Corp.),
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incorporating a 10 KDa cut-off filter was found to be more practical (section 2.24.2). 
Prior to concentration in the latter, it was necessary to dialyse culture supernatant 
samples against 10 mM Tris-HCl, pH 7.0 (section 2.24.2). This removed substances 
(presumably medium salts) which were found to interfere with subsequent protein 
staining.
The protein concentration of each sample was determined using the Bio-Rad protein 
assay as described in section 2.22. Cell extract and supernatant samples adjusted to 
contain the same amount of protein (as indicated), were then analysed by 11% (w/v) 
SDS-PAGE as described in section 2.25.1 with protein molecular weight (MW) markers 
of size range 14.4-94.0 KDa (section 2.29). The proteins were visualised by silver 
staining (section 2.25.2), destained if necessary (section 2.25.3) and photographed 
(section 2.26).
Figure 3.10 shows a SDS polyacrylamide gel of cell extract and concentrated 
supernatant samples (tracks A and B respectively), of a stationary phase culture of E. 
coli 0157:H7 (ATCC 35150) grown on Penassay broth. In tracks A and B it can be seen 
that a protein (arrowed), estimated to have a MW of approximately 34 KDa, is present 
which comigrates with purified 0157:H7 VT (provided by Sue Colby, Warwick 
University). This is thought to correspond to the A subunit of the toxin, with the much 
smaller B subunit comigrating with the dye front. Later in the project, gene probing 
studies demonstrated that strain 0157:H7 contained both VT1 and VT2 gene sequences 
(section 3.5). Purely on a MW basis, the purified protein was tentatively identified as 
the A subunit of VT2, as the A subunit of VT1 is slightly smaller (table 1.2). 
Furthermore it was shown in section 3.6.3 that VT1 appears to be located 
predominately intracellularly, whereas VT2 is present in much higher titres than VT1 in 
culture supernatants. As the purified VT had been isolated from the supernatant of a 
culture of 0157:H7 (ATCC 35150), it is more likely that VT2 rather than VT1 was 
purified. Confirmation of the identities of the proteins corresponding to the VT1 and
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Figure 3.10 SDS-PAGE of cell extract and concentrated supernatant samples of a 
stationary phase culture of E. coli 0157:H7 (ATCC 35150) grown on 
Penassay broth.
A B C
Key to tracks
A : 6 hour cell extract • 45 /¿g protein.
B : 6 hour concentrated supernatant - 90 ng protein.
C : Purified VT from E. coli Oi57:H7 (ATCC 35150) - 10ft\ (unknown concentration)
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VT2 A subunits would have required Western blotting with specific antibodies to each, 
unfortunately these were not available at the time.
Figure 3.11 shows a SDS polyacrylamide gel of cell extract (tracks A to C) and 
concentrated supernatant (tracks D to F) samples of E. coli 0157:H7 (ATCC 35150), 
prepared at the culture growth times indicated. It would appear that as late 
exponential/early stationary phase is reached, there is a sudden appearance in the 
supernatant of the protein thought to correspond to the VT2 A subunit. Production of 
the latter continues into the stationary phase, as evidenced by the denser protein band 
in track F. The ability of VT2 to readily leak across the outer membrane has already 
been discussed (section 3.6.2). Furthermore, it would appear (figure 3.11), that VT2 
leaks significantly from the cells only as stationary phase of growth is approached and 
not earlier in the growth cycle. This may purely be the result of accumulation of VT2 to 
such an extent that leakage occurs at this point of growth. Alternatively, VT2 may have 
a role other than as a virulence determinant which as yet has not been recognised, for 
example, the aquisition of a specific nutrient which may have become limiting as the 
medium becomes spent.
3.8 Pulse labelling of £  coli 0157:H7 (ATCC 3515«) with 35S-methionine.
In an attempt to more clearly define at what time during growth VT2 is produced, 
pulse-labelling experiments with 33S-methionine were performed (section 2.28). 
Studies to determine the kinetics of 35S-methionine incorporation by growing cultures 
of E. coli 0157:H7 on Penassay containing IfiCi ml' 1 final concentration of 35S- 
methionine (section 2.27), revealed an initial lag in incorporation (figure 3.12). Similar 
kinetics of incorporation were observed when 0157:H7 was grown on Penassay 
containing 2/iCi ml' 1 final concentration of 3^S-methionine (data not shown). As a 
final concentration of 1/tCi ml' 1 was equivalent to 7.69 x 10*^  nM methionine, L- 
methionine (7.7/d of 10/*M) was added 1 hour prior to addition of the 35S-methionine
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Figure 3.11 SDS-PAGE of cell extract and concentrated supernatant samples 
prepared during growth of E. coli 0157:H7 (ATCC 35150) on Penassay 
broth.
A B O D E  F
i l l  ?
Key to tracks
A : 2 hour cell extract - 55 ng protein.
B : 4 hour cell extract - 55 fig protein.
C : 6 hour cell extract - 55 ng protein.
D : 2 hour concentrated supernatant - 55 fig protein.
E : 4 hour concentrated supernatant - 55 fig protein.
F : 6 hour concentrated supernatant - 55 ng protein.
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to ensure there was no lag in the incorporation of label during pulse-labelling (section 
2.28). In figure 3.12 it can be concluded that the available ^S-methionine 
concentration did not become limiting during the time course of the experiment as the 
radioactive level of the precipitated cells did not plateau, except as the cells reached 
early stationary phase. To ensure excess available ^S-methionine however, 3/zCi ml"* 
were added in the pulse labelling experiments.
Figure 3.12 ^S-methionine incorporation during growth of E. coli Oi57:H7 (ATCC 
35150) on Penassay broth
At the time arrowed, ^S-methionine was added to a growing culture of E. coli 0157:H7 
(ATCC 35150) to a final concentration of 1 /¿Ci m l'1. Assays were performed as 
described in materials and methods.
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Figures 3.13 and 3.14 show silver stained SDS polyacrylamide gels of cell extract and 
supernatant samples prepared at known time intervals after a 10 min pulse with ^S- 
methionine and the corresponding autoradiographs after 22 days exposure at room 
temperature (section 2.28). Samples in figures 3.13 and 3.14 had been adjusted to 
contain the same amount of protein or counts respectively as indicated. Once again it 
appeared that VT2 was only produced extracellularly as the culture reached early 
stationary phase (tracks H & I, figures 3.13 & 3.14). VT2 synthesis appeared to occur 
throughout growth but was slightly greater at 2 hours growth (track M, figures 3.14 & 
3.15), when the culture was growing exponentially. Labelling of the VT2 toxin A 
subunit with ^S-methionine was poor, labelled toxin A subunit could not be seen in the 
supernatant fractions of the autoradiographs and longer exposure to the ^S-labelled 
material was required. Another factor that may have contributed to the poor degree of 
toxin labelling is that only five of the 296 amino acids that correspond to the processed 
A subunit of VT2 are methionine (Jackson et al., 1987b). It can however be concluded 
from these results that VT2 synthesis occurred throughout growth and that the toxin 
accumulated intracellularly until stationary phase was approached.
3.9 Summary and overview.
The growth characteristics and nutritional requirements of the E. coli strains used in the 
project have been defined. Additionally the toxin genotype o f each strain was 
determined/confirmed and the possession of lysogenic phage and the ability to produce 
active toxin was demonstrated. Differences in the secretion and localisation of VT1 and 
VT2 within E. coli E3787 and E32511 respectively have been shown. Whilst VT1 was 
strongly cell associated, VT2 readily leaked into the extracellular medium during 
growth. Furthermore VT2 was shown to possess N-glycosidase activity much more 
readily than VT1 and was produced into the supernatant only as the bacterial culture 
reached stationary phase.
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Figure 3.13 SDS-PAGE of cell extract and concentrated supernatant samples of E.
coli 0157:H7 (ATCC 35150) grown on Penassay broth and pulsed with 
33S-methionine.
Samples were adjusted to contain the same amount of protein per track as indicated.
Key to tracks
A&J: C 14 labelled protein markers (200,92.5,69,46,30 &  14.3 KDa).
B : 1 hour cell extract -16 fig protein.
C : 2 hour cell extract -16 fig protein.
D : 4 hour cell extract -16 ng protein.
E : 6 hour cell extract -16 fig protein.
F : 1 hour concentrated supernatant - 32 fig protein.
G : 2 hour concentrated supernatant - 32 fig protein.
H : 4 hour concentrated supernatant - 32 fig protein.
1 : 6 hour concentrated supernatant - 32 fig protein.
Tracks K to T are autoradiographs of the corresponding tracks A to J showing 35S- 
methionine labelled proteins in the sample.
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Figure 3.14 SDS-PAGE of cell extract and concentrated supernatant samples of E.
coli 0157:H7 (ATCC 35150) grown on Penassay broth and pulsed with 
•^S-methionine.
Samples were adjusted to contain the same counts min' 1 per track as indicated.
Key to tracks
A&J: C14 labelled protein markers (200, 92.5,69,46, 30 & 14.3 KDa).
B : 1 hour cell extract -12377 counts min'1.
C : 2 hour cell extract -12380 counts min'1.
D : 4 hour cell extract -12351 counts min'1.
E : 6 hour cell extract - 12386 counts min'1.
F : 1 hour concentrated supernatant - 679 counts min'1.
G : 2 hour concentrated supernatant - 678 counts min'1.
H : 4 hour concentrated supernatant - 678 counts min'1.
1 : 6 hour concentrated supernatant - 679 counts min'1.
Tracks K to T are autoradiographs of the corresponding tracks A to J showing 35S- 
methionine labelled proteins in the sample.
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4.1 Introduction
The project was undertaken to examine the influence of various nutritional and physical 
parameters on toxin expression. A rapid simple and specific test to detect and quantify 
the amount of toxin produced was therefore required. At the time three types of assay 
to identify VTEC and their toxins were available (section 1.8)
(1) Cell culture toxicity assays (section 1.8.3) - Vero and HeLa cells are used in tissue 
culture to test for cytotoxicity and neutralisation of cytotoxicity with specific antibodies. 
Whilst these bioassays are highly sensitive, they are slow, expensive, labour intensive 
and reproducibility is difficult to achieve.
(2) Enzyme-linked immunosorbent assay (ELISA) methods, (section 1.8.4) - are more 
accurate, simpler, rapid and less expensive than the Vero/Hela cell assays but not as 
sensitive in that only high/moderate levels of VT are detected.
(3) Specific DNA probes (section 1.8.8) - are rapid, specific and sensitive but expensive. 
They give no indication as to the levels of VT produced (i.e. a cell may possess the 
appropriate gene sequence but it may only be expressed under certain conditions).
Two lines of research were pursued to develop an assay which would enable 
quantification of VT1 and VT2 gene expression at the molecular level
(1) Development of a VT RNA assay.
(2) Formation of a VT2-alkaline phosphatase gene fusion.
These are considered separately in sections 4.2 and 5.2 respectively.
4. Development o f an assay system to monitor VT gene expression
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4 2 Development o f a RNA assay
One of the primary uses of RNA isolation procedures is the analysis of gene expression. 
In order to elucidate specifically VT1 and VT2 expression, an assay was developed that 
involved probing of Northern dot blots with DNA probes for VT1 and VT2 sequences. 
The basic protocol for this assay, termed the Verotoxin RNA assay, is shown in figure 
4.1. The assay would enable the effects of various parameters on VT gene expression to 
be determined by measuring changes in the overall steady state level of sit operon 
transcription (i.e. VT messenger RNA (mRNA) synthesis). It is, however, assumed that 
changes in transcription of the genes reflect changes in the rate of transcription and 
hence changes in toxin production. Comparisons are made against a control set of 
conditions in each individual hybridisation with data for VT expression normalised so 
that the amount of mRNA in the control was 100%. As variations can occur in the 
degree of probe oligo-labelling, only relative changes and not direct comparisons 
between each hybridisation can be made. The relative expression can then be 
calculated by the formula 
100 x (VTsampie/VTcontroi).
To verify mRNA recovery, blots could subsequently be stripped by boiling in water and 
then reprobed with a DNA probe to an abundant E. coli protein.
4.2.1 Preparation and probing of RNA
Northern hybridisation can be used to accurately determine the steady state level of a 
particular mRNA and initial experiments focussed on extracting intact RNA to give 
discrete bands on a Northern blot. Most procedures for isolating RNA from a 
biological source involve disruption of the cells, followed by steps to remove DNA and 
protein. A method for extracting RNA was adopted which was small scale and 
reproducible, enabling rapid sampling over a time course (section 2.30). Cells were
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lysed in the presence of SDS and salt to denature the protein and precipitate the 
chromosomal DNA. After protein removal by organic extraction, the remaining RNA 
was recovered and concentrated by ethanol precipitation. Although deproteinisation 
should have prevented potential degradation of the cellular RNA by bacterial 
ribonucléase (RNase), rigorous precautions were taken to prevent incidental 
contamination by RNases from other sources (section 2.30). Any water used in RNA 
preparation was treated with diethylpyrocarbonate (DEPC). This inactivates RNases by 
covalent modification. However, solutions containing Tris cannot be effectively treated 
with DEPC since Tris contains a primary amine that reacts with DEPC causing 
inactivation.
Figure 4.1 Protocol for the Verotoxin RNA assay
The assay involves extracting intact RNA to give discrete bands on a Northern blot. 
Northern dot blots, adjusted to contain the same amount of RNA, are transferred to 
nitrocellulose using a S & S manifold dot blot. After baking, prehybridisation, 
hybridisation and washing, dots are cut out, placed in a scintillation vial and counted. A 
quantitative relationship between fig RNA and counts per minute can then be made.
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Typically (unless otherwise stated), the RNA concentration was determined and 
samples, adjusted to contain the same amount of total RNA (as stated), were denatured 
in formaldehyde loading buffer (FLB) and electrophoresed on a formaldehyde 
denaturing gel (sections 2.31 & 2.32). Either formaldehyde or glyoxal/DMSO can 
potentially be used as the denaturant. However, formaldehyde gels were used in this 
study as they do not smear as much as glyoxal gels and can be photographed 
immediately using FLB. Also, agarose/formaldehyde gels allow good electrophoretic 
separation of RNAs over a wide range of molecular weights (MW), (Selden, 1989). 
RNA MW markers (BRL), VT1 and VT2 control DNA probe fragments were also 
denatured and electrophoresed (unless stated otherwise). The separated RNA was then 
transferred to a nitrocellulose membrane as described in section 2.33. Essentially 
transfer was exactly as for Southern blotting (section 2.18), except that the gel was 
pretreated with salt and not alkali since treatment of the gel with alkali and 
neutralisation buffer had been found to substantially reduce the efficiency of transfer of 
RNA from the gel to the nitrocellulose paper, particularly for larger RNAs (Thomas, 
1980). Northern filters were probed exactly as for Southern filters, except that washes 
were less stringent (section 2.33(a)).
4 J 2  Northern blotting of VT-producing E. coli
E. coli 0157:H7 (ATCC 35150) contains both slt-l and slt-ll coding sequences (section 
3.5.2). Studies have shown that the sit-1 and s/MI operons are both transcribed from 
polycistronic mRNA from a promoter upstream of the sit A  gene (section 1.4.2). The 
size of the polycistronic mRNA species produced from each operon was estimated from 
published sit-1 and s/f-II sequence data (Calderwood et al., 1987; Jackson et al., 1987b 
respectively) to be approximately 1.6 Kb (for slt-l) and 1.7 Kb (for slt-U).
Figure 4.2 (tracks B & C) shows electrophoresed total RNA prepared from a stationary
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Figure 4.2 Northern blot analysis o f E. c o li 0157:H 7 (ATCC 35150)
Total cellular RNA was denatured in formaldehyde loading buffer and electrophoresed 
on a 1.5% (w/v) agarose, 2.2 M formaldehyde gel in 1 XLMOPSJbuffer at 80V. The 
RNA was transferred to nitrocellulose and probed with ^PdCTP labelled VT1 and 
VT2 DNA fragments as described in materials and methods.
Key to tracks
A: RNA markers (BRL). Fragment sizes were 9.49, 7.46, 4.4, 2.37, 1.4 & 0.24 Kb.
B: Total RNA isolated from E. coli 0157:H7 (ATCC 35150) - concentration unknown. 
C: Total RNA isolated from E. coli 0157:H7 (ATCC 35150) - concentration unknown.
Tracks D  & E correspond to tracks A and B respectively probed with a ^PdCTP 
labelled 0.75 Kb H indi fragment from plasmid NTP705 which contant VT1 B subunit 
coding sequences. Track F corresponds to track C probed with a ^PdCTP labelled 
0.85 Kb Smal-Pstl fragment from plasmid NTP707 which contains VT2 A subunit 
coding sequences. Filters were washed in 1 x SSC at 65°C for 1 hour and exposed to 
autoradiographic film for 21 days at -70°C.
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phase culture of E. coli 0157:H7 (ATCC 35150) and the subsequent blots obtained 
after probing Northern filters with the ^P-dCl'P labelled VT1 and VT2 probes (tracks 
E & F respectively). RNA was prepared as described in section 3.30 except that in this 
case attempts were made to extract the RNA from a 50 ml cell pellet. The cell 
concentration was, however, too high and a small aliquot of this was removed for RNA 
preparation. It can be seen that upon electrophoresis of 5 /A of the 0157:H7 (ATCC 
35150) cellular RNA, the 23S, 16S and 5S ribosomal RNA (rRNA) bands are clearly 
visible, indicating that there has been no gross degradation of the RNA. The 
corresponding Northern blots, after washing with 2 x SSC, 0.1 % (w/v) SDS and then 1 x 
SSC, 0.1% (w/v) SDS at 65°C for 1 hour, showed evidence of hybridisation to the 
labelled DNA probes (tracks E & F). Non-specific hybridisation with material within 
the RNA marker lane was also observed (track D). There was no apparent difference 
in the pattern of the hybridised material in tracks E & F. The arrowed fragments, 
estimated to be approximately 1.5 Kb, were thought to correspond to the polycistronic 
mRNA produced by transcription of the sit operons in this strain. In an attempt to wash 
away the non-specifically bound material, filters were washed more stringently with 0.1 x 
SSC, 0.1% (w/v) SDS at 65°C for 1 hour. After 9 days exposure to autoradiographic 
film at -70°C, however, the filters showed no evidence of hybridisation. This could have 
been a consequence of
(a) The filters were over 4 weeks old and it is possible that any ^P-labelled material 
had decayed to such an extent as to be undetectable, or, (b) the labelled probes had 
been removed by the stringent washing conditions.
Figure 4.3 shows electrophoresed total RNA prepared from 1.5 ml overnight cultures of 
VT producing strains E3787, E32511, 0157:H7 (ATCC 35150) and 0157:H7 (Cl), 
(section 2.30). Gel B contains double the amount of RNA per track (i.e. 10 /A per 
track) as gel A. Northern filters were washed in either 2 x SSC, 0.1% (w/v) SDS, at 
65°C for 45 min (gel A) or 2 x SSC, 0.1% (w/v) SDS, at room temperature for 45 min 
(gel B). Other than the DNA fragment controls, autoradiographs showed no evidence
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Figure 4 3  Northern blot analysis o f  VT-producing E. co li
Duplicate samples of total cellular RNA from the strains indicated were denatured in 
formaldehyde loading buffer and electrophoresed on a 1.5% (w/v) agarose, 2.2 M 
formaldehyde gel in 1 X MOPS buffer at 80V (gel A) and 30V (gelB). Gel B contained 
double the amount of RNA as gel A  (concentration unknown). RNA was transferred to 
nitrocellulose and probed with ^PdCTP labelled VT1 and VT2 DNA fragments as 
described in materials and methods. Only one half of each gel is illustrated.
Key to tracks (Gels A & B)
1 & 6 : RNA markers (BRL). Fragment sizes were 9.49, 7.46, 4.4, 2.37, 1.4 & 0.24 Kb.
2 & 7 : Total RNA isolated from E. coli E3787.
3 & 8 : Total RNA isolated from E. coli E32511.
4 & 9 : Total RNA isolated from E. coli 0157:H7 (ATCC 35150).
5 & 10 : Total RNA isolated from£. coli 0157:H7 (Cl).
8 fil of VT1 Hindi DNA probe fragment and VT2 Smal-Pstl DNA probe fragment were 
included on each gel as controls.
Gel A Gel B
1 2 3 4 5  6 7 8 9  10
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of hybridisation with either probe after exposure to the Northern filters for 4 days and 
27 days at -70°C (autoradiographs not shown). DNA control probe fragments 
hybridised specifically with the homologous probes as a dark smear from the well of the 
track due to the denaturing conditions employed.
In another experiment RNA was prepared from E. coli strains 60R363 and 60R746 from 
which the VT1 and VT2 probes had been prepared (figure 4.4). Upon probing of 
Northern filters with the labelled VT1 and VT2 probes and washes in 2 x SSC, 0.1% 
(w/v) SDS and 1 x SSC, 0.1% (w/v) SDS at room temperature for 1 hour each, the 
control probe fragments were seen to hybridise with the homologous probes as 
expected. In addition, bands in the wells of tracks 2 & 6 hybridised with the VT1 probe 
and the VT2 probe respectively. This was thought to be due to plasmid DNA 
contamination and to confirm this, RNA samples were treated with deoxyribonuclease 
(DNase) as described in section 2.34. 20 n\ of the DNase treated RNA was denatured 
and electrophoresed as previously described. Subsequent autoradiographs only showed 
hybridisation to the control DNA probe fragments, confirming that contamination with 
plasmid DNA had occurred in figure 4.4 (autoradiographs not shown).
4.2.3 Probing or RNA from different points in the growth cycle of VT-producing
strains
It was not known whether VT mRNA synthesis occurred throughout growth of the 
organisms or only at specific points in the growth cycle. In an attempt to detect VT 
mRNA transcripts, RNA was prepared from E. coli strains E3787, E32511, 60R746 and 
60R363 at 2 (exponential), 4 (early stationary) and 6 (stationary) hours culture as 
described in section 2.36. Samples, adjusted to contain 15 /¿g of cellular RNA were 
denatured, electrophoresed on formaldehyde gels and Northern blotted as described 
above (figure 4.5). Filters were washed in 2 x SSC, 0.1% (w/v) SDS and 1 x SSC, 0.1% 
(w/v) SDS at room temperature for 1 hour each. After three weeks exposure at -70°C,
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Figure 4.4 Northern blot analysis o f  E. c o li strains 60R746 &  60R363
Total cellular RNA was denatured in formaldehyde loading buffer and electrophoresed 
on a 1.5% (w/v) agarose, 2.2 M formaldehyde gel in 1 XlMOPSbuffer at 60V. The 
RNA was transferred to nitrocellulose and probed with •}ZPdCTP labelled VT1 and 
VT2 DNA fragments as described in materials and methods.
Key to tracks
1 RNA markers (BRL). Fragment sizes were 9.49, 7.46, 4.4, 2.37,1.4 & 0.24 Kb.
2 & 5 : 5 n\ of total RNA isolated from E. coli 60R746.
3 & 6 : 5 /il total RNA isolated from E. coli 60R363.
4 : 8 /d 0.75 kb Hindi VT1 DNA probe fragment.
7 : 8 fi\ 0.85 kb Smal-Pstl VT2 DNA probe fragment.
Tracks 8-11 and 12-14 correspond to tracks 1-4 and 5-7 after probing with a ^PdCTP 
labelled 0.75 Kb Hindi fragment of plasmid NTP705 which contains VT1 B subunit 
coding sequences and a •’“^ PdCTP labelled 0.85 Kb Smal-Pstl fragment of plasmid 
NTP707 which contains VT2 A subunit coding sequences. Filters were washed in 1 x 
SSC at room temperature and exposed to autoradiographic film for 3 days at -70°C.
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Figure 4.5 Northern blot analysis of RNA isolated from different points in the
growth phase of E. coli 60R746 and 60R363
Total cellular RNA was prepared from E. coli strains 60R746 and 60R363 at the times 
shown. Duplicate samples, adjusted to contain 15 /xg of RNA, were denatured in 
formaldehyde loading buffer and electrophoresed on a 1.5% (w/v) agarose, 2.2 M 
formaldehyde gel in j  X MOPS buffer at 80V. RNA was transferred to nitrocellulose 
and probed with ^PdCTP labelled VT1 and VT2 DNA probes as described in 
materials and methods.
Key to tracks
A : RNA markers (BRL). Fragment sizes were 9.49, 7.46, 4.4, 2.37, 1.4 & 0.24 Kb.
B-D : Total RNA isolated from 60R746 at 2, 4 and 6 hours growth respectively.
E-G : Total RNA isolated from 60R363 at 2, 4 and 6 hours growth respectively.
A B C D E F G
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autoradiographs showed no evidence of hybridisation except to the control probe 
fragments (results not shown).
4.2.4 Determination of VT messenger RNA half-life
An important characteristic of prokaryotic mRNA is that its half-life is short compared 
to other types of prokaryotic RNA molecules. For bacteria, the half-life of a typical 
mRNA molecule is a few minutes. This feature has an important regulatory function. If 
a protein is no longer required, a cell need only turn off synthesis of the mRNA that 
encodes the protein, soon afterwards, none of that particular mRNA will remain and 
synthesis of the protein will no longer occur. One possible explanation for the inability 
to detect VT mRNA was that the transcripts once produced were being degraded very 
rapidly by the cell. In order to determine the mRNA half-lives for VT1 and VT2 
(section 2.35), RNA was isolated from late exponentially growing cultures of VT- 
producing strains E3787 and E32511 at known times (in minutes), after the addition of 
100 ng ml"* of rifampicin, an inhibitor which specifically blocks RNA synthesis by 
interaction with the DNA-dependent RNA polymerase. Rifampicin inhibits chain 
initiation by binding to the /S subunit of RNA polymerase thereby blocking the 
transition from the chain initiation to the elongation phase. Rifampicin and related 
drugs have been used extensively in investigations of transcription as they can be added 
to a growing culture for in vivo studies or to a reaction mixture for in vitro studies and 
will rapidly inhibit the initiation of new chains. Since it takes only a few seconds to 
complete a growing RNA chain, RNA synthesis is quickly terminated. Samples, 
adjusted to contain 5 ng of RNA, were denatured in FLB and electrophoresed overnight 
on formaldehyde gels.
In both E. coli strains it appeared that there was little change in the amount of total 
RNA present in the cell population until thirty minutes after addition of rifampicin 
(figure 4.6). After this time there appeared to be gross turnover in the total RNA with
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Figure 4.6 Northern blot analysis of RNA isolated from E . c o li E3787 and E32511
after addition of rifampicin
Total cellular RNA was prepared at the times shown after addition of rifampicin to a 
final concentration of 100 ng ml’1. Duplicate samples adjusted to contain 5 ng of RNA 
were denatured in formaldehyde loading buffer and electrophoresed on a 1.5 % (w/v) 
agarose. 2.2 M formaldehyde gel in 1 X MOPS .buffer at 30V overnight. The RNA was 
transferred to nitrocellulose and probed with JZPdCTP labelled VT1 and VT2 DNA 
fragments as described in materials and methods.
Key to tracks
A & J: RNA markers (BRL). Fragment sizes were 9.49, 7.46, 4.4, 2.37, 1.4 & 0.24 Kb. 
B to I: Total RNA isolated from E. coli E3787 after 0,5,10, 20,30,40, 50 & 60 
minutes respectively.
K to Q: Total RNA isolated from E. coli E32511 after 0 ,5,10,20, 30,40 & 60 minutes 
respectively.
A B C  D E F G H  I
J K L M N O P Q
R S T U V W X Y Z
t*
Tracks R to Z correspond to tracks A  to I after probing with a ^PdCTP labelled 0.75 
Kb H indi fragment from plasmid NTP705 which contains VT1 B subunit coding 
sequences. The filter was washed in 1 x SSC at room temperature and exposed to 
autoradiographic film for 5 days at -70°C.
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visible deterioration of the rRNA subunits (track F & O). After probing, Northern 
filters showed no evidence of hybridisation except for a band of less than 0.24 Kb in 
tracks H & I which hybridised with the VT1 H indi fragment (tracks Y & Z). This band 
is much smaller than the expected size of a transcript proceeding from the putative sit-1 
promoter to the terminator (Jackson et al., 1987a) and most likely represents non­
specific hybridisation to a degradation product. When the experiment was repeated, no 
hybridisation to the Northern filters was observed (results not shown).
4.2.5 Northern blot analysis of varying concentrations of cellular RNA
It was thought that the inability to detect the VT transcripts might have been due to 
insufficient loading of RNA on the formaldehyde gels. To prepare a much more 
concentrated RNA sample, RNA was extracted from late exponential growing cultures 
of E. coli strains 60R363 and 60R746 as described in section 2.30, except that 15 ml of 
culture was pelleted for extraction and the final RNA precipitate was resuspended in 
100 n\ of SAE. Samples, adjusted to contain 50, 100, and 200 ng of cellular RNA from 
each strain, were electrophoresed and transferred to nitrocellulose as previously 
described.
The resulting agarose gel is shown in figure 4.7. The RNA markers appeared to have 
degraded, however, the rRNA subunits can be used as internal size standards as they 
correspond to molecular sizes of 3.5, 1.7 & 0.12 Kb for the 23S, 16S and 5S subunits 
respectively (Sung et al., 1990). Duplicate filters were probed under two different 
protocols, as described in sections 2.33(a) & 2.33(b). No hybridisation was observed 
except with a fragment of approximately 1.1 Kb (track K), with the VT1 labelled probe 
using protocol 2.33(a). As previously mentioned, strain 60R746 is an E. coli K12 strain 
carrying the recombinant plasmid NTP705. Plasmid NTP705 carries a 0.75 Kb Hindi 
fragment containing sequences encoding the B subunit of VT1 (Willshaw et al., 1987) 
cloned into the ampicillin resistance (Apr) gene of the plasmid cloning vector
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60R363
Figure 4 .7  Northern blot analysis of RNA isolated from E . c o li  strains 60R746 and
Duplicate samples of total cellular RNA prepared from late exponential growing 
cultures of E. coli strains 60R746 and 60R363 were adjusted to contain the amounts of 
RNA indicated, denatured in formaldehyde loading buffer and electrophoresed on a 
1.5% (w/v) agarose. 2.2 M formaldehyde cel in 1 X MOPS buffer at 30V overnight. 
RNA was transferred to nitrocellulose ana probed with JZPdCTP labelled VT1 and 
VT2 DNA probes as described in materials and methods.
Key to tracks
A : RNA markers (BRL). Fragment sizes were 9.49, 7.46, 4.4, 2.37, 1.4 & 0.24 Kb.
B : Total RNA isolated from E. coli 60R746 (50 ng).
C : Total RNA isolated from E. coli 60R746 (100/ig).
D : Total RNA isolated from E. coli 60R746 ( 200 fig).
E : Total RNA isolated from E. coli 60R363 (50 /xg).
F : Total RNA isolated from£. coli 60R363 (lOO^g).
G : Total RNA isolated from E. coli 60R363 (200 ng).
A B C D E F G  H I J K  L M N
Tracks H-N correspond to tracks A-G after probing with a -^PdCTP labelled 0.75 Kb 
H indi fragment from plasmid NTP705 which encodes VT1 B subunit sequences. The 
filter was washed in 1 x SSC at room temperature and exposed to autoradiographic film 
overnight at -70°C.
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pACYC177 (Willshaw et al., 1985). Therefore, the 1.1 Kb fragment cannot correspond 
to polycistronic mRNA transcribed from the promoter upstream of the A subunit gene 
of sit-1. There are two possible explanations for the presence of a mRNA transcript 
containing s/MB coding sequence. Firstly, transcription from the RNA polymerase 
recognition site for the Apr gene in which the 0.75 Kb H indi fragment is cloned is being 
initiated. Transcriptional readthrough of the s/MB subunit sequence occurs, with 
termination of mRNA transcription from either the termination sequence of the Apr 
gene or from the termination sequence encoded in the cloned B subunit gene of VT1. 
Alternatively, transcription of the slt-lB coding sequence could occur independently 
from a promoter upstream of the sit-IB gene. Although there has been no direct 
evidence for a second promoter for independent transcription of the s/MB gene, 
existance of the latter has not been precluded (De Grandis et al., 1987; Newland et al., 
1985; Weinstein et al., 1988b). Furthermore, an examination of the transcription of the 
Shiga toxin operon (stx) by Northern blot analysis has revealed both a polycistronic 
message (about 1.7 Kb in size) and a putative B subunit message (about 0.7 Kb), 
(Koslov et al., 1988). The 1.1 Kb fragment however, is too large to represent a mRNA 
species produced by transcription from an independent promoter for the s/MB gene, 
unless termination of transcription occurs at a point downstream of the s/MB RNA 
polymerase termination site, perhaps from the termination sequence of the Apr gene. 
To explore these hypotheses, a detailed study of the insertion of the 0.75 Kb H indi 
fragment within the Apr gene of pACYC177 would be required. This, however, was not 
pursued during the course of this project.
Whatever the explanation, it is obvious that either the mRNA transcript containing the 
sit-IB coding sequence is not highly expressed (with hybridisation only being observed 
when 200 n% of RNA was loaded), or the sensitivity of the Northern analysis is 
insufficient to enable detection of the expressed mRNA transcript at lower total RNA 
concentrations.
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43 Summary and overview
In the development of an RNA assay system to specifically quantify VT1 and VT2 
expression, experiments were performed to extract intact RNA from VT-producing 
strains for Northern blotting. Although RNA extraction and electrophoresis proved 
successful, subsequent probing of Northern filters to produce discrete bands on a 
Northern blot was not achieved.
The most likely cause of problems in a Northern analysis is poor quality of the RNA 
being analysed. The major source of failure in any attempt to produce RNA is 
contamination by RNase. RNases are very stable, active enzymes that require no 
cofactors to function, therefore, a small amount of RNase in an RNA preparation will 
create a real problem. However, great care was taken to avoid RNase contamination 
and rRNA bands remained sharp, indicating there was no gross degradation and, hence, 
no substantial contamination with RNase during sample preparation.
Both denatured and native RNA molecules are capable of binding to nitrocellulose 
filters. In order to transfer efficiently from agarose gels, however, the RNA must be 
denatured (Thomas, 1980). It is possible that RNA transfer may not have been 
successful, the conditions may not have been appropriate or degradation of the message 
could have occurred upon RNA transfer to the nitrocellulose and subsequent probing. 
Presoaking of the gel in high salt and staining the gel with ethidium bromide has been 
found to reduce transfer of eukaryotic RNA to nitrocellulose (Thomas, 1980). When 
DNA control probe fragments were run on gels, hybridisation with the VT DNA probes 
was observed, however, nitrocellulose has a higher binding capacity for DNA compared 
to RNA. To confirm successful transfer of RNA the Northern filters could have 
additionally been probed with a DNA probe to an abundant E. coli protein.
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The most obvious reason for the inability to detect transcripts was lack of sensitivity due 
to the toxin genes not being expressed sufficiently under the conditions employed to 
enable detection of the mRNA with the VT1 and VT2 DNA probes. Selden (1989) 
recommends that 0.5 to 10 fig of RNA be probed, however, Sung et al. (1990) 
subsequently published data in which they showed detection of the sit-II mRNA 
transcript. In the latter case, 50 fig of total cellular RNA was electrophoresed and 
probed with, on average, 5-10 times more RNA than probed in the present study. Also 
the RNA was prepared from an E. coli strain carrying the entire s//-II operon cloned 
into a high copy number plasmid vector pBR328, whereas in the present study RNA was 
typically prepared from VT-producing strains in which the VT operons were 
chromosomally encoded. In the study of regulation of gene expression it is desirable to 
have a single copy of the operon of interest as the presence of cloned genes on 
multicopy plasmids can cause misleading or erroneous results that do not accurately 
reflect the "normal" level of transcription. This is largely due to the fact that plasmid 
copy number can vary with growth conditions, the size of DNA insert, as well as the 
presence of other plasmids (Adams & Hatfield, 1984).
Further development of this assay protocol was suspended due to the difficulties 
encountered. If research in this area had been continued, attempts would have been 
made to increase expression of the VT operons by using mitomycin C (section 1.4.4.5), 
and growth under low iron conditions (section 1.4.4.3).
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5. Formation of a slt-\\::TnphoA gene fusion
5.1 Introduction
Protein fusions have played a central role in molecular genetic studies of the 
mechanism of protein export in bacteria (Michaelis & Beckwith, 1982; Beckwith & 
Silhavy, 1983). Conventionally this approach involves the fusion of a selectable 
"reporter" gene, which possesses an easily assayed activity, to the promoter and 
controlling regions of the particular gene under study. The "reporter" gene may be used 
in either transcriptional (operon) fusions, where it retains its own translational start but 
is dependent on the attached DNA for transcription, or in translational protein fusions, 
where both transcription and translation are dependent on signals in the attached 
upstream DNA.
Most studies have utilised hybrids containing amino-terminal sequences of an exported 
protein fused to the lacZ gene that encodes the cytoplasmic protein /3-galactosidase. 
Use of such hybrid proteins is limited however, as they are frequently lethal to the cell 
when produced in large amounts because of the inaoility of the /3-galactosidase moiety 
to pass through the bacterial cytoplasmic membrane (Bassford et al., 1979). This 
phenotype is known as "over-production lethality" where the hybrid protein is thought to 
contain sequences that block the cell export machinery, thus hindering normal protein 
export.
Subsequently, Hoffman & Wright (1985) constructed a set of plasmids which encode the 
gene (p/ioA) for the E. coli periplasmic protein alkaline phosphatase (PhoA), missing its 
own signal sequence. Enough of the mature protein is retained such that highly active 
PhoA can be generated in vitro by attachment to phoA of appropriate restriction 
fragments containing the amino termini of other proteins. PhoA only displays activity 
when exported from the cytoplasm as it must dimerise to be active and the environment
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in the cytoplasm of the bacterial cell is too reducing to allow the formation of the 
necessary disulphide bonds. Manoil & Beckwith (1985) extended this approach with the 
formation o f TnphoA, a transposon vector that allows generation of gene fusions 
between the amino terminal portion of a target gene and the coding sequence of 
bacterial PhoA in vivo. A derivative of Tn5, TnphoA is composed of phoA lacking its 
promoter, its translation initiation site, and the DNA corresponding to the signal 
sequence and first five amino acids of the protein (figure 5.1 (a)). Hybrid proteins 
expressing PhoA activity only occur when 'TnphoA inserts in the proper orientation and 
reading frame to a signal that promotes the export of the protein from the cytoplasm. 
This signal can correspond to those found in periplasmic, outer membrane, cytoplasmic 
membrane or secreted proteins. As most bacterial virulence determinants are 
expressed at the cell surface, this technique selects for TnphoA insertions into such 
genes. Hybrid proteins generated by TnphoA insertion contain 17 amino acid residues 
at their fusion joints resulting from the translation of Tn5 and linker sequences. This 
junction sequence neither blocks export nor acts as an export signal for the hybrid 
proteins (Manoil & Beckwith, 1985). The use of transposon TnphoA combines the 
advantages o f working with hybrid proteins able to be secreted (Hoffman & Wright, 
1985), with the versatility of Tn5 transposition in generating hybrids (Bruijn & Lupski, 
1984). PhoA is an easily assayable enzyme which can be detected even at low levels in 
bacterial colonies by the use of the chromogenic substrate 5-bromo-4-chloro-3-indolyl 
phosphate p-toluidine (XP). When PhoA hydrolyses XP in an appropriate agar medium 
E. coli colonies are blue.
The use of phoA  fusions has proven to be a powerful tool for the study of protein 
secretion, membrane protein topological structure, protein export signals and the 
identification of genes for cell envelope and extracellularly secreted proteins (for a 
review, see Manoil et al., 1990). Use of the sensitive indicator media and enzyme assay 
for PhoA (section 2.44.2), also provides a simple way to monitor the expression of the 
hybrid gene, which in turn reflects the activity of the exogenous promoter. There are
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Figure 5.1 The transposon vector T n p h o A  (Manoil & Beckwith, 1985)
(a) Detailed structure of TnphoA
n
r  f
CTttACTCTTAT*C*CA»aTAQCaTCC TttaACQaA*CCTTTC(X»l  m  TeC lX TaTTCTO
There are 50 base pairs (bp) at the beginning of the phoA coding region. Of this 
sequence, 48 bp are derived from IS50L of transposon 'n5 and 2 bp originate from the 
Pstl linker of plasmid pCH39 (Hoffman & Wright, 1985). The amino acid residues that 
are shown are present at the ftision joint of every hybrid protein generated. The DNA 
sequence differs from that of the IS50L region of Tn5 by an A-to-G change at position 
29. All of the phoA is encoded except the signal sequence and 5 amino acid residues of 
the mature protein (Inouye et al., 1982).
(b) Restriction enyme map o f TnphoA
t  O ra l tP v o ll  ÎEeoRI TP i H tB gl I ?X ho l 
^H ind 111 |  Sa l I jB am H  I
I kb
N o  sites  ■ EcoRV, S a c l, X bal, Pvul 
O n e  site ■ D ra l, H p a l .  Bam H I, S a i l
IS 5 0 l w ith  j i b e *  
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163
significant advantages to using such an approach. Whereas lac operon fusions limit 
analysis of regulation to the transcriptional level, phoA gene fusions allows screening for 
an effect of a given regulatory parameter at any step in gene expression, including 
transcription, mRNA processing or stability, and translational or post-translational 
controls.
Gene fusion technology has previously been exploited to assess the regulation of VT1 
expression by iron (Calderwood & Mekalanos, 1987). This involved the creation of 
hybrid genes between the promoter and proximal portions of slt-lA and TnphoA (figure
5.2) . The VT\::TnphoA gene fusion plasmid, pSC105 was kindly provided by Dr S 
Calderwood, Harvard University, to enable study of VT1 gene expression. In order to 
quantitate VT2 gene expression, fusions between TnphoA and the cloned sit-II operon 
carried on plasmid NTP707 were made in this study. The protocol for formation of 
these fusions is outlined in figure 5.3 and discussed in detail in section 5.2.
In the formation of aslt::TnphoA gene fusion (figure 5.4), both the A and B subunits are 
synthesised with amino terminal signal sequences. TnphoA can therefore fuse into 
either subunit gene and be exported into the periplasm to give enzyme activity. As both 
genes are transcribed from a single promoter upstream of the A subunit gene in s/f-II 
both possible gene fusions allow monitoring of VT2 gene expression to be undertaken.
5.2 Results
52.1 Isolation of slt-U::TnphoA gene fusions
Plasmid NTP707 contains a 4.7 Kb EcoRI fragment encoding the entire s//-II operon, 
inserted into the chloramphenicol resistance (Cmr) gene of plasmid pACYC184 (table
3.2) . E. coli CC118 (table 2.1), which is PhoA negative, was electroporated with 
caesium chloride density gradient purified pNTP707 (section 2.37.1) and the
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Figure 5.2 Schematic diagram of the protocol for the form ation o f  plasmid pSC105
Calderwood & Mekalanos (1987) cloned a 1.5 Kb EcoRV/HindlH  fragment from phage 
H19B into plasmid pBR377. This fragment contained the promoter and proximal 
portion of the sit-IA subunit gene. The recombinant plasmid pSC2 was transformed 
into E. coli CC118, carrying TnphoA on a F  plasmid. Growth of transformants on 
plates containing Kn (300 pg  ml**) selected for transposition o f  TnphoA onto the high 
copy number plasmid vector. CC118 was retransformed with plasmid preparations of 
the transformants and blue colonies on LB + Ap + Kn(30) + XP plates isolated. These 
contained in-frame fusions of TnphoA to secreted gene products. The presence and 
location of TnphoA within pSC105 was subsequently confirmed by restriction mapping.
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1
Figure S3  Schematic diagram of the protocol for the formation of a slt-ll::TnphoA 
gene fusion
The recombinant plasmid NTP707 (Willshaw et al„ 1987) was electroporated into E. 
coli CC118 and transformants selected on LB + Tc plates. TnphoA was introduced by 
transduction of a log phase culture of CC118 (pNTP707) with lambda TnphoA 
(Gutierrez et al., 1987). Growth of transformants on LB + Tc+Kn(300) + XP plates 
selected for transposition of TnphoA onto the high copy number plasmid vector. CC118 
was retransformed with plasmid preparations of the transformants and blue colonies on 
LB+Tc+Kn(50) + XP plates isolated. These contained in-frame fusions of TnphoA to 
secreted gene products on plasmid NTP707.
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Figure 5.4 Schematic diagram to illustrate the potential gene fusion products from
random insertion of TnphoA into the sit operon
The structural genes for A and B polypeptides of VT, slt-A  and sit-B respectively, are 
organised into an operon (sit) which is transcribed from a promoter upstream of the A 
subunit gene to produce a polycistronic messenger RNA (Sung et al., 1990). As the A 
and B subunit genes both possess amino terminal signal sequences, insertion of TnphoA 
downstream of the signal peptidase cleavage site in either subunit gene will result in an 
exportable gene fusion product.
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transformants plated onto LB plates containing tetracycline (Tc) to select for pNTP707. 
Plasmid DNA was prepared from transformants displaying Tc resistance (Tcr) as 
described in section 2.13.2, restricted with Sma\-Pst\ and electrophoresed on an agarose 
gel. Restriction with Smal-Pstl produced the expected 8 and 0.85 Kb fragments (figure 
5.5), confirming the presence of pNTP707 within E. coli CC118.
Specially designed broad host-range plasmid vectors carrying TnphoA have 
predominantly been used to deliver TnphoA into target genes of a variety of Gram­
negative bacteria (Taylor et al., 1987). Typically the broad host-range plasmid vector is 
introduced into the target organism by conjugation, whereupon transposition of the 
plasmid encoded TnphoA, which encodes kanamycin resistance (Knr), into the 
chromosome is caused by superinfection with an incompatible plasmid and selection for 
Knr (Taylor et al., 1987; Peterson et al., 1988; Donnenberg et al., 1990). In the present 
study, TnphoA was introduced into E. coli CC118 (pNTP707) on a defective lambda 
suicide phage as described in section 2.38. Lambda TnphoA contains a nonsense 
mutation within a gene essential for bacteriophage replication (Gutierrez et al., 1987). 
Such a bacteriophage can propagate in a suppressing (Sup+ ) host, but is unable to 
establish itself in a non-supressing (Sup0) host. The high concentration of Kn (300 pg 
ml"*) preferentially selects for transposition of TnphoA onto the high copy number 
plasmid vector (Berg et al., 1983). Individual blue colonies on this medium after 
incubation at 37°C for 2 days, contained in-frame fusions of TnphoA to secreted gene 
products, whereas white colonies represented those strains in which TnphoA had not 
fused to an exported protein. To ensure TnphoA was not chromosomally encoded, 
plasmid DNA was prepared from each blue fusion strain on a small scale (section
2.13.2) and used to transform freshly competent CC118 (section 2.37.2). Blue colonies 
on LB plates containing XP, Tc and Kn (30 pg  ml'*), contained in-frame fusions of 
TnphoA to secreted gene products on NTP707. The presence and location of TnphoA 
within nine fusion-bearing plasmids was then confirmed by restriction mapping. These
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Figure 5.5 Agarose gel electrophoresis of plasmid DNA from CC118 (pNTP707)
Plasmid DNA prepared from E. coli CC118 (pNTP707) was restricted as indicated and 
electrophoresed on a 1% (w/v) agarose gel at 50mA in 1 x TBE and stained with 
ethidium bromide.
Key to tracks
A : Phage lambda DNA restricted with HindW 1.
B : Plasmid DNA from CC118 (pNTP707) - unrestricted.
C : Plasmid DNA from CC118 (pNTP707) - Smal/Pstl restricted.
A B C
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were designated pSLF9, pSLFlO, pSLF17, pSLF18, pSLF22, pSLF23, pSLF29, pSLF32 
and pSLF34.
5.2.2 Restriction mapping of slt-WxiTnphoA fusions
Plasmids were prepared from the nine fusion bearing strains by small scale alkaline lysis 
(section 2.13.2), and digested with the enzyme EcoRV. This restriction endonuclease 
cuts plasmid NTP707 at one site in the vector plasmid pACYC184 (figure 3.2 (a)), and 
three sites in the 4.7 Kb EcoRI insert (figure 3.2 (b)). Transposon TnphoA has no 
EcoRV restriction enzyme sites (figure 5.1 (b)). Thus EcoRV digestion of plasmid 
NTP707, without a TnphoA insert, gives rise to four fragments of approximately 0.9, 1.3, 
3.0, and 3.8 Kb (tracks 2 & 3, figure 5.6). It can be seen that in all the nine fusion 
bearing plasmids (tracks 4 to 12, figure 5.6), the 3.8 Kb EcoRV fragment carries the 
TnphoA insert, leading to production of the expected 11.7 Kb large fragment. 
Comparison with the published nucleotide sequence of the i/f-II operon cloned from E. 
coli strain 933 (figure 5.7), and the physical map of the i/f-II operon (figure 5.8), shows 
that the EcoRV restriction enzyme site lies within the slt-U A subunit gene, 68 base 
pairs (bp) downstream from the N-terminal signal cleavage site of the VT2 A subunit. 
Thus in all nine fusion bearing plasmids, insertion of TnphoA has occurred downstream 
of this EcoRV restriction site.
To more finely define the site of insertion of TnphoA within these fusion plasmids, each 
plasmid was restriction mapped using single and multiple restriction endonucleases. 
The enzymes used were EcoRI, EcoRV, Pstl, Smal, Kpnl/BamHl and Kpn/SalI. It 
became evident almost immediately from the pattern of EcoRI digested plasmid DNA 
(figure 5.9), that the location of the fusion joint was not randomly distributed over the 
whole s/f-II operon. Clustering occurred at two different sites with pSLF17, pSLF18, 
pSLF22, pSLF23, pSLF29 and pSLF32 forming one group and pSLF9, pSLFlO and 
pSLF34 the other. Only restriction enzyme digests of a representative of each type of
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Figure 5.6 Agarose gel electrophoresis of the Tnp/joy4-insertion plasmids pSLF9, 
pSLFIO, pSLF17, pSLFIS, pSLF22, pSLF23, pSLF29, pSLF32 and 
pSLF34
Plasmid DNA was restricted with EcoRV as indicated and electrophoresed on a 0.7% 
(w/v) agarose gel at 30V overnight in 1 x TBE and stained with ethidium bromide.
Key to tracks
1: Phage lambda DNA restricted with Hind III.
2 : CsCl density gradient purified pNTP707 - EcoRV restricted.
3 : pNTP707 - EcoRV restricted.
4 to 12: pSLF9, pSLFIO, pSLF17, pSLF18, pSLF22, pSLF23, pSLF29, pSLF32 &
pSLF34 respectively - EcoRV restricted.
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Figure 5.8 Restriction enzyme map o f the slt-II operon (Jackson e t  a l., 1987b)
M4t M l
I------------------- ►
Restriction sites are given within the 3250 bp Sphl to fcoR I fragment isolated from the 
hybrid plasmid pNN76. The location and orientation of the structural genes, slt-lIA and 
s/i-IIB, are shown above the restriction map.
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Figure 5.9 Agarose gel electrophoresis of sltll::TnphoA gene fusion plasmids
Plasmid DNA from the fusion plasmids indicated was restricted with EcoRI and 
electrophoresed on a 0.7% (w/v) agarose gel at 30V overnight in 1 x TBE and stained 
with ethidium bromide.
Key to tracks
1: CsCl density gradient purified pNTP707 - EcoRI restricted.
2 : Alkaline lysis small-scale preparation of pNTP707 - EcoRI restricted.
3-11 : pSLF9, pSLFlO, pSLF17, pSLF18, pSLF22, pSLF23, pSLF29, pSLF32 & 
pSLF34 respectively - £coRI restricted.
1 2  3 4  5  6 7 8 9  10 11
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insertion, pSLF22 and pSLF34, are shown for convenience (figures 5.10 & 5.11). From 
this data a restriction map of each type of insertion was determined as detailed in figure 
5.12. All fusions mapped to the B subunit gene of the ift-II operon. Fusion plasmids 
pSLF22 (pSLF17, pSLF18, pSLF23, pSLF29 and pSLF32) mapped to a point 
approximately 100 bp downstream of the Pstl site, whilst pSLF34 (pSLF9 and pSLFlO) 
mapped to a position approximately 200 bp further downstream.
As mentioned above, the high frequency at which the two types of fusion were isolated 
suggests that insertion of the transposon into the slt-ll operon may not be random. 
Although T nphoA has been reported to show a low sequence specificity of insertion 
(Manoil & Beckwith, 1985), such "hot-spot" insertion sites for TnphoA have been 
described elsewhere (Gott & Boos, 1988). Alternatively the topological organisation of 
some fusion proteins might be lethal to the cell and therefore are not selected.
5.2.3 Sequence analysis of pSLF22 and pSLF34
As stated earlier, TnphoA must insert itself in the correct orientation and reading frame 
to create an active fusion. Gott & Boos (1988), however, have shown TnphoA to be 
capable o f generating active fusions, even when inserted out of frame by +1. This is 
thought to be due to in vivo frameshifting where the translational machinery corrects 
the wrong frame by reading a sequence of four nucleotides as a sense codon.
To locate the exact site of insertion of TnphoA and to determine whether in-frame 
fusions had been created, the dideoxynucleotide chain terminator/M13 vector method 
of DNA sequencing was initially applied to provide sequence data across the fusion 
joints o f pSLF22 and pSLF34 (section 2.39.2). Large scale plasmid preparations of 
pSLF22 and pSLF34 were made (2.13.1(b)), and the appropriate Pstl/EcoRl fragment 
purified. Double digestion with Pstl and EcoRI was found to be inappropriate for 
isolation o f  the required Pstl/EcoRl fragments as comigration with internal Pstl
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Figure 5.10 Restriction endonuclease mapping o f pSLF22 and pSLF34
Plasmid DNA was restricted as indicated and electrophoresed on a 0.6% (w/v) agarose 
gel at 50mA in 1 x TBE and stained with ethidium bromide.
Key to tracks
l& ll: Phage lambda DNA restricted with HindlU.
2-4: pNTP707, pSLF22 & pSLF34 respectively - EcoRI restricted.
5-7: pNTP707, pSLF22 & pSLF34 respectively - EcoRV restricted.
8-10: pNTP707, pSLF22 & pSLF34 respectively - Pst l restricted.
1 2 3 4  5  6 7 8 9  10 11
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Plasmid DNA was restricted as indicated and electrophoresed on a 0.7% (w/v) agarose 
gel at 50mA in 1 x TBE and stained with ethidium bromide.
Key to tracks
1&6: Phage lambda DNA restricted with Hindlll.
2 : pNTP707 - Kpnl restricted.
3-5: pNTP707, pSLF22 & pSLF34 respectively - Kpnl/Sail restricted.
The additional fragments in tracks 4 & 5 that comigrate with the 6.78 Kb Hindlll 
fragment in track 6 are due to partial digestion at the Kpnl site in pACYC184.
Figure 5.11 Restriction endonuclease mapping o f  pSLF22 and pSLF34
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Figure 5.12 Partial restriction endonuclease map showing the relative positions of 
insertion of TnphoA in fusion plasmids pSLF22 and pSLF34
Fusion joints between s/fll and TnphoA were estimated from restriction endonuclease 
mapping o f the fusion plasmids pSLF22 and pSLF34.
Position (1) »  pSLF22 (fusion plasmids pSLF17, pSLF18, pSLF23, pSLF29 & pSLF32 
also mapped to this point).
Position (2) *  pSLF34 (fusion plasmids pSLF9 & pSLFlO also mapped to this point).
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fragments of TnphoA occurred in each case (figure 5.13). From figure 5.13 the sites of 
insertion of TxxphoA within each plasmid was more finely mapped to approximately 150 
bp and 280 bp downstream of the Pstl site in pSLF22 and pSLF34 respectively. It was 
found that isolation of the appropriate ITcoRI fragment, followed by Pstl digestion 
resulted in a larger yield of the required Pstl/EcoRl fragment than secondary £coRI 
restriction of the isolated Pstl fragment. This was due to the production of partially 
digested fragments in the latter. Once separated by electrophoresis the desired 
fragments containing the fusion joints were excised from the gel and purified. Two 
methods of purification were tried and the Gene Clean kit (section 2.39.1(b)) was found 
to result in a smaller loss of fragment than electroelution (section 2.39.1(a)).
The purified Pstl/EcoRl fragments containing the fusion joints from each plasmid were 
ligated into Pstl/EcoRl restricted M13mpl9 vector DNA as described in section 
2.39.2.1. After overnight ligation, competent E. coli TGI cells (section 2.37.2), were 
transformed with between 1-3 of ligation mix and the subsequent lawns on agar 
plates containing 5-bromo-4-chloro-3-indoxyl /?-D-galactoside (X-gal), examined for 
plaque formation (section 2.39.2.2). M13 vectors produce the a-peptide of /J-
galactosidase which complements the lac deletion mutation in E. coli strains such as 
TGI (table 2.1). When such strains are transfected by non-recombinant vectors, blue 
plaques are generated on plates containing X-gal. Vectors with inserts give rise to 
colourless plaques.
Small clear plaques were isolated and the viral DNA from these was propagated in E. 
coli TGI and purifed (section 2.39.2.3). The large fragment of E. coli DNA polymerase 
I (Klenow enzyme) was used to sequence across the fusion joint of single stranded 
DNA, primed with a 19 bp portion of the IS50L o f Tn5 
(5’CAGGACGCTACTTGTGTAT3 ), as described in sections 2.39.2.4 & 2.39.4.
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Figure 5.13 Agarose gel electrophoresis o f  P stl and £coRI restricted plasmids
Plasmids were restricted as indicated and electrophoresed on a 0.7% (w/v) agarose gel 
at 30V overnight in 1 x TBE and stained with ethidium bromide. Fusion joint 
containing fragments are arrowed : (1) = pSLF22, (2) = pSLF34.
Pstl restriction of pSLF22 produces fragment sizes : 0.92, 1.05, 2.36, 2.7 & 9.8 Kb (track
B) . Pstl/EcoRl restriction of pSLF22 results in digestion of the 2.7 & 9.8 Kb Pstl 
fragments to fragments of size : 4.24, 3.3, 2.27, 1.5 & 0.33 Kb. Additionally the 
Pstl/EcoRl fusion joint containing fragment comigrates with the 0.92 Kb Pstl fragment 
(track D).
Pstl restriction of pSLF34 produces fragment sizes : 0.92, 1.05, 2.36, 2.9 & 9.4 Kb (track
C) . Pstl/EcoRl restriction of pSLF34 results in digestion of the 2.9 & 9.4 Kb Pstl 
fragments to fragments of size : 4.24, 3.3, 2.07, 1.5 & 0.33 Kb. Additionally the 
Pstl/EcoRl fusion joint containing fragment comigrates with the 1.05 Kb Pstl fragment 
(track E).
pSLF22 and pSLF34
A B C D E
4-2
6  7
9-4
2 2 
2 0
23
1
with Hindlll.
B&C: pSLF22 & pSLF34 respectively
- Pstl restricted.
D&E: pSLF22 & pSLF34 respectively
Key to tracks
A : Phage lambda DNA restricted
2
- Pstl/EcoRl restricted.
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Despite numerous attempts, sequencing by this method proved unsuccessful, no clear 
sequence being obtained. This could either be due to lack of template DNA or a 
primer site deletion (Bankier et al., 1986). Subsequent sequence analysis of 
recombinant vector DNA using a 17 base M13 primer G I'l l 1CCCAGTCACGACP) 
provided by Don Cardy, Warwick University, showed the clones sequenced to 
consistently correspond to M13 deletions. M13 has been shown to be an unstable vector 
for inserts much greater than 2 Kb and some sequences, often highly repetitive, clone 
very rarely or are deleted readily from M13 (Bankier et al., 1986). In this study the size 
of insert DNA was within the range expected to produce stable recombinants (0.92 &
1.03 Kb for pSLF22 & pSLF34 respectively), and the reason for the inability to obtain 
stable M13 recombinants was unclear.
Direct plasmid sequencing (section 3.39.3) proved to be more successful. The Tn5 
primer was end-labelled (section 2.39.3.1) and denatured plasmid DNA (section 
2.39.3.2) sequenced using the Sequenase Version 2.0 kit (US Biochemical Corp.) as 
described in section 2.39.3.3. Sequenase Version 2.0 is derived from bacteriophage T7 
DNA polymerase and has been genetically altered to have no 3'-5' exonuclease activity. 
It's properties include high processivity with less background radioactivity and a more 
uniform band intensity. Manganese buffer, provided in the sequenase kit, was added to 
the reaction mix prior to addition of the sequenase enzyme as this leads to a reduction 
in the average length of DNA synthesised in the termination step, intensifying bands 
corresponding to the sequences close to the primer. Sequence analysis of the resulting 
autoradiographs enabled the site of insertion of TnphoA within the slt-l1 operon of 
pSLF22 to be obtained. Comparison with the published sequence data for VT2 
(Jackson et al., 1987b) showed that TnphoA had inserted in-frame, in the B subunit gene 
adjacent to nucleotide 1276. This position was 10 bp downstream of the signal peptide 
cleavage site (figure 5.14), and 129 bp downstream of the Pstl cleavage site. Attempts 
to sequence the fusion joint in pSLF34 were unsuccessful and could have been due to
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impurities in the plasmid preparation. Plasmid pSLF22 was subsequently selected for 
use in the study of VT2 gene expression.
Figure 5.14 Sequence analysis of the insertion site of TnphoA into j//II in plasmid 
pSLF22.
VT2 B s u b u n it T n5 lin k er
MET LYS LYS
J
ALA PRO ASP SER ASP SER
ir.-rtn. ..IB.
ATG AAG A A G ------------- -GCG CCT G AT T c t g a c  tc t
-19 +1 1276
The sequence shows the beginning of the B subunit gene of j/f-II and the insertion site 
of TnphoA (arrowed) in j/r-IIB. The last base pair of slt-llB  is underlined with the 
deduced s/f-II amino-acid sequence shown above the line and the N-terminal alanine of 
the processed B polypeptide depicted as +1.
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5.2.4 Cytotoxicity assays of E. coli CC118 (slt-WvJYnphoA) gene fusion strains
Polymyxin B extracts of E. coli strains E3787, E32511, 60R363, CC118 (pSLF22) and 
CC118 (pSLF34) were prepared (section 2.21.1) and assayed for cytotoxicity using the 
Ricin assay as previously described (section 2.21.2). All strains produced active A 
subunit, evidenced by a distinctive aniline releasable fragment (figure 5.15). When 
Vero cell monolayers (section 2.21.3) were challenged with polymyxin B cell extracts of 
E. coli strains 0157:H7 (ATCC 35150), DH1, 60R363, CC118(pSLF22) and CC118 
(pSLF34) however, only the monolayers which had been challenged with polymyxin B 
cell extracts from E. coli 60R363 and 0157:H7 (ATCC 35150) were observed to be 
cytotoxic, causing destruction and death of the cells in the monolayer. In comparison, 
monolayers which had been challenged with polymyxin B cell extracts from E. coli DH1, 
CC118 (pSLF22) and CC118 (pSLF34) remained intact and there was no significant 
evidence of cytotoxicity, even after 48 hours incubation. This evidence supports the 
results obtained in section 5.2.2 that insertion of TnphoA had occurred in the B subunit 
of s/r-II in plasmids pSLF22 and pSLF34. Active PhoA is produced indicating that 
translation of the slt-U B subunit occurs, however, insertion of TnphoA into the B 
subunit not unexpectedly disrupts B subunit function (i.e. attachment of the holotoxin to 
the target cell). The A subunit can still exhibit N-glycosidase activity in a cell-free 
system such as the Ricin assay, where A subunit delivery by the B subunit to the target 
site is not required.
5.3 Homologous recombination of slt-lssTaphoA and slt-ll::TnphoA gene
fusions into the chromosome
The fusion of TnphoA to the slt-lA subunit gene (Calderwood & Mekalanos, 1987), and 
to the s/f-IIB subunit gene (this study) allows measurement of expression of the slt-l and 
sti-U operons under different growth conditions by assay of PhoA activity. Although 
many studies have involved the use of multicopy fusion plasmids, plasmid copy number
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Figure 5.15 Analysis o f  yeast ribosomal RNA treated with E . c o li CC118 (pSLF22)
and CC118 (pSLF34) polymyxin B cell extracts
Electrophoresis of RNA was performed on a 1.2% (w/v) agarose, 50% (v/v) formamide 
gel. The gel was electrophoresed at 20 mA constant current in Leicester Biocenter gel 
tanks for 2-3 hours in 0.1 x TPE buffer, stained in 2 ng ml'1 ethidium bromide for 30 
minutes and destained in distilled water for 30 minutes.
Key to tracks
A : Yeast rRNA treated with recombinant ricin A chain i- aniline).
B : Yeast rRNA treated with recombinant ricin A chain (+ aniline).
C : Yeast rRNA treated with E3787 polymyxin B cell extract (- aniline).
D : Yeast rRNA treated with E3787 polymyxin B cell extract (+  aniline).
E : Yeast rRNA treated with E32511 polymyxin B cell extract (- aniline).
F : Yeast rRNA treated with E32511 polymyxin B cell extract (+  aniline).
G : Yeast rRNA treated with 60R363 polymyxin B cell extract (- aniline).
H : Yeast rRNA treated with 60R363 polymyxin B cell extract (+  aniline).
- aniline).
+ aniline).
- aniline).
+ aniline).
A B C D E F G H I  J K L
Yeast rRNA treated with CC118 (pSLF22) polymyxin B cell extract ( 
J : Yeast rRNA treated with CC118 ipSLF22) polymyxin B cell extract (
K : Yeast rRNA treated with CC118 (pSLF34) polymyxin B cell extract (
L : Yeast rRNA treated with CC118 (pSLF34) polymyxin B cell extract (
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has been shown to vary considerably with such parameters as promoter strength and 
cellular growth conditions (Adams & Hatfield, 1984). It is therefore desirable to have 
single copy derivatives of the slt-l::TnphoA and slt-U::TnphoA fusions to eliminate the 
problems associated with uncontrolled fluctuations in plasmid copy number which affect 
gene dosage. In the 1987 study of iron regulation of the slt-l operon using pSC105, 
Calderwood and Mekalanos accounted for this by determining /3-lactamase activity, 
encoded for by the Apr gene on plasmid pSC105, in parallel with PhoA activity. 
Plasmid pSLF22 does not have such an assayable activity and as there has been no 
report of plasmid encoded VT production, attempts were made to more closely mimic 
the in vivo condition by introducing fusion plasmids pSC105 and pSLF22 into E. coli 
strains E3787 and E32511 respectively. To achieve single copies, homologous 
recombination between the gene fusions on the plasmid and the equivalent regions on 
the chromosome of the wild type E. coli strains was then attempted.
53.1 Transformation of E. coli E3787 and E32511 with plasmids pSC105 and
pSLF22 respectively
E. coli strains E3787 and E32511 were selected to act as the recipients for homologous 
recombination of slt::TnphoA gene fusions. Sensitivity of E3787 to Ap and Kn and 
E32511 to Tc and Kn was confirmed by plating the strains onto the appropriate plates. 
Caesium chloride gradient pure pSC105 and pSLF22 (section 2.13.1(b)) were 
electroporated into the host strains E3787 and E32511 respectively (section 2.37.1) and 
transformants selected according to the drug resistance markers of the recombinant 
plasmids. Presence of plasmid from a single transformant of each was confirmed by 
small scale plasmid preparation as described in section 2.13.2, (figure 5.16). In track C 
it can be seen that the additional plasmid bands in the E3787 (pSC105) transformant 
comigrate with caesium chloride gradient purified pSC105 (track D), whilst EcoRV 
restriction of plasmid DNA from the E32511 (pSLF22) transformant showed the four 
distinctive EcoRV bands indicative of presence of pSLF22 (tracks I & J respectively).
185
Figure 5.16 Agarose gel electrophoresis of plasmid DNA from E. coli E3787 and 
E32511 before and after electroporation with pSC105 and pSLF22 
respectively
Plasmid DNA was restricted as indicated and electropnoresed on a 0.7% (w/v) agarose 
gel at 40mA in 1 x TBE and stained with ethidium bromide.
Key to tracks
A,E & H : Phage lambda DNA restricted with Hindlll.
B : Plasmid DNA from E3787 - unrestricted.
C : Plasmid DNA from E3787 (pSC105) - unrestricted.
D  : CsCl density gradient purified pSC105 - unrestricted.
F : Plasmid DNA from E32511 - unrestricted.
G : Plasmid DNA from E32511 (pSLF22) - unrestricted.
I : Plasmid DNA from E32511 - EcoRV restricted.
J : Plasmid DNA from E32511 (pSLF22) - EcoRV restricted.
A B  C D  E F G  H I J
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Permeabilised cells (section 2.44.1(b)) were assayed for PhoA activity as described in 
section 2.44.2, before and after electroporation with pSC105 and pSLF22 (table 5.1). 
Background levels of endogenous activity for E. coli strains E3787 and E32511 were 
very low and found to increase 143 and 86 fold in E3787 and E32511 respectively, 
indicating that pSC105 and pSLF22 had been successfully introduced.
5 3 2  Low phosphate treatment of E3787 (pSC105) and E32511 (pSLF22)
The approach taken to create single copy derivatives was based on destabilising pSC105 
and pSLF22 such that they were lost from the bacterial cell. By selecting for Knr during 
the process, homologous recombination should occur between the sequences on the 
plasmid and the equivalent regions on the E. coli chromosome to leave a single copy of 
the gene fusion within the cell.
An assessment of the relative plasmid stabilities within E3787 and E32511 (section 2.40) 
showed that both plasmids were stably maintained under normal growth conditions, 
with no significant loss from the population when some degree of selective pressure was 
applied. With no selective pressure imposed pSC105 was still found in 100% of the 
viable cell population, whilst 85% of the population still carried pSLF22. This stable 
maintenance is not unexpected as under normal growth conditions the high plasmid 
copy number of pSC105 and pSLF22 ensures continued distribution among the 
daughter cells upon segregation. Under limiting growth conditions however, plasmid 
copy number is reduced, thus diminishing the probability that a plasmid will be 
distributed to both daughter cells during cell division (Roeder & Collmer, 1985). 
Roeder & Collmer (1985) have shown that plasmid pBR322 is rendered unstable under 
phosphate limitation and utilised this phenomenon to obtain high frequencies of 
exchange recombination in Erwinia chrysanthemi carrying a pelCwKn mutation on 
pBR322. A similar approach was adopted in this study to construct single copy 
derivatives of pSC105 and pSLF22.
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Plasmid curing was performed by growing the transformants on low phosphate media 
for 48 and 96 hours at 37°C and selecting for maintenance of Knr (section 2.41). After 
each 2 day incubation in phosphate limited media, serial dilutions were plated onto LB 
+ Kn and LB + Ap or LB + Tc plates as appropriate. The results are summarised in 
table 5.2 where it can be seen that after one round of plasmid curing approximately 
70% of E3787 and 85% of E32511 transformants were Knr but Ap or Tc sensitive (Aps 
or Tc5) respectively. After a second round of plasmid curing this rose to 99.6% for 
E3787 and 97.5% for E32511.
After the second round of plasmid curing, 50 colonies displaying Ap or Tc sensitivity 
were patched onto LB + Kn plates to confirm plasmid loss, rather than that a deletion 
or mutation of the plasmid-borne antibiotic resistance genes had occurred. All were 
found to display Knr. Similarity 50 colonies displaying Knr were patched onto Ap or Tc 
plates as appropriate and all were found to display Aps or Tc5.
Colonies displaying Knr could either have occurred as a result of exchange 
recombination or by transposition of TnphoA into the chromosome of the E. coli strain. 
Obvious differences were apparent in the relative PhoA activity of the Knr/Ap5 and 
Knr/Tcs colonies on plates containing XP, with some colonies appearing much bluer 
(i.e. more PhoA active) than others. There are two possible explanations for this:-
(1) Colonies displaying higher PhoA activity represent homologous recombinants or 
strains in which transposition of TnphoA to an exported target gene in the chromosome 
has occurred.
(2) Colonies displaying limited PhoA activity represent homologous recombinants or 
strains in which transposition of TnphoA to a non-exportable target gene has occurred.
It is therefore necessary to confirm whether, and in which colonies, exchange 
recombination has in fact occurred. This was performed by Western blotting gene 
fusion products with PhoA antibody (section 2.43) and Southern blotting potential
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Table 5.1 Alkaline phosphatase activity of E. coli strains grown on Luria Bertani 
media
The E. coli strains indicated were grown overnight on LB at 37°C with shaking (250 rpra). The OD600nm of 
each culture was taken and cells permeabilised and assayed for PhoA as described in sections 2.44.1(b) & 
2.44.2. Units of PhoA activity are normalised to the OD600nm of the bacterial culture
Strain PhoA activity (U)
E. coli E3787 1.5
E. coli E32511 1.4
E. coli CCI 18 (pSC 105) 270.1
E. coli CCI 18 (pSLF22) 87.1
E. coli E3787 (pSC105) 214.8
E. coli E32511 (pSLF22) 120.9
Table 5.2 Low phosphate treatment of E. coli E3787 (pSC105) and E32511 
(pSLF22)
Following 48 hours (round 1), and 96 hours (round 2). growth in low phosphate medium containing 
kanamycin. cultures were serially diluted in phosphate buffered saline and spread plated onto selective agar 
plates as indicated. Apr or Tcr  colonies were taken to represent E3787 and E32511 cells that had retained 
plasmids pSC 105 and pSLF22 respectively.
Viable Count (cfu ml'*)
Strain LB + Kn LB + Ap L B + T c
Round 1
E3787 (pSCl05) 6.5 x 108 1.91 x 108 .
E32511(pSLF22) 4.7 x 108 - 7.3 x 107
Round 2
E3787 (pSC105) 3.8 x 108 1.6 x 106 .
E32511(pSLF22) 6.7 x 108 - 1.7 x 107
189
homologous recombinants to determine whether insertion of TnphoA into the 
chromosomal sit operon had occurred.
5 3 3  Western blotting of gene fusion products
The point of insertion of TnphoA is 85 nucleotides (28 amino acids) and 10 nucleotides 
(3 amino acids) downstream from the signal sequence cleavage site in pSC105 
(Calderwood & Mekalanos, 1987) and pSLF22 (section 5.2.3) respectively. Assuming 
that the average molecular weight (MW) of one amino acid residue is 110 daltons 
(Boquet et al., 1987), the phoA gene in TnphoA encodes a protein of 450 amino acids, 
and correct processing of the signal peptide takes place, the size of the slt-l::TnphoA 
and slt-U::TnphoA fusion proteins can be predicted as being 52.58 KDa & 49.83 KDa 
respectively.
As the size of the chimeric protein produced by the sti-U::TnphaA gene fusion is not 
significantly larger than native alkaline phophatase (MW 47 KDa) it was anticipated 
that there might be a problem in differentiating this protein from non-s/f-II::TnphoA 
gene fusion products of similar size that might occur upon transpositon of TnphoA into 
the chromosome. In addition, degradation of gene fusion products to native PhoA has 
been previously reported by Hoffman & Wright (1985). To overcome this problem and 
as a more rapid screen for potential homologous recombinants, mitomycin C (final 
concentration 1 pg  ml’*), which has been shown to increase VT1 and VT2 production 
(section 1.4.4.5), was added to exponentially growing cultures of the single copy 
candidates in LB. After overnight incubation, periplasmic proteins were released from 
the bacterial cells in response to cold osmotic shock treatment as described in section 
2.42. Samples adjusted to contain the same amount of protein were then separated by 
SDS PAGE, transferred to nitrocellulose and probed with antibody to PhoA as 
described in section 2.43.1. Antigen-antibody complexes were subsequently detected 
using a horse radish peroxidase colour reaction (section 2.43.2). Sltr.TnphoA
190
homologous recombinants were inferred when increased expression of a PhoA 
containing protein in the presence of mitomycin C was observed in comparison to a 
control of the same culture grown on LB alone.
Figure 5.17 shows the Western blots obtained from single copy fusion candidates after 
growth with or without mitomycin C (gel A & gel B respectively). Purified bacterial 
PhoA (£. coli type IIIL, Sigma) was added as a control and it can be seen that CC118, a 
phoA mutant, does not produce PhoA as expected. E. coli strains E3787 and E32511 
also appear to be only very slightly PhoA positive. Low MW proteins that cross-react 
with the antibacterial PhoA antibody are evident in all tracks except 7 & 19. These are 
taken to represent proteolysis or degradation products that have arisen during sample 
preparation. It is immediately apparent that expression of phoA is under the control of 
a mitomycin C inducible promoter in E. coli E32511 slt-ll::TnphoA single copy fusion 
candidates 1 & 2. None of the other single copy fusion candidates in figure 5.17 appear 
to be mitomycin C  inducible. E. coli CC118 harbouring plasmids pSLF22 and pSC105 is 
not mitomycin C inducible as the plasmids contain only part of the cloned sit operons 
and not the phage sequences responsible for mitomycin C induction. High MW 
proteins are evident, especially in tracks 1 & 2, that comigrate with the 94 KDa protein 
marker. These might possibly represent PhoA containing holotoxin that has not 
completely dissociated under the denaturing conditions employed. Further Western 
analysis of potential E3787 slt-l::TnphoA single copy fusion candidates failed to show 
evidence of mitomycin C induction (results not shown).
Iron limitation has been shown to increase expression of VT1 but not VT2 (section 
1.4.4.3). If VT1 expression was not under the control of phage sequences in potential 
single copy derivatives, this would explain why no mitomycin C induction was observed. 
To rule out this possibility, it was decided therefore, to screen for potential slt- 
IvJYnphoA homologous recombinants under iron limiting conditions. Cultures were 
grown overnight in iron limited LB (section 2.3.2) and Western analysis of periplasmic
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Figure 5.17 Western analysis of E. coli E3787 (sltluTnphoA) and E32511 
(sltlluTnphoA) single copy fusion candidates
Strains were grown on LB with or without mitomycin C (final concentration 1 ng ml"1) 
as indicated. Periplasmic protein preparations (section 2.42), adjusted to contain 30 ng 
of protein were separated by electrophoresis through an 11% (w/v) linear SDS 
polyacrylamide gel and immunoblotted with rabbit antialkaline phophatase antibody 
(sections 2.43.1 & 2.43.2).
Key to tracks
Blot A (mitomycin C added)
1 E. coli E32511 sltlI::TnphoA single copy fusion candidate 2
2 E. coli E32511 sltll::TnphoA single copy fusion candidate 1
3 E. coli E3787 sltV/.TnphoA single copy fusion candidate 4
4 E. coli E3787 sltl::TnphoA single copy fusion candidate 3
5 E. coli E3787 sltl::TnphoA single copy fusion candidate 2
6 E. coli E3787 sltl::TnphoA single copy fusion candidate 1
7 E. coli alkaline phosphatase
8 E. coli CCUS
9 E. coli CC118 harbouring pSLF22
10 E. coli CC118 harbouring pSC105
11 E. coli E32511
12 E. coli E3787
Blot B
Tracks 13-24 correspond to tracks 1-12 respectively except that samples were from 
strains grown in LB without mitomycin C.
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proteins performed as described above. Expression of PhoA fusions were compared to 
cultures grown on LB (i.e. iron replete conditions). In figure 5.18 it can be seen that 
expression of plasmid encoded slt-l::TnphoA and slt-WvJYnphoA gene fusions increased 
under iron limitation. Calderwood & Mekalanos (1987) reported a 13-16 fold increase 
in PhoA activity for £. coli CC118 (pSC105) grown under iron limited conditions. Iron 
regulation of VT2 has not been reported however, and it is likely that plasmid copy 
number fluctuations as a result of the physiological constraint applied could have led to 
an increase in the respective gene dosages in this case. Lack of VT2 induction under 
iron limitation in potential slt-\\vJTnphaA homologous recombinants 1 & 2 supports this 
hypothesis. Of all the potential VT1 single copy derivatives tested, only three (24,25, & 
45) appeared to be induced under iron limitation (figure 5.19 & 5.20).
As a consequence of this work, VT1 single copy fusion candidates 24, 25 & 45 and VT2 
single copy fusion candidates 1 & 2 were selected for Southern analysis to confirm 
whether insertion of TnphoA into the chromosomally encoded sit-1 and slt-ll operons 
had occurred.
5.3.4 Southern blot analysis of single copy fusion candidates
Figure 5.21 shows the results obtained when 10 fig of chromosomal DNA (section 
2.12(a)), prepared from E. coli E32511 and the slt-U::TnphoA single copy fusion 
candidates 1 & 2 were digested with £coRV, electrophoresed on a 0.6% (w/v) agarose 
gel, Southern blotted and probed with freshly prepared -^PdCTP labelled VT2 probe 
(sections 2.18 & 2.19). E32511 contains two sit operons, slt-ll and s/MIc (section 3.5.2) 
and two £coRV fragments of estimated size 6.4 and 5.6 Kb hybridised with the VT2 
probe (tracks 10 & 13). In both single copy fusion candidates 1 & 2, the 6.4 Kb fragment 
increased in size to approximately 14.5 Kb, indicating that insertion of TnphoA had 
occurred (tracks 11, 12 & 14, 15). As it was unknown whether the 6.4 Kb £coRV 
fragment corresponded to 5//-II or sit-lie coding sequence, 10 fig of each chromosomal
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Strains were grown on LB with or without 0.2 mM 2,2' dipyridyl (Sigma) as indicated. 
Periplasmic protein preparations (section 2.42), adjusted to contain 15 pg  of protein 
were separated by electrophoresis through an 11% (w/v) linear SDS polyacrylamide gel 
and immunoblotted with rabbit antialkaline phophatase antibody (sections 2.43.1 & 
2.43.2).
Key to tracks
Blot A (iron limited LB)
1 E. coli alkaline phosphatase
2 E. coli E32511 sltlly.TnphoA single copy fusion candidate 2
3 E. coli E32511 sltll::TnphoA single copy fusion candidate 1
4 E. coli E3787 sltly.TnphoA single copy fusion candidate 28
5 E. coli E3787 sltly.TnphoA single copy fusion candidate 18
6 E. coli E3787 sltly.TnphoA single copy fusion candidate 16
7 E. coli E3787 sltly.TnphoA single copy fusion candidate 14
8 E. coli E3787 sltl::TnphoA single copy fusion candidate 11
9 E. coli E3787 sltly.TnphoA single copy fusion candidate 5
10 E. coli E3787 sltlyJTnphoA single copy fusion candidate 3
11 E. coli E3787 sltly.TnphoA single copy fusion candidate 2
12 E. coli CC118 harbouring pSLF22
13 E. coli CC118 harbouring pSC105
Blot B
Tracks 14-26 correspond to gel A tracks 1-13 respectively grown in iron replete LB.
Figure 5.18 Western analysis o f  single copy fusion candidates grown under iron
limited and iron replete conditions
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Figure 5.19 Ponceau S and chloronaphthol stained Western blot o f single copy fusion
candidates grown under iron replete conditions
The strains indicated were grown on LB and periplasmic protein preparations (section 
2.42), adjusted to contain 15 ¡xg of protein, separated by electrophoresis through an 11% 
(w/v) linear SDS polyacrylamide gel and immunoblotted with rabbit antialkaline 
phophatase antibody (sections 2.43.1 & 2.43.2).
Key to tracks
Blot A (Ponceau S stained)
1&15 Protein markers 
2 E. coli alkaline phosphatase
3 E. coli E3787 slth-.TnphoA single copy fusion candidate 45
4 E. coli E3787 sltï.JTnphaA single copy fusion candidate 42
5 E. coli E3787 sltl::TnphoA single copy fusion candidate 25
6 E. coli E3787 sltlv.TnphoA single copy fusion candidate 24
7 E. coli E3787 sltl::TnphoA single copy fusion candidate 13
8 E. coli E3787 sltk.TnphoA single copy fusion candidate 12
9 E. coli E3787 siti : :TnphoA single copy fusion candidate 10
10 E. coli E3787 sltl::TnphoA single copy fusion candidate 9
11 E. coli E3787 siti.\T nphoA single copy fusion candidate 8
12 E. coli E3787 sltV.ïYnphoA single copy fusion candidate 7
13 E. coli E3787 sitivinphoA single copy fusion candidate 6
14 £. coli CCI 18 harbouring pSC105
Blot B
Tracks 16-28 correspond to gel A tracks 2-14 respectively after probing with PhoA 
antibody and detection of antigen-antibody complexes using a horseradish peroxidase 
colour reaction.
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Figure 5.20 Ponceau S and chloronaphthol stained Western blot o f single copy fusion
candidates grown under iron limited conditions
The strains indicated were grown on LB containing 0.2 mM 2, 2' dipyridyl (Sigma) and 
periplasmic protein preparations (section 2.42), adjusted to contain 15 ng of protein, 
separated by electrophoresis through an 11% (w/v) linear SDS polyacrylamide gel and 
immunoblotted with rabbit antialkaline phophatase antibody (sections 2.43.1 & 2.43.2).
Key to tracks
Blot A (Ponceau S stained)
1&15 Protein markers
2 £. coli alkaline phosphatase
3 E. coli E3787 sltl::TnphoA single copy fusion candidate 45
4 E. coli E3787 sltl::TnphoA single copy fusion candidate 42
5 E. coli E3787 sltl::TnphoA single copy fusion candidate 25
6 £. coli E3787 sltl::TnphoA single copy fusion candidate 24
7 E. coli E3787 sltl::TnphoA single copy fusion candidate 13
8 £. coli E3787 sltl::TnphoA single copy fusion candidate 12
9 £. coli E3787 sltl::TnphoA single copy fusion candidate 10
10 £. coli E3787 slth.TnphoA single copy fusion candidate 9
11 £. coli E3787 sltl::TnphoA single copy fusion candidate 8
12 £. coli E3787 sltV.^nphoA single copy fusion candidate 7
13 £. coli E3787 sltl::TnphoA single copy fusion candidate 6
14 £. coli CC118 harbouring pSC105
Blot B
Tracks 16-28 correspond to gel A tracks 2-14 respectively after probing with PhoA 
antibody and detection of antigen-antibody complexes using a horseradish peroxidase 
colour reaction.
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Figure 5.21 Southern analysis of EcoRV digested E. coli E32511 s lt- \\::T n p h o A  single
copy fusion candidates 1 & 2
Chromosomal DNA was digested with EcoRV and the products size-fractionated by 
0.6% (w/v) TBE agarose gel electrophoresis at 100V. DNA was transferred to 
nitrocellulose and probed with a -^PdCTP labelled 0.85 Kb Smal-Pstl fragment from 
plasmid NTP707 that encodes the slt-llA  gene sequence.
Key to tracks
1 : Lambda DNA digested with BamHl.
2 : Lambda DNA digested with BglU.
3&6: E. coli E32511 chromosomal DNA digested with EcoRV.
4&7: Single copy fusion candidate 1 chromosomal DNA digested with EcoRV.
5&8: Single copy fusion candidate 2 chromosomal DNA digested with EcoRV.
9 : Lambda DNA restricted with Hindlll.
1 2 3 4 5 6 7 8 9 10 II 12 13 14 15
Tracks 10-15 is the autoradiograph of corresponding tracks 3-8 after washing in 1 x SSC, 
0.1% (w/v) SDS at 65°C and 2 days exposure at -70°C.
m  DNA size marker produced by lambda DNA digestion 
Bam HI - 16.8, 7.2, 6.8 , 6.5. 5.6 & 5.5 Kb.
Belli - 22. 13.3, 9.7. 2.4. 0.65, 0.42 & 0.06 Kb. 
tfindlU - 23.6, 9.46, 6.78, 4.34, 2.26, 1.98 «Sc 0.56 Kb.
Fragments have cos ends and can reassociate to form additional bands.
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DNA preparation was digested to completion with EcoRI, electrophoresed on a 1% 
(w/v) agarose gel and Southern blotted as before. The resulting autoradiograph is 
shown in figure 5.22. In figure 5.21 two EcoRI fragments, of estimated size 5.8 & 5.2 
Kb, hybridise with the VT2 probe. These correspond to the 4.9 Kb j/i-IIc and 4.3 Kb sti­
ll  operons respectively (table 3.3). In the single copy fusion candidates 1 & 2 however, 
the 5.2 Kb fcoR I fragment has decreased in size to approximately 5.0 Kb indicating that 
exchange recombination had occurred into the sti-11 operon and not the sti-Uc operon in 
E32511. The E. coli sti-llvilnphoA single copy fusion candidates 1 & 2 were designated 
E. coli E32511 (SLF22/1) and E325U (SLF22/2) respectively.
Chromosomal DNA was also prepared from E. coli E3787 and the slt-l::TnphaA fusion 
candidates 24, 25 & 45. The non-iron inducible single copy fusion candidate 42 was also 
included for comparison purposes. 10 ng of DNA sample was digested to completion 
with £coRV, electrophoresed on a 0.7% (w/v) agarose gel and the resulting Southern 
blot probed with freshly prepared •^PdCTP labelled VT1 probe (figure 5.23). In all the 
strains a 9.3 Kb fragment hybridised with the VT1 probe. This indicated that TnphoA 
insertion into the chromosomally encoded s/r-I operon, had not occurred in any of the 
single copy fusion candidates tested. Single fusion candidates 24, 25, 42 & 45 appeared 
much more PhoA active on plates containing XP. From this it was concluded that 
single copy fusion candidate 42 represented a strain in which transposition of TnphoA 
had occurred to a chromosomally encoded exported protein that was not iron inducible, 
whereas single copy fusion candidates 24, 25, 45 represent transpositions of TnphoA to 
iron inducible exported proteins.
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Figure 5.22 Southern analysis o f EcoRI digested E . co li E32511 s lt- \\v JT n p h o A  single
copy fusion candidates 1 & 2
Chromosomal DNA was digested with EcoRI and the products size-fractionated by 1% 
(w/v) TBE agarose.gel electrophoresis at 100V. D N A  was transferred to nitrocellulose 
and probed with a ~*2PdCTP labelled 0.85 Kb Smal-Pstl fragment from plasmid NTP707 
that encodes sit-IIA gene sequence.
Key to tracks
1 : Lambda DNA digested with Hindlll.
2 : E. coli E32511 chromosomal DNA digested with EcoRI.
3 : Single copy fusion candidate 1 chromosomal DNA digested with EcoRI.
4 : Single copy fusion candidate 2 chromosomal DNA digested with £coRI.
I H 1 W
Tracks 5-7 is the autoradiograph of corresponding tracks 2-4 after washing in 0.1 x SSC, 
0.1% (w/v) SDS at 65°C and 30 hours exposure at -70°C.
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Figure 5.23 Southern analysis o f EcoRV digested E. co li E3787 s lt- lu T n p h o A  single
copy fusion candidates 24 ,25,42 & 45
Chromosomal DNA was digested with EcoRV and the products size-fractionated 
0.7% (w/v) TBE agarose gel electrophoresis at 20V overnight. D N A  was transferred 
nitrocellulose and probed with a ^PdCTP labelled 0.75 Kb H in di fragment fr< 
plasmid NTP705 that encodes the s/MB gene sequence.
Key to tracks
1&7: Lambda DNA digested with Hindlll.
2 : E. coli E3787 chromosomal DNA digested with EcoRV.
3 : Single copy fusion candidate 24 chromosomal DNA digested with EcoRV.
4 : Single copy fusion candidate 25 chromosomal DNA digested with EcoRV.
5 : Single copy fusion candidate 42 chromosomal DNA digested with EcoRV.
6 : Single copy fusion candidate 45 chromosomal DNA digested with EcoRV.
Tracks 8-12 is the autoradiograph of corresponding tracks 2-6 after washing in 0.1 x 
SSC, 0.1% (w/v) SDS at 65°C and 4 days exposure at -70°C.
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The initial sections of this chapter have described the successful fusion of the phoA gene 
to the E. colislt-IIB structural gene so that expression of the former is brought under the 
control of the 5//-II regulatory regions. Following from this work, the slt-l::TnphoA and 
slt-lh’.TnphoA gene fusion vectors pSC105 and pSLF22 were introduced into wild type 
E. coli strains E3787 and E32511 respectively by electroporation The ultimate aim was 
to construct single copy fusion derivatives of pSC105 and pSLF22 via exchange- 
recombination to enable studies on the regulation of the sit-1 and sit-II operons.
Evidence (i.e. loss of plasmid marker, retention of Kn resistance, mitomycin C induction 
and disruption of the sit- II operon) strongly suggest that single copy fusion derivatives of 
pSLF22 had been constructed. These were termed SLF22/1 and SLF22/2. A single 
copy fusion derivative of pSC105 however, was not obtained in this study under low 
phosphate conditions. Although loss of plasmid marker and retention of Kn resistance 
was demonstrated after growth under phosphate limitation, mitomycin C induction and 
disruption of the slt-l operon was not apparent in any of the single copy fusion 
candidates studied. Plasmid copy number fluctuations of pSC105 however, can be 
monitored by assaying /3-lactamase activity in association with PhoA (Calderwood & 
Mekalanos, 1987). E. coli strains CC118 (pSC105) and E32511 (SLF22/1) were 
therefore selected to form the basis of the following chapter which examines the effect 
of several physical parameters on sit-1 and 5&-II production.
5.4 Summary and overview
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6. Studies on expression or the sit-1 and ¿/MI opérons
6.1 Introduction
Major differences in the regulation of the sit-1 and s/r-II operons became apparent when 
transcription of the sit-1 but not the sit-Il operon was shown to dramatically increase 
under conditions of iron starvation (De Grandis et al., 1987; section 1.4.4.3). As stated 
in section 1.10, this project was initiated to examine the physiology of VT production by 
E. coli. As a simple and sensitive means of monitoring VT2 expression, the transposon 
vector TnphoA was subsequently used to create a fusion between the B subunit of the 
cloned j/f-II operon and the gene for bacterial alkaline phophatase (chapter 5). 
Measurement of the PhoA activity of a single copy derivative of this fusion in strain 
E32511 (designated SLF22/1), and a plasmid encoded slt-l::TnphoA gene fusion 
pSC105 (provided by S. B. Calderwood, Harvard University), enables rapid and 
quantitative assay of VT2 and VT1 expression respectively. This chapter describes the 
findings of experiments in which the sltwTnphoA gene fusions were used to ascertain 
whether defined parameters affected VT1 and VT2 expression. PhoA activity was 
determined by measuring the rate of hydrolysis of p-nitrophenyl phosphate (Sigma 104), 
by permeabilised cells (section 2.44.1) and the data presented as a function of culture 
optical density at 600nm (OD600). To control for possible differences in plasmid copy 
number or a generalised increase in transcription of plasmid-encoded genes under the 
growth conditions examined, /3-lactamase activity was determined in parallel with PhoA 
activity in strain CC118 (pSC105) by measuring the hydrolysis of nitrocephin (section 
2.44.2). PhoA activities were also adjusted to account for background levels of 
endogenous activity for bacterial strains CC118 and E32511 where stated.
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To examine the expression of the sit-1 and slt-ll operons with respect to the growth 
phase of the bacterium, growth on LB was examined as described in section 2.45. The 
results are shown in table 6.1 and displayed graphically in figures 6.1 and 6.2.
Maximum toxin yields were present at 24 and 8 hours for VT1 and VT2 respectively and 
strain CC118 (pSC105) consistently produced higher levels of PhoA than E32511 
SLF22/1. It has been observed that the cytotoxic activities in cell lysates of VT1- 
producing EHEC strains are 100 to 1000 fold higher than for VT2 or VTe producing 
strains (O'Brien & Holmes, 1987). In the present study however, at least part of the 
higher expression of VT1 is due to gene dosage associated with the multicopy plasmid in 
which the slt-\:fir\phoA gene fusion is cloned. During exponential growth of CC118 
(pSC105) on LB (figure 6.1), VT1 synthesis occurred until the late exponential/early 
stationary phase (6-8 hours culture), when a sudden drop in the PhoA activity of the 
bacterial population was observed. This observation was consistently reproducible. 
The reason for the sudden drop in PhoA activity is unknown but may result from a 
decrease in the plasmid copy number as the /Mactamase activity also dropped suddenly 
at this point in growth (figure 6.4). There may also have been an increase in the 
turnover of the hybrid protein by cellular proteases at this time. As the culture entered 
stationary phase (8-10 hours culture) however, there appeared to be a sudden burst in 
VT1 synthesis, with continued synthesis for the next 14 hours. This could not be the 
result of an increase in the plasmid copy number as the /3-lactamase activity was 
observed to steadily decrease during this time. After 48 hours growth VT1 synthesis 
appeared to have slowed as the total PhoA activity had hardly changed to that observed 
at 24 hours growth. In contrast, VT2 synthesis appeared to mimic growth (figure 6.2). 
There was an initial lag in VT2 production, followed by rapid synthesis throughout the 
exponential phase until the culture reached stationary phase, whereupon the cellular
6.2 Expression o f VT1 and VT2 during growth on Luria Bertani medium
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(a ) C C118 (pSC lO S)
T a b le  6 .1  V T 1  a n d  V T 2  e x p r e ss io n  d u r in g  g row th  o f  E .  c o l i  C C 118
(p S C lO S )  a n d  E 32S 11  S L F 2 2 /1  o n  LB
Hours PhoA activity (U ) B-Lact activity (mU)
culture C ell Sup Total C ell Sup Total
2 288.2 60.3 348.5 4105 772 4877
4 436.0 58.8 590.9 8798 1339 10137
8 330.7 63.6 394.3 7086 1631 8717
12 711.3 57.7 769.0 4852 1099 5951
24 1516.3 77.4 1593.7 43 1165 1208
48 1401.6 123.2 1524.8 50 1354 1404
(b ) E32511 S L F 2 2 /1
Hours
culture C ell
PhoA activity (U ) 
Sup Total
2 17.5 1.7 19.2
4 24.7 0.38 25.1
6 81.0 0.99 82.0
8 84.0 12.9 96.9
12 57.1 32.4 89.5
24 49.7 29.9 79.6
48 46.3 33.4 79.7
The synthesis of s l tlr .T n p h o A  and s itll::T n p h o A  fusion proteins during grow th on LB was 
determ ined as described  in section 2.4S. Cell extract and  supernatant (Sup) sam ples were assayed 
fo r alkaline phosphatase (PhoA ) and B-Lactamase (B-Lact), sections 2.44.2 &. 2.44.3 respectively, 
in duplicate on two separa te  occasions. The figures rep resen t the calculated mean activity from
one experim ent, co rrec ted  fo r background PhoA activity perform ed on E . c o l i  CC118 (a) and
E32511 (b) during grow th.
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F ig u r e  6 .1  E x p r e s s io n  o f  V T 1 d u r in g  g r o w th  o n  L u r ia  B e r t a n i  m ed ium
V T l expression during  grow th was determ ined by m onitoring the synthesis of the VTl-PhoA 
hybrid protein produced  by CC118 (pSC105), as described in the legend fo r tab le 6.1.
Hours culture
Growth Total PhoA activity Call lyaata PhoA activity Sup PhoA activity
Figure 6.2 E xp ress ion  of VT2 during grow th on Luria B er ta n i medium
VT2 expression during grow th was determ ined by m onitoring the synthesis of the VT2-F 
hybrid protein produced  by E32511 SLF22/1, as described  in the legend fo r tab le  6.1.
Growth Total P:
Hours culture 
A activity Call lyaata PhoA a< Sup PhoA activity
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V T l and VT2 expression during growth was determ ined by monitoring the synthesis of the VT1- 
PhoA and V T2-PhoA  hybrid proteins produced by CC118 (pSClOS) and E32311 SLF22/1, as 
described in the legend fo r table 6.1. E xtracellular V Tl and VT2 production during growth was 
determ ined by expressing the supernatant V T l-PhoA  and VT2-PhoA activity as a percentage of 
the total V T l-P h o A  and VT2-PhoA activity using the data shown in tab les 6.1(a) and 6.1(b) 
respectively.
F ig u r e  6 .3  E x tr a c e l lu la r  V T 1 an d  V T 2  p r o d u c tio n  d u r in g  grow th  o n  L u ria
B e r t a n i  m ed ium
ee<t((MciMi i i a tn  »vsivi
Figure 6 .4  E xp ression  of B eta-lactam ase during grow th o f  CC118 (pSC 105) 
on  L u ria  Bertani m edium
B-lactamase expression  was determ ined during grow th of CC118 (pSClOS), as described in the 
legend fo r tab le 6.1 and plotted using data from  table6.1(a).
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VT2-PhoA activity suddenly decreased (8-10 hours culture). There appeared to be little 
turnover of the hybrid VT2-PhoA protein between 24 and 48 hours culture.
Translational fusions made by using TnphoA can be used to gain information about the 
subcellular locations of the gene products by assaying the PhoA activity in cell fractions. 
Comparison of the culture supernatant PhoA activity as a percentage of the total PhoA 
activity of the two cultures indicated that there were significant differences in secretion 
and localisation of VT1 and VT2 in E. coli (figure 6.3). The VTl-PhoA hybrid protein 
was primarily cell associated throughout the growth cycle with the cell lysate containing 
between 83% to 95% of the total PhoA activity. This is in agreement with the findings 
of Weinstein et al. (1988b) who showed VT1 to be predominantly cell associated, with at 
least 75% of the total toxin cell associated. As the /3-lactamase activity of the 
supernatant did not increase significantly in the stationary phase of growth (figure 6.4) it 
can be concluded that there was little cell lysis during the course of the experiment. A  
large proportion of the VT2-PhoA fusion protein on the otherhand was extracellularly 
located with at least 36% of the total PhoA activity present in the supernatant after 12 
hours growth. This data correlates well with earlier work in the project which showed 
that VT1 predominates in cell lysates whilst VT2 is readily found in culture 
supernatants (section 3.6.3). Furthermore, the sudden decrease in cellular PhoA 
activity as the culture reached stationary phase coincided with the sudden production of 
the VT2-PhoA hybrid into the supernatant. This corroborates the observations made 
on the protein profiles of E. coli 0157:H7 (ATCC 35150) in section 3.7. The 
appearance in the supernatant did not result from increased cell lysis and may have 
occurred as a result of leakage of VT2 across the outer membrane once the intracellular 
VT2 concentration reached a certain level.
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Calderwood & Mekalanos (1987) developed plasmid pSC105 to enable study, at the 
molecular level, of the mechanism by which the iron concentration of the growth 
medium regulates the production of VT1 in E. coli. They found that growth of CC118 
(pSC105) under low-iron conditions resulted in marked induction of PhoA activity 
compared with growth in the presence of iron. VT2 production on the otherhand was 
not determined by iron levels in the media (De Grandis et al., 1987; Sung et al., 1990).
Calderwood & Mekalanos (1987) examined the regulation of the slt-l operon by iron 
after overnight growth of CC118 (pSC105) at 37°C with shaking. Expression of VTI 
and VT2 have been shown to vary during the growth phase (section 6.2) and in order to 
determine whether iron regulation of VTI varied during growth, the PhoA and /S- 
lactamase activity of CC118 (pSC105) was monitored as described in section 2.46. Iron 
regulation of SLF22/1 was also determined. The results are shown in table 6.2 and 6.3 
and displayed graphically in figures 6.5 and 6.6 for VTI and VT2 respectively.
In both CC118 (pSC105) and E32511 SLF22/1, iron-limited LB was observed to 
support less growth than iron replete LB (figures 6.5 & 6.6). Under both cultural 
regimes VTl-PhoA activity was predominantly cell associated and VTI synthesis, not 
unexpectedly, was higher under low iron conditions. In contrast, VT2 synthesis did not 
differ significantly from that observed under iron replete conditions when PhoA titres 
were plotted as a function of culture absorbance. Again VT2-PhoA synthesis decreased 
as stationary phase was reached and an increase in extracellular VT2-PhoA production 
was observed. Chart et al. (1987) reported that strain E32511 produced less VT2 under 
iron restriction than iron replete organisms. In Chart's study however, culture filtrate 
titres, rather than total VT2 titres were plotted as a function of culture absorbance. In 
figure 6.7 extracellular VT2 production appeared less rapid under low iron conditions 
which may explain the observations of Chart and colleagues in 1987.
6.3 Expression o f VT1 and VT2 under iron lim itation
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(a ) Iron rep lete  LB
T a b le  6 .2  V T 1 e x p r e s s io n  d u rin g  g ro w th  o f  E .  c o l i  C C 1 1 8  (p S C 1 0 5 )  o n  iron
r e p le te  a n d  ir o n  lim ite d  LB
Hours Mean PhoA activity (U ) Mean B-Lact activity (raU)
culture Cell Sup Total Cell Sup Total
3 407.0 33.8 440.8 3605 851 4456
5 489.2 66.2 555.4 5382 1512 6894
7 430.4 78.9 509.3 6867 1668 8535
9 463.7 66.1 529.8 6122 1214 7336
24 1421.0 81.3 1502.3 86 1238 1324
(b ) Iron lim ited  LB
Hours Mean PhoA activity (U ) Mean fl-Lact activity (mU)
culture Cell Sup Total Cell Sup Total
3 592.3 72.7 665.0 3339 1015 4354
5 964.2 92.5 1056.7 4752 1179 5931
7 1674.4 145.3 1819.7 5766 1200 6966
9 2073.7 167.9 2241.6 5217 1179 6396
24 2739.1 218.7 2957.8 1707 1048 2755
(c) T he e ffec t o f iron on s i t  I exp ression
Hours U PhoA activity mU fi-Lact activity Induction
culture + Fec -Fe<i + Fea -F eD ratio
3 440.8 665.0 4456 4354 1.54
5 555.4 1056.7 6894 5931 2.21
7 509.3 1819.7 8535 6966 4.38
9 529.8 2241.6 7336 6396 4.85
24 1502.3 2957.8 1324 2755 0.95
The effect of iron on the synthesis of the s ltl: :T a p h o A  fusion p ro tein  was determined during 
growth on iron replete (a) and iron limited (b) LB as described in section 2.46. Cell extract and 
supernatant (Sup) sam ples w ere assayed fo r alkaline phosphatase (PhoA ) and B-Lactamase (B- 
Lact) in duplicate (sections 2.44.2 & 2.44.3 respectively), and the m ean activity calculated. T he 
induction ratio  on iron lim ited (-Fe) com pared to  iron replete ( + Fe) LB was adjusted for th e  B- 
Lact activity expressed under th e  two culture regim es using the equation  : a / b  x d /c  (Calderwood 
& M ekalanos, 1987).
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T a b le  6 .3  V T 2  e x p r e ss io n  d u r in g  g r o w th  o f  E .  c o l i  E 3 2 5 1 1  S L F 2 2 /1  o n  iron
r e p le te  and  iro n  l im ite d  L B
(a ) A lk a lin e  phosphatase activity
Hours Mean PhoA activity ( + Fe) Mean PhoA activity (-Fe)
culture Cell Sup Total Cell Sup Total
2 10.2 1.0 11.2 12.8 0.8 13.6
4 36.1 0.3 36.4 38.9 0.5 39.4
6 58.3 1.5 59.8 58.5 1.6 60.1
8 58.9 9.8 68.7 60.0 3.9 63.9
10 52.6 16.0 68.6 55.8 10.2 66.0
26 50.6 24.3 74.9 42.9 20.8 63.7
(b) T h e e ffec t o f iron on s i t II exp ression
Hours
culture
(U )P hoA  
+ Fé®
activity
-Fe*
Induction 
ratio (a /b )
2 11.2 13.6 1.21
4 36.4 39.4 1.08
6 59.8 60.1 1.01
8 68.7 63.9 0.93
10 68.6 66.0 0.96
26 74.9 63.7 0.85
The effect of iron on the synthesis of the s l tl lr .T a p h o A  fusion protein (b), was determ ined during 
growth on iron replete and iron limited LB (a ), as described in section 2.46. Cell extract and 
supernatant (Sup) samples were assayed fo r alkaline phosphatase (PhoA ) in duplicate (sections 
2.44.2 & 2.44.3 respectively), and the m ean activity calculated. The figures are corrected fo r the 
background PhoA activity from  assays perform ed on E32S11 during grow th under the two culture 
regimes.
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F ig u re  6.5 T he e ffe c t  o f iron on  growth and V T 1 production  by C CI 18 
(pSC 105)
V T l expression during grow th on iron limited and iron rep le te LB w as determ ined by m onitoring 
the synthesis of the V T l-PhoA  hybrid protein produced by CC118 (pSClOS), as described in the 
legend fo r table 6.2.
F igu re  6.6 T h e e ffe c t  o f iron on growth and V T 2  production  by E32511  
S L F 22/1
VT2 expression during grow th on iron limited and iron replete LB w as determ ined by m onitoring 
th e  synthesis of the VT2-PhoA hybrid protein produced by E32S11 S L F22/1 , as described in the 
legend fo r table 6.3.
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Figure 6 .7  T h e e f f e c t  o f  iron on extracellu lar V T2 p rod uction  by E32S11 
S L F 2 2 /1
VT2 expression during g row th  on iron limited and iron replete LB was determ ined by m onitoring 
the synthesis of the V T2-PhoA  hybrid protein produced by E32S11 SLF22/1, as d esc rib ed  in the 
legend fo r tab le 6.3. E x tracellu lar VT2 production during growth was determ ined by expressing 
the supernatant V T2-PhoA  activity as a percentage of the total VT2-PhoA activity using  the data 
shown in tab le 6.3(a).
eiaaii *uraa/i (*r»i n a n  i w a / i  (-*•>
Figure 6 .8  T h e e f f e c t  o f iron on VT1 and VT2 production  by C C I 18 (pSC 105) 
and E 3 2 5 1 1  SL F 22/1  resp ectively
The induction of iron lim ita tion  on VT1 and VT2 synthesis was p lotted from data show n in tables 
6.2(c) and 6.3(b) respectively.
Hour* eultur*
CCH* »«CIO* I12SM SLT22/1
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Figure 6.8 illustrates the observed induction ratios, from tables 6.2(c) and 6.3(b), under 
iron limiting conditions during growth of CC118 (pSClOS) and E32S11 SLF22/1 
respectively. It can be seen that whilst iron limitation had no effect on VT2 synthesis it 
dramatically increased VT1 synthesis. Furthermore, the ability of VT1 to be induced 
varied with growth phase, with synthesis much greater as the bacterial population 
approached stationary phase. After 24 hours growth the PhoA activity under low iron 
was double that observed under iron replete conditions. This difference however, was 
accounted for by the different /¡-lactamase activities of the two cultures at this time. 
Growth in low-iron conditions has been reported to result in a 13- to 16-fold increase in 
PhoA activity (Calderwood & Mekalanos, 1987). In another study Weinstein et al. 
(1988a) reported that VT1 synthesis was 10-fold higher under low-iron conditions than 
under high-iron conditions. The reason for the lower levels of induction observed in the 
present study is thought to reflect the varying growth media and conditions used.
In an attempt to show that induction of VT1 synthesis during growth was reproducible, 
VTl-PhoA activities were assayed after 8 hours and 24 hours culture in iron replete and 
iron limited LB in a glass universal as described in section 2.47. The results are 
summarised in table 6.4. After 24 hours a 10-fold increase in VT1 synthesis was 
observed. This was vastly different to the effect of iron limitation after 24 hours growth 
in a 500 ml Erlenmeyer flask (table 6.2(c)). The reason for these differences is 
unknown but clearly factor(s) other than iron affect the expression of VT1.
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T ab le  6 .4  VT1 expression  by E . c o l i  CC118 (p SC 105) a fter 8 and 24 hours 
growth on iron re p le te  and iron lim ited  LB in a g la ss universal
(a ) Iron re p le te  LB
Hours Mean PhoA activity (U ) Mean B-Lact activiity (mU)
culture C ell Sup Total Cell Sup Total
8 641.5 72.7 714.2 5694 r w ~ 6880
8 661.2 67.2 728.4 5816 1098 6914
8 622.6 66.6 689.2 5249 1142 6391
24 323.5 58.2 381.7 2556 835 3391
24 324.1 48.3 372.4 3286 823 4109
24 N /D N /D N /D 2074 957 3031
(b ) Iron lim ited  LB
Hours Mean PhoA activity (U ) Mean B-Lact activity (mU)
culture Cell Sup Total Cell Sup Total
3 m o — 120.7 1859.2 4061 570- 5031
8 1910.4 109.0 2019.4 3755 954 4709
8 1874.1 119.9 1994.0 4463 1035 5498
24 4466.7 158.0 4624.7 3079 817 3896
24 3639.0 131.8 3770.8 2876 560 3436
24 3609.0 128.3 3737.3 3059 552 3611
(c )  T h e e f fe c t  o f iron on s i t  I exp ression
Hours U PhoA activity . mU B-Lact activity Induction
culture + Fec -Fed + Fea -Fe» ratio
s "'71Ü.Ó 1957.5 5725 -----5075 3.65
24 377.1 4044.3 3510 3648 10.32
The effec t of iron  on the synthesis of the sltlvJT nphoA  fusion protein was determ ined afte r 8 and 
24 hours grow th on iron replete (a) and  iron limited (b) LB as described in section 2.47. Cell 
extract and supernatan t (Sup) sam ples from  triplicate cu ltures w ere assayed fo r alkaline 
phosphatase (PhoA ) and B-Lactamase (B-Lact) activity in duplicate (sections 2.44.2 & 2.44.3 
respectively), and  the mean activity calculated. The induction ra tio  (c) of the average activities of 
the trip licate cu ltures on iron limited (-Fe) com pared to iron rep le te ( + Fe) LB was adjusted for 
the B-Lact activity expressed under the two culture regimes using the equation : a / b  x d /c  
(C alderw ood & M ekalanos, 1987). N /D  = No Data.
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6.4 Expression o fV T l and VT2 under anaerobic conditions
Konowalchuk et al. (1978) reported that aeration had no effect on production of VT1 
but enhanced the production of VT not neutralised by VT1 antibody (VT2). More 
recently, Macleod & Gyles (1989) showed that aerobic cultures resulted in significantly 
higher yields of VTe than did anaerobic culture. In order therefore, to examine the 
effect of anaerobiosis on VT1 and VT2 expression, VTl-PhoA and VT2-PhoA 
production during growth was determined under aerobic and anaerobic conditions as 
described in section 2.48. The results are shown in table 6.5 and 6.6 and are displayed 
graphically in figures 6.9 and 6.10 for VT1 and VT2 respectively.
In both CC118 (pSC105) and E32511 SLF22/1, anaerobic growth resulted in a 
substantially lower cell yield than aerobic growth. Furthermore, cultures were observed 
to reach stationary phase much earlier. Anaerobiosis appeared to immediately suppress 
VT1 synthesis (figure 6.9), whereas VT2 synthesis initially appeared similar to that of 
aerobic growth until stationary phase was reached. Anaerobiosis resulted in production 
of less extracellular VT2 than under aerobic growth conditions (figure 6.11). This is in 
agreement with the hypothesis that VT2 only leaks from the cell once the intracellular 
concentration reaches a certain level as anaerobiosis resulted in a lower cellular VT2 
concentration and premature termination of VT2 synthesis.
Figure 6.12 illustrates the observed effect of growth under anaerobic conditions on VT1 
and VT2 expression. Anaerobiosis clearly has an immediate effect on VT1 synthesis 
with levels approximately one third of those seen under aerobic growth. The response 
to anaerobiosis by SLF22/1 was less immediate with VT2-PhoA activities only reaching 
half that of those under aerobic conditions as the culture reached stationary phase.
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T a b le  6 .5  V T 1  e x p r e ss io n  d u rin g  g r o w th  o f  E .  c o l i  C C 1 1 8  (p S C lO S ) u n d er
a e r o b ic  and  a n a e r o b ic  c o n d it io n s
(a ) A erob ic  con d ition s
Hours Mean PhoA activity (U ) Mean B-Lact activity (m U )
culture C ell Sup Total Cell Sup Total
3 ----------5 5 0 -------- 32.9 481.4-------- 5233--------- 682 " 4915----
4 421.9 38 .0  459.9 4739 749 5488
6 592.2 96.2 688.4 6138 2268 8406
8 829.1 107.9 937.0 7792 1822 9614
24 1066.4 93.3 1159.7 2331 1005 3336
(b ) A naerob ic con d ition s
Hours Mean PhoA activity (U ) Mean B-Lact activity (mU)
culture C ell Sup Total C ell Sup Total
3— ------ 1 3 0 ---- — r e i r T3TT3--------- ÏÏ75----- 1177 5653
4 141.2 13.3 154.5 5151 1164 6315
6 142.7 19.9 162.6 4794 1814 6608
8 162.9 19.0 181.9 5191 1374 6565
24 147.9 26.6 174.5 1625 1134 2759
(c) The e ffe c t  of an aerob iosis  on s i t  I exp ression
Hours
culture
U PhoA activity 
+ 0 2c - 0 2 d
mU B-Lact activity
+ o 2 a  - o 2b
Induction
ratio
3------------ I3ÏTC 5913 5653 0.2T
4 459.9 154.5 5488 6315 0.29
6 688.4 162.6 8406 6608 0.30
8 937.0 181.9 9614 6565 0.28
24 1159.7 174.5 3336 2759 0.18
The effect of anaerobiosis on th e  synthesis of the s lt\: :T n p h o A  fusion protein was determ ined 
during growth on LB under ae rob ic  (a) and anaerobic (b ) conditions as described in section 2.48. 
Cell extract and supernatant (Sup) samples w ere assayed fo r alkaline phosphatase (PhoA ) and B- 
Lactamase (B-Lact) in duplicate (sections 2.44.2 & 2.44.3 respectively), and the mean activity 
calculated. The induction ratio  under anaerobiosis (-O 2 ) com pared to aerobic ( + O2 ) conditions 
was adjusted fo r the B-Lact activity expressed u nder the two culture regim es using the equation : 
a/b x d /c  (Calderwood & M ekalanos, 1987).
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T a b le  6 .6  V T 2  e x p r e s s io n  d u rin g  g r o w th  o f  E .  c o l i  E 3 2 5 1 1  S L F 2 2 /1  u n d er
a e r o b ic  a n d  a n a e r o b ic  c o n d it io n s
(a ) A lk a lin e  p h osp h atase  activity
Hours Mean PhoA activity ( + O?) Mean PhoA activity (-O 2 )
culture Cell Sup Total C ell Sup T ota i
2 8.8 2.7 11.5 9.3 2.5 11.8
4 23.9 0.6 24.5 34.2 0.8 35.0
6 59.7 0.9 60.6 34.9 1.1 36.0
8 84.0 6.7 90.7 38.6 1.4 40.0
24 50.8 32.5 83.3 42.3 7.0 49.3
(b ) T he e f fe c t  o f  an aerob iosis  on s l t l l  exp ression
Hours (U ) PhoA activity Induction
culture + C>2b - o 2» ratio (a /b )
2 11.5 11.8 1.03
4 24.5 35.0 1.43
6 60.6 36.0 0.59
8 90.7 40.0 0.44
24 83.3 49.3 0.59
The effect of anaerobiosis on the synthesis of the s ltllr .T n p h o A  fusion protein (b), was 
determ ined during grow th on LB under aerobic and anaerobic conditions (a ), as described in 
section 2.48. Cell ex tract and supernatant (Sup) sam ples w ere assayed fo r alkaline phosphatase 
(PhoA) in duplicate (sections 2.44.2 & 2.44.3 respectively), and the mean activity calculated. The 
figures are correc ted  fo r th e  background PhoA activity from  assays perform ed on E32511 during 
growth under the two cu ltu re  regimes.
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Figure 6.9 T he e ffec t o f an a ero b io sis  on growth and VT1 production  by 
C C 118 (pSC 105)
V T l expression during growth under aerobic and anaerobic conditions was determ ined by 
m onitoring the synthesis of the V T l-PhoA  hybrid protein produced by C C I 18 (pSC105), as 
described in the legend fo r table 6.S.
Figure 6.10  The e ffec t o f a n aerob iosis  on growth and VT2 p roduction  by 
E 32511 S L F22/1
VT2 expression during growth under aerobic and anaerobic conditions was determ ined by 
m onitoring the synthesis of the V T2-PhoA hybrid protein produced by E32511 SLF22/1, as 
described in the legend fo r table 6.6.
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Figure 6 .11  T h e e ffec t o f an aerob iosis on ex tracellu lar  V T2 production  by 
E 3 2 5 1 1 S L F 2 2 /1
VT2 expression during growth under aerobic and anaerobic conditions was determ ined by 
m onitoring th e  synthesis of the VT2-PhoA hybrid protein produced by E32S11 SLF22/1, as 
described in th e  legend fo r table 6.6. Extracellular VT2 production during  growth was determ ined 
by expressing the supernatant V T2-PhoA activity as a percentage of the total VT2-PboA activity 
using the data  shown iin table 6.6(a).
Figure 6 .1 2  T h e e ffec t o f an aerob iosis  on VT1 and V T 2 production  by C C I 18 
(p SC 105) and E 32511 S L F 22/1  re sp ectively
The induction of anaerobiosis on VT1 and VT2 synthesis was p lo tted  from  data shown in tables 
6.5(c) and 6.6 (b ) respectively.
■ 12111 f I f 31/1 CC1 I t  pSCIOft
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6.5 Summary and overview
Major differences in the synthesis of VT1 and VT2 during growth have been 
demonstrated using the slt-I::TnphoA and slt-ll::TnphoA gene fusion bearing strains 
CC118 (pSC105) and E32511 SLF22/1 respectively.
VT1 synthesis was observed to dramatically increase as the bacterium entered the 
stationary phase of growth with maximum toxin yields present after 24 hours culture. 
VT2 synthesis on the other hand appeared to closely parallel growth with maximum 
toxin yields present after 8 hours culture.
VT1 was shown to be primarily cell associated throughout the growth cycle whereas 
VT2 was more evenly distributed between the bacterial cell and the extracellular 
medium. Furthermore, VT2 was suddenly produced into the culture supernatant from 
the bacterial cell as the stationary phase was reached. This was not the result of cell 
lysis and it is hypothesised that VT2 leaked across the outer membrane when a certain 
intracellular VT2 concentration was reached.
As expected iron limitation was shown to increase VT1 but not VT2 expression. 
Induction of VT1 under low-iron conditions has previously been shown to result in a 
marked induction of VT1 synthesis (Calderwood & Mekalanos, 1987), however, in the 
present study it has been shown for the first time that the ability of VT1 to be induced 
varied with the growth phase of the bacterium. Induction of VT1 synthesis was much 
higher as the stationary phase of growth was approached.
Anaerobiosis was shown to immediately suppress VT1 synthesis whereas VT2 synthesis 
occurred initially as under aerobic conditions. A premature entry into stationary phase 
under anaerobic conditions was reflected in final VT2 yields half those of aerobic 
growth.
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It is possible that these characteristics could have important implications on the relative 
abilities o f VT1 and VT2 carrying organisms to cause disease in vivo.
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7. Concluding remarks
Pathogens of many different types have evolved the ability to genetically vary the 
expression of virulence properties in order to balance the pathogenic cycle and to 
optimise the survival o f the microbe within the individual host (Dirita & Mekalanos, 
1989; Mekalanos, 1992). One of the better postulated means of control is through 
environmental cues that signal the entry of the microbe into the host tissue(s). 
Pathogenic bacteria sense these signals and respond accordingly by expressing gene 
products necessary for survival in the host. Physical parameters such as low iron 
concentration, elevated temperature, osmolarity, pH, oxygen, CO2, or the presence or 
absence of specific ions besides iron could play such a role. Alternatively, because 
many of these latter parameters vary widely within different host tissues, the pathogen 
may use these as signals to actively change its properties, allowing it to take full 
advantage of new environmental regimes.
Historically, VTs have been intensively studied with respect to their epidemiological, 
clinical, genomic and pathogenic significance. Little information however, has been 
published on the regulation of toxin gene expression. While the in vivo environment 
(i.e. that of host tissues) is clearly the most relevant, use of laboratory (in vitro) models 
can offer pertinent insights into the mechanisms of signal transduction in pathogenesis. 
The purpose of this project therefore, was to study the effect of various nutritional and 
physical parameters on VT1 and VT2 synthesis in laboratory culture. This involved the 
development of an appropriate assay system to enable specific quantification of VT1 
and VT2 expression at the molecular level.
Early work described in this thesis showed that VT1 and VT2 displayed differences in 
activity and localisation. VT2 produced by strain E32511 did not require reduction with 
/3-mercaptoethanol to be catalytically active, whereas VT1 produced by strain E3787 
required prolonged exposure to this reducing agent before displaying N-glycosidase
2 2 2
activity in the ricin assay (section 3.6.1). Only E32511 and not E3787 was found to 
produce active toxin in PBS treated cell extracts in the ricin assay (section 3.6.3). 
Furthermore, SDS-PAGE of proteins prepared from E. coli 0157:H7 during growth 
(section 3.7) revealed that as the late exponential/early stationary phase of growth was 
reached there was a sudden production of toxin (VT2) into the supernatant.
A single copy sltWv^TwphoA gene fusion in the wild type VT2-producing strain E32511 
was subsequently developed (chapter 5). Use of the latter assay system in association 
with the stik'JTxyhoA gene fusion on the recombinant plasmid pSC105 (Calderwood & 
Mekalanos, 1987), enabled specific quantification of VT1 and VT2 expression during 
growth under aerobic, anaerobic and iron limiting conditions (chapter 6).
VT1 was shown to be primarily cell associated throughout growth and there was a 
sudden increase in intracellular VT1 synthesis as stationary phase was reached, with 
maximum toxin yields present after 24 hours culture. VT2 was more evenly distributed 
between the cell and the culture supernatant and synthesis was closely associated with 
growth. As described above, production o f VT2 into the culture supernatant from the 
bacterial cell occurred abruptly as stationary phase was reached. Unlike VT1, however, 
VT2 synthesis appeared to cease as the culture entered stationary phase and maximum 
toxin yields were observed after 8 hours culture.
Iron limitation was shown to increase VT1, but not VT2 expression. Induction of VT1 
under low iron conditions has previously been shown (De Grandis et al., 1987; 
Calderwood & Mekalanos, 1987) however, in the present study it was shown that the 
ability of VT1 to be induced under iron limitation varied with the growth phase of the 
bacterium with induction much more pronounced as the culture approached stationary 
phase. Anaerobiosis repressed VT1 synthesis immediately to approximately one third 
of the levels observed during aerobic growth, whereas VT2 synthesis appeared
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unaffected, with lower toxin levels under anaerobic conditions thought to reflect 
premature entry of the culture into the stationary phase.
These findings suggest significant differences in the synthesis, secretion and localisation 
abilities of the two different toxins and may have important implications on the relative 
abilities of VT1 and VT2 producing organisms to cause disease in vivo.
Lower levels of VT2 compared to VT1 were consistently produced. VT2 however, was 
more readily produced into the extracellular medium. The sudden production of VT2 
into the supernatant was thought to be the result of leakage across the outer membrane 
once the intracellular VT2 level reached a certain point as there was no cell lysis at this 
point in the growth cycle. This, coupled with a readily available N-glycosidase activity, 
may result in VT2 being the more potent toxin in vivo and involved in the early 
pathogenesis of VTEC infection. VT2 could conceivably lead to a sudden onset of 
more severe symptoms than VT1 and this may be reflected in the findings of a number 
of groups that strains producing VT2 alone, or together with VT1, are most frequently 
associated with HUS (section 1.7.4.2). VT2 production appeared to closely parallel 
growth and iron limitation or anaerobiosis appeared to have no significant effect on 
VT2 synthesis. It may be that an underlying regulatory system for VT2 still exists which 
has not been determined as yet.
VT1 was produced at much higher levels than VT2 and synthesis increased as the 
culture entered stationary phase. Toxin was however, predominately cell associated and 
it is likely that only upon cell lysis did significant levels of VT1 enter the culture 
supernatant. An extended investigation of VT1 synthesis during growth is required to 
confirm this. It is customary to test culture filtrates from bacteria for cytotoxicity on cell 
monolayers (Chart et al., 1987). Due to the obvious differences in the extracellular 
production abilities of VT1 and VT2 shown in the present study however, it is 
recommended that periplasmic fractions also be tested for cytotoxicity in order to give a
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true indication of the levels of VT production. The observed variation in induction of 
VT1 during growth under low iron conditons might be important in vivo where levels of 
free iron are kept low by the action of transferrin and lactoferrin. Should the cell 
population depart from exponential growth under such conditions, an increase in 
synthesis of VT1 could result in increased survival and growth of the pathogenic 
organism. The mechanism whereby anaerobiosis repressed VT1 synthesis is unknown 
and the molecular basis for these observations requires exploration.
These investigations have reached an interesting point. Due to the time constraints 
imposed, further investigation of the regulation of VT1 and VT2 expression was not 
possible. Future studies on the influence of appropriate physical and nutritional 
parameters on toxin synthesis should provide practical benefits as it will be possible to 
use knowledge of the genetic control apparatus and its phenotypic consequences to 
design vaccines and new antibiotics. In addition, determination o f the culture 
conditions that affect the yield of VT1 and VT2 should identify optimal conditions that 
might be applied to improve purification schemes for these toxins.
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